PAT_ID,PAT_SEX,PAT_DOB,IndexAdmissionCSN,IndexAdmitDt,IndexDischDt,Deceased,H2H,SystolicHF,DiastolicHF,HeartTx,CAD,DM,CKD,COPD,EchoCount,EchoLowDate,EchoLowValue,EchoHighDate,EchoHighValue,EchoCountSevere,EchoCountLow,EchoCountLowNormal,EchoCountNormal,ADM1_PAT_ENC_CSN_ID,ADM1_AdmitDt,ADM1_DischDt,ADM1_LOS,ADM1_ICUDays,ADM1_DischargeUnit,ADM1_DischargeDx,ADM1_Labs_BUN,ADM1_Labs_Cr,ADM1_Labs_NA,ADM1_Labs_Lymphocytes,ADM1_EKG_QRSD,ADM1_BMI,ADM1_SysBP,ADM1_Charlson,ADM1_DischargeEF,ADM1_Antihypertensive__ACE Inhibitors,ADM1_Antihypertensive__Angiotensin II Receptor Antagonists,ADM1_Antihypertensive__Selective Aldosterone Receptor Antagonists (SARAs),ADM1_Beta Blockers__Beta Blocker Combinations,ADM1_Beta Blockers__Beta Blockers Cardio-Selective,ADM1_Beta Blockers__Beta Blockers Non-Selective,ADM1_Diuretics__Potassium Sparing Diuretics,ADM2_PAT_ENC_CSN_ID,ADM2_AdmitDt,ADM2_DischDt,ADM2_LOS,ADM2_ICUDays,ADM2_DischargeUnit,ADM2_DischargeDx,ADM2_Labs_BUN,ADM2_Labs_Cr,ADM2_Labs_NA,ADM2_Labs_Lymphocytes,ADM2_EKG_QRSD,ADM2_BMI,ADM2_SysBP,ADM2_Charlson,ADM2_DischargeEF,ADM2_Antihypertensive__ACE Inhibitors,ADM2_Antihypertensive__Angiotensin II Receptor Antagonists,ADM2_Antihypertensive__Selective Aldosterone Receptor Antagonists (SARAs),ADM2_Beta Blockers__Beta Blocker Combinations,ADM2_Beta Blockers__Beta Blockers Cardio-Selective,ADM2_Beta Blockers__Beta Blockers Non-Selective,ADM2_Diuretics__Potassium Sparing Diuretics,ADM3_PAT_ENC_CSN_ID,ADM3_AdmitDt,ADM3_DischDt,ADM3_LOS,ADM3_ICUDays,ADM3_DischargeUnit,ADM3_DischargeDx,ADM3_Labs_BUN,ADM3_Labs_Cr,ADM3_Labs_NA,ADM3_Labs_Lymphocytes,ADM3_EKG_QRSD,ADM3_BMI,ADM3_SysBP,ADM3_Charlson,ADM3_DischargeEF,ADM3_Antihypertensive__ACE Inhibitors,ADM3_Antihypertensive__Angiotensin II Receptor Antagonists,ADM3_Antihypertensive__Selective Aldosterone Receptor Antagonists (SARAs),ADM3_Beta Blockers__Beta Blocker Combinations,ADM3_Beta Blockers__Beta Blockers Cardio-Selective,ADM3_Beta Blockers__Beta Blockers Non-Selective,ADM3_Diuretics__Potassium Sparing Diuretics,CATH_DATE,RA_MEAN,PA_SYS,PA_DIA,PA_MEAN,PCW_MEAN,FICK_HR,FICKCO,FICKCI,TDCO,TDCI,PA_SAT,DeathDate
Z392970,Female,10/6/52,70827485,2/13/17,5/8/17,1,,1,,1,,,,,25,12/9/15,<15%,2/28/17,>70%,4,,,21,70827485,2/13/17,5/8/17,84,82.97,UVHE 4 NORTH,Status post orthotopic heart transplant,31,0.6,135,0.65,92,26,45/22,,60 - 65%,,,,,,,,69379999,12/6/16,12/22/16,16,2.1,UVHE 4 EAST,"Anemia, unspecified",13,1,141,,186,25.9,106/60,,<15%,,,,,,,,68634569,10/31/16,11/6/16,6,1.02,UVHE 4 EAST,S/P MVR (mitral valve replacement),14,1.2,141,,,,79/0,,,,,,,,,1,4/20/17,10,32,17,23,13,99,4.13,2.58,3.23,2.02,61.7,5/8/17
Z96296,Female,10/2/48,2.00E+11,4/1/19,4/10/19,1,,,1,,,1,1,,6,3/11/19,55 - 60%,10/23/19,>70%,,,,6,2.00E+11,4/1/19,4/10/19,9,3.77,UVHE 4 EAST,Cardiogenic shock,34,1.3,132,,127,27.6,107/52,,65 - 70%,1,,,,,,,2.00E+11,3/10/19,3/18/19,8,2.36,UVHE 3 WEST,Acute respiratory failure with hypoxia and hypercapnia,17,0.9,129,3.64,122,,146/56,,55 - 60%,1,,,,,,,66791309,8/3/16,8/10/16,7,3.82,UVHE 3 EAST,Acute respiratory failure with hypoxia and hypercapnia,12,0.8,136,0.82,124,,131/63,,60 - 65%,1,,,,,,,10/30/19,4,31,11,18,7,70,2.32,1.44,3.5,2.17,58.4,12/24/19
Z928524,Male,3/18/67,2.00E+11,11/11/18,11/30/18,1,1,1,,,1,1,1,,6,5/9/16,<15%,11/20/18,25 - 30%,5,1,,,2.00E+11,11/11/18,11/30/18,19,7.52,UVHE 4 EAST,Acute on chronic systolic heart failure,64,2.3,137,1.56,131,35.4,117/61,,25 - 30%,,,,,1,,1,65024750,5/6/16,5/11/16,5,,UVHE 4 CENTRAL CV,Chronic systolic (congestive) heart failure,46,2.4,134,,,,125/79,,<15%,1,,,,1,,1,,,,,,,,,,,,,,,,,,,,,,,,11/13/18,21,62,32,42, 24; 22,66,2.38,1.01,2.03,0.87,37.1,5/24/20
Z254061,Male,1/16/62,2.00E+11,11/5/20,11/15/20,1,,1,,,1,1,,,9,4/30/16,20 - 25%,7/3/14,55 - 60%,2,5,1,1,2.00E+11,11/5/20,11/15/20,10,10,UVHE 4 SOUTH CVICU,Cardiogenic shock,20,1.9,137,0.62,103,41.8,99/52,,35 - 40%,,,,,,,,2.00E+11,10/9/19,10/19/19,10,3.77,UVHE 5 CENTRAL,Gastrointestinal hemorrhage with melena,16,1.6,139,2.82,74,,138/88,,,1,,,,1,,,2.00E+11,4/11/18,4/12/18,1,,UVHE 4 WEST,Atrial fibrillation with rapid ventricular response,17,1.4,139,,104,,133/81,,,1,,,,1,,,,,,,,,,,,,,,11/15/20
Z177553,Female,7/12/30,2.00E+11,2/21/20,2/28/20,1,,,,,1,,1,,6,2/22/20,45 - 50%,3/25/14,55 - 60%,,,1,5,2.00E+11,2/21/20,2/28/20,7,3.62,UVHE CORONARY CARE,Cardiogenic shock,73,4.3,131,1.04,116,22.4,100/69,,45 - 50%,,,,,,,,2.00E+11,12/30/18,1/2/19,3,,UVHE 4 CENTRAL CV,Atrial tachycardia,30,1.3,137,,112,,111/70,,,1,,,,1,,,2.00E+11,9/16/18,9/19/18,3,,UVHE 4 WEST,Pleuritic chest pain,35,1.4,136,1.63,114,23,122/68,,,1,,,,1,,,,,,,,,,,,,,,2/28/20
Z205741,Male,10/30/77,2.00E+11,1/19/18,1/23/18,1,,1,,,,1,1,,9,11/15/13,<15%,10/9/17,20 - 25%,9,,,,2.00E+11,1/19/18,1/23/18,4,4.53,UVHE CORONARY CARE,Cardiogenic shock,76,4.6,123,0.59,111,31.7,121/70,,<15%,,,,,,,,2.00E+11,12/27/17,1/3/18,7,4.79,UVHE 4 EAST,Acute on chronic systolic congestive heart failure,54,3.1,128,0.8,127,31.5,106/70,,,,,,,1,,,2.00E+11,12/6/17,12/13/17,7,,UVHE 4 EAST,Acute on chronic systolic congestive heart failure,35,3.3,129,0.64,119,,118/83,,,,,,,1,,1,12/29/17,30,66,41,49,35,92,3.05,1.54,4.17,2.11,23.9,1/23/18
Z141617,Male,7/6/58,2.00E+11,10/26/19,12/9/19,,1,1,,,,1,1,,12,4/13/18,<15%,12/18/14,15 - 20%,12,,,,2.00E+11,10/26/19,12/9/19,44,12.16,UVHE 4 EAST,"Combined systolic and diastolic congestive heart failure, unspecified HF chronicity",12,1.5,135,1.42,219,37,80/64,,15 - 20%,,,1,,1,,1,2.00E+11,10/21/19,10/25/19,4,,UVHE 4 EAST,Acute on chronic systolic heart failure,28,1.7,140,,211,36.6,122/73,,,,,,,1,,1,2.00E+11,8/5/19,8/7/19,2,,UVHE 4 EAST,Wide-complex tachycardia,46,2,134,,192,36.7,102/65,,15 - 20%,,,,,1,,1,10/31/19,11, 55; 48, 28; 27, 42; 35, 27; 25,105,3.64,1.56,5.43,2.33,56,
Z1152224,Female,1/8/46,2.00E+11,3/7/18,5/1/18,,,1,,,,1,,,16,3/7/18,<15%,3/16/18,15 - 20%,16,,,,2.00E+11,3/7/18,5/1/18,55,33.39,UVHE 4 EAST,Acute on chronic systolic heart failure,8,0.7,132,,103,23.7,78/0,,15 - 20%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3/12/18,25,58,36,47, 36; 37,96,2.19,1.32,2.33,1.41,49.2,
Z1152638,Female,6/1/59,72089195,4/10/17,4/29/17,1,,,,,,,1,,4,4/14/17,35 - 40%,4/13/17,45 - 50%,,1,3,,72089195,4/10/17,4/29/17,19,15.59,UVHE 3 EAST,"CKD (chronic kidney disease) stage 3, GFR 30-59 ml/min",20,2.1,139,1.5,78,24.1,89/67,,45 - 50%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4/29/17
Z680479,Male,12/14/80,2.00E+11,1/26/18,1/27/18,1,,,,,,,,,1,1/27/18,20 - 25%,1/27/18,20 - 25%,1,,,,2.00E+11,1/26/18,1/27/18,1,0.67,UVHE 4 NORTH,,14,0.9,142,1.44,85,30.8,65/48,,20 - 25%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1/27/18
Z347991,Female,2/12/39,2.00E+11,12/2/17,12/5/17,1,,,,,1,,,,1,12/3/17,30 - 35%,12/3/17,30 - 35%,,1,,,2.00E+11,12/2/17,12/5/17,3,2.9,UVHE CORONARY CARE,"ST elevation myocardial infarction (STEMI), unspecified artery",52,3.8,134,0.47,129,,82/40,,30 - 35%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12/5/17
Z598002,Male,11/4/88,2.00E+11,5/22/20,6/2/20,1,,,,,,,,,7,5/23/20,<15%,5/28/20,20 - 25%,7,,,,2.00E+11,5/22/20,6/2/20,11,11.21,UVHE 4 NORTH,Atrial fibrillation with RVR,24,2.1,136,0.17,161,36.2,73/52,,15 - 20%,,,,,,,,14432529,7/8/97,7/12/97,4,,UVHE 7 WEST,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6/2/20
Z352714,Female,4/11/78,2.00E+11,1/28/19,2/7/19,1,,1,,,,1,,,10,1/31/19,15 - 20%,10/23/18,60 - 65%,4,,2,4,2.00E+11,1/28/19,2/7/19,10,9.89,UVHE 4 NORTH,Cardiogenic shock,33,1.7,134,5.73,104,,96/61,,20 - 25%,,,,,,,,2.00E+11,12/5/18,12/8/18,3,0.62,UVHE 4 EAST,NSTEMI (non-ST elevated myocardial infarction),12,0.6,137,3.39,95,31.8,114/55,,40 - 45%,,1,,,1,,,2.00E+11,4/5/18,4/6/18,1,,UVHE 4 EAST,NSTEMI (non-ST elevated myocardial infarction),17,0.7,137,,96,33,122/62,,,,1,,,1,,,,,,,,,,,,,,,2/7/19
Z139969,Male,2/2/49,2.00E+11,8/13/19,8/23/19,1,1,1,,,,,1,,13,6/28/18,20 - 25%,3/20/14,60 - 65%,1,6,3,3,2.00E+11,8/13/19,8/23/19,10,,UVHE 4 CENTRAL CV,Rapid atrial fibrillation,66,3.4,142,,110,,128/64,,40 - 45%,,,,,1,,,2.00E+11,3/31/19,4/7/19,7,,UVHE 8 WEST,"Altered mental status, unspecified altered mental status type",47,2.4,142,0.51,120,,146/70,,,,,,,1,,,2.00E+11,3/14/19,3/20/19,6,,UVHE 8 NORTH ONC,Neck pain,68,2.7,140,0.31,103,,117/64,,,,,,,1,,,,,,,,,,,,,,,9/21/20
Z130389,Male,5/2/31,2.00E+11,3/10/19,3/13/19,,,,,,,1,,1,4,1/4/21,35 - 40%,11/3/15,55 - 60%,,1,,3,2.00E+11,3/10/19,3/13/19,3,3.05,UVHE CORONARY CARE,Cardiogenic shock,24,1.2,139,0.56,170,22.9,99/65,,,,,,,1,,,3153179,3/5/05,3/9/05,4,,UVHE 4 WEST,,12,0.9,135,1.07,,,,,,,,,,,,,1917057,2/24/05,3/4/05,8,,UVHE 4 WEST,,19,1,139,,,,,,,,,,,,,,,,,,,,,,,,,,
Z934960,Male,6/2/58,72855885,5/16/17,6/2/17,1,1,,1,,1,,1,,8,12/9/15,50-55%,2/7/17,65 - 70%,,,,8,72855885,5/16/17,6/2/17,17,8.22,UVHE 4 EAST,Atrial flutter with rapid ventricular response,60,2.9,136,0.77,84,33.8,92/54,,60 - 65%,,,,,1,,,72512937,4/30/17,5/10/17,10,,UVHE 4 EAST,Diabetic foot infection,47,2.3,137,,88,37.9,129/76,,,,,,,1,,,72343399,4/21/17,4/26/17,5,,UVHE 4 EAST,Paroxysmal atrial fibrillation,74,3.8,133,1.5,80,,118/76,,,,,,,1,,,,,,,,,,,,,,,3/2/20
Z832937,Female,1/16/64,2.00E+11,1/21/19,1/26/19,1,,,,,,,,,3,1/22/19,<15%,1/21/19,15 - 20%,3,,,,2.00E+11,1/21/19,1/26/19,5,5.03,UVHE 4 NORTH,Cardiogenic shock,23,1.8,133,1.76,148,,66/56,,<15%,,,,,,,,15365919,6/28/95,7/2/95,4,,UVHE 5 WEST,,,,,,,,,,,,,,,,,,15337677,4/26/95,4/29/95,3,,UVHE 3 EAST,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1/26/19
Z888333,Male,2/27/73,2.00E+11,2/28/20,4/8/20,,,1,,,,1,,1,2,3/1/20,25 - 30%,8/12/20,>70%,,1,,1,2.00E+11,2/28/20,4/8/20,40,31.03,UVHE 6 WEST,"Fever, unspecified fever cause",24,0.9,134,2.72,97,43.3,123/78,,25 - 30%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z267969,Male,3/30/44,2.00E+11,5/7/18,5/9/18,1,,1,,,1,1,,,,,,,,,,,,2.00E+11,5/7/18,5/9/18,2,2.06,UVHE CORONARY CARE,Cardiogenic shock,116,3.8,137,0.34,126,,83/61,,,,,,,,,,48401543,11/17/13,11/22/13,5,,UVHE 4 CENTRAL CV,Pacemaker complications,38,1.8,138,1.88,102,30.5,110/61,,,,1,,,1,,,47400840,9/23/13,9/24/13,1,,UVHE 4 CENTRAL CV,Chest pain,37,2.2,137,,84,32,116/67,,,,1,,,1,,,,,,,,,,,,,,,5/9/18
Z522948,Female,2/23/45,72702949,5/9/17,5/18/17,1,,,1,,,,,,3,2/17/17,65 - 70%,2/17/17,65 - 70%,,,,6,72702949,5/9/17,5/18/17,9,17.9,UVHE MEDICAL ICU,Acute on chronic diastolic heart failure,115,2.6,140,0.24,97,,118/51,,65 - 70%,,,,,,,,70937094,2/17/17,3/7/17,18,21.52,UVHE 4 EAST,Pulmonary hypertension,59,1.6,140,0.56,88,41.4,101/55,,65 - 70%,1,,,,1,,,70937094,2/17/17,3/7/17,18,21.52,UVHE 4 EAST,Pulmonary hypertension,59,1.6,140,0.56,88,41.4,101/55,,65 - 70%,1,,,,1,,1,3/2/17,,97,37,62,21,87,4.18,2.28,4.07,2.21,59.4,5/18/17
Z95784,Female,9/2/33,70136715,1/15/17,2/10/17,1,,,1,,,,,,4,1/16/17,35 - 40%,12/2/14,60 - 65%,,1,,3,70136715,1/15/17,2/10/17,26,24.32,UVHE CORONARY CARE,Acute renal failure with tubular necrosis,32,1.4,136,1.07,98,34.7,103/44,,50-55%,,,,,,,,62601180,1/10/16,1/14/16,4,,UVHE 3 CENTRAL,"Acute on chronic congestive heart failure, unspecified congestive heart failure type",58,1,139,,80,33.3,121/60,,55 - 60%,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2/10/17
Z175536,Male,6/19/61,2.00E+11,1/24/18,1/28/18,1,1,1,,,1,,1,,8,1/26/18,<15%,1/8/15,20 - 25%,16,,,,2.00E+11,1/24/18,1/28/18,4,7.44,UVHE CORONARY CARE,Delirium,54,2.3,135,0.7,162,27.3,130/59,,<15%,,,,,,,,2.00E+11,1/16/18,1/22/18,6,,UVHE 4 WEST,Acute on chronic systolic heart failure,36,2,131,,180,,96/60,,,1,,,,,,,2.00E+11,1/7/18,1/10/18,3,3.14,UVHE 4 WEST,"Laceration of spleen, initial encounter",29,1.9,128,1.12,196,,130/85,,,1,,,,,,,,,,,,,,,,,,,1/28/18
Z662963,Male,12/11/31,2.00E+11,9/8/19,9/10/19,1,,,,,,1,,,2,9/9/19,20 - 25%,3/1/19,40 - 45%,1,,1,,2.00E+11,9/8/19,9/10/19,2,2.29,UVHE CORONARY CARE,,38,1.9,144,0.42,94,23,84/35,,20 - 25%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9/10/19
Z297565,Male,1/15/42,2.00E+11,2/18/20,2/26/20,1,1,1,,,1,,1,,17,10/28/19,15 - 20%,11/7/13,55 - 60%,4,5,5,3,2.00E+11,2/18/20,2/26/20,8,3.05,UVHE 4 EAST,Other ascites,50,1.7,139,,151,23.1,95/52,,15 - 20%,,,,,1,,,2.00E+11,11/4/19,11/9/19,5,,UVHE 4 WEST,Acute systolic congestive heart failure,65,2.1,139,,155,25,105/74,,25 - 30%,,,,,1,,,2.00E+11,9/24/19,9/26/19,2,,UVHE 4 WEST,Atypical atrial flutter,36,1.4,131,,150,26.1,109/62,,20 - 25%,1,,,,,,,,,,,,,,,,,,,11/12/20
Z368984,Female,8/24/61,2.00E+11,11/28/17,12/18/17,,1,,,,1,,,,6,11/28/17,20 - 25%,12/3/17,40 - 45%,1,4,1,,2.00E+11,11/28/17,12/18/17,20,13.92,UVHE 4 WEST,VSD (ventricular septal defect),11,1.3,131,2.79,81,,93/64,,35 - 40%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z86557,Male,2/17/61,2.00E+11,10/3/18,10/12/18,,,1,,1,,1,1,,20,7/27/17,<15%,12/12/13,60 - 65%,6,24,2,8,2.00E+11,6/2/20,6/24/20,22,,UVHE 4 EAST,"Uncontrolled type 2 diabetes mellitus with complication, with long-term current use of insulin",96,2.9,142,,133,46.7,116/62,,25 - 30%,,,,,1,,1,2.00E+11,10/3/18,10/12/18,9,,UVHE 4 EAST,Heart replaced by transplant,124,2.9,141,,152,41.6,115/67,,30 - 35%,,,,,1,,1,2.00E+11,10/3/18,10/12/18,9,,UVHE 4 EAST,Heart replaced by transplant,124,2.9,141,,152,41.6,115/67,,30 - 35%,,,,,1,,1,5/29/18,32,58,35,44,37,82,,,4.93,1.82,62.5,
Z2070836,Male,12/30/35,2.00E+11,7/4/20,7/19/20,,,,,,,,,,3,7/10/20,20 - 25%,7/6/20,35 - 40%,1,2,,,2.00E+11,7/4/20,7/19/20,15,3,UVHE 4 WEST,NSTEMI (non-ST elevated myocardial infarction),32,1.1,131,,103,31.2,107/54,,20 - 25%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2074618,Male,6/26/57,2.00E+11,2/28/20,4/2/20,1,,,,1,1,,1,,43,1/18/16,<15%,3/2/18,60 - 65%,22,6,3,12,2.00E+11,2/28/20,4/2/20,34,28.96,UVHE 4 EAST,Acute systolic heart failure,61,6.5,138,0,103,29.8,102/73,,20 - 25%,,,,,1,,,2.00E+11,2/11/20,2/22/20,11,,UVHE 4 WEST,Heart transplant rejection,53,1.5,137,0.28,93,30.1,130/88,,35 - 40%,1,,,,,,,2.00E+11,8/21/18,8/23/18,2,,UVHE 4 EAST,S/P orthotopic heart transplant,24,1.3,139,,84,33.8,123/76,,,1,,,,,,,12/4/19,4, 23; 25, 13; 14, 17; 17,8,96,5.68,2.55,5.77,2.59,69.8,4/19/20
Z2164252,Male,10/21/49,2.00E+11,11/17/17,11/28/17,,,1,,,1,,,1,17,12/20/17,<15%,12/9/20,25 - 30%,16,1,,,2.00E+11,11/17/17,11/28/17,11,7.06,UVHE 4 CENTRAL CV,Cardiogenic shock,23,1,125,1.05,181,20,112/57,,15 - 20%,1,,,,1,,1,30548151,7/28/11,7/30/11,2,,UVHE 4 CENTRAL CV,,8,0.8,133,,,,94/63,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,11/20/17,3, 45; 44, 17; 16, 27; 27,19,69,3.87,2.01,2.63,1.37,66.9,
Z2183955,Male,1/27/91,2.00E+11,8/1/17,8/25/17,1,,1,,,,,,,17,8/13/17,<15%,7/7/19,30 - 35%,15,2,,,2.00E+11,8/1/17,8/25/17,24,14.72,UVHE 4 EAST,NICM (nonischemic cardiomyopathy),9,0.8,139,2.77,127,29.3,120/70,,<15%,1,,1,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8/2/17,12,45,32,35,29,103,3.6,1.6,,,47.6,2/9/20
Z2255131,Male,4/30/52,2.00E+11,10/21/20,10/28/20,1,,,,,,1,1,,1,10/28/20,20 - 25%,10/28/20,20 - 25%,1,,,,2.00E+11,10/21/20,10/28/20,7,5.69,UVHE TCV POST OP,Shock circulatory,55,4.5,129,0.66,185,,96/53,,20 - 25%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/28/20
Z2520314,Male,3/14/81,71907993,4/2/17,6/30/17,,,1,,,,,,,19,3/1/17,<15%,4/22/17,15 - 20%,19,,,,71907993,4/2/17,6/30/17,89,64.58,UVHE 4 EAST,Cardiogenic shock,10,0.6,139,1.47,94,21.2,108/78,,<15%,,1,,,,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,10/30/17,7,21,9,15,6,88,4.57,2.36,5.2,2.69,68.4,
Z2551097,Male,11/2/47,2.00E+11,1/31/18,2/12/18,1,,1,,,1,1,,,9,2/4/18,20 - 25%,12/14/16,40 - 45%,1,7,1,,2.00E+11,1/31/18,2/12/18,12,8.22,UVHE 3 NORTH,Acute on chronic respiratory failure with hypoxia and hypercapnia,38,1.4,137,0,104,,154/112,,25 - 30%,,,,,,,,72419751,4/25/17,5/2/17,7,0.13,UVHE 3 WEST,"Pneumonia due to infectious organism, unspecified laterality, unspecified part of lung",20,0.8,132,1.53,84,24.8,114/58,,,1,,,,1,,,70664102,2/8/17,2/16/17,8,,UVHE 4 EAST,"Type 2 diabetes mellitus without complication, with long-term current use of insulin",23,1.2,132,2.65,74,,93/53,,,1,,,,1,,1,,,,,,,,,,,,,2/12/18
Z2561844,Male,9/28/64,72366103,4/24/17,4/29/17,1,1,1,,,1,1,,1,10,4/25/17,<15%,9/18/19,20 - 25%,20,,,,2.00E+11,12/29/17,1/24/18,26,52.56,UVHE 4 NORTH,Cardiogenic shock,12,0.8,132,0.36,122,22.6,98/76,,<15%,,,,,,,,2.00E+11,7/2/17,7/5/17,3,2.06,UVHE 4 EAST,Acute on chronic systolic heart failure,14,1.3,137,0.84,138,26.4,110/62,,,,1,,,1,,,72366103,4/24/17,4/29/17,5,6.94,UVHE 4 EAST,Cardiogenic shock,37,1.3,132,0.94,128,,88/62,,<15%,,1,,,1,,,4/25/17,17,77,46,56,27,123,2.86,1.44,3.8,1.91,38.6,9/30/19
Z119217,Male,4/15/44,2.00E+11,10/9/18,10/19/18,,,,,,1,1,,,1,10/10/18,55 - 60%,10/10/18,55 - 60%,,,,1,2.00E+11,10/9/18,10/19/18,10,6.63,UVHE 4 CENTRAL CV,Cardiogenic shock,51,2.4,140,,134,29.1,119/73,,55 - 60%,,,,,,,,15149144,10/14/08,10/15/08,1,,UVHE SHORT STAY UNIT,,,,,,,,,,,,,,,,,,15512221,8/18/99,8/19/99,1,,UVHE 4 CENTRAL CV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z328494,Female,6/18/47,2.00E+11,1/27/20,2/6/20,1,,,,,,1,1,1,4,2/6/20,35 - 40%,3/18/16,55 - 60%,,1,,3,2.00E+11,1/27/20,2/6/20,10,10.88,UVHE CORONARY CARE,Shock,57,2.8,139,0,128,38.1,100/44,,35 - 40%,,,,,,,,8103215,10/15/00,10/18/00,3,,UVHE 4 CENTRAL CV,,,,,,,,,,,,,,,,,,12860970,6/28/99,6/30/99,2,,UVHE 4 EAST,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2/6/20
Z88699,Female,5/16/46,70793447,2/12/17,3/2/17,1,,1,,,1,,1,,2,11/25/16,15 - 20%,11/25/16,15 - 20%,2,,,,70793447,2/12/17,3/2/17,18,15.82,UVHE 3 EAST,Cardiogenic shock,125,2.9,145,0.94,98,34.4,111/60,,15 - 20%,,,,,,,,69799201,12/28/16,1/7/17,10,,UVHE 4 CENTRAL CV,Acute on chronic systolic heart failure,18,2,135,1.32,124,32.7,103/63,,,,,,,1,,,69126385,11/24/16,12/16/16,22,6.7,UVHE 4 EAST,Acute on chronic systolic heart failure,26,2.1,135,1.64,124,,106/62,,15 - 20%,1,,,,1,,,12/13/16,5,30,7,21,15,, 3.5600; 3.5600, 1.8700; 1.8700,4.04,2.13, 55.0000; 55.0000,3/2/17
Z440310,Male,9/13/58,2.00E+11,3/16/20,3/17/20,1,,,,,,,,1,1,3/17/20,15 - 20%,3/17/20,15 - 20%,1,,,,2.00E+11,3/16/20,3/17/20,1,0.5,UVHE CORONARY CARE,Cardiogenic shock,50,2.2,127,1.18,155,38.9,87/48,,15 - 20%,,,,,,,,7498055,11/16/01,11/21/01,5,,UVHE 4 EAST,,15,0.7,140,1.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3/17/20
Z1959901,Male,7/5/45,2.00E+11,8/6/18,8/17/18,,1,,,,1,,,,4,8/12/18,25 - 30%,8/7/18,40 - 45%,,3,1,,2.00E+11,8/6/18,8/17/18,11,4.64,UVHE 4 WEST,Acute on chronic systolic heart failure,41,1.6,135,,158,24.3,126/59,,30 - 35%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z515876,Male,10/4/62,2.00E+11,12/28/17,2/1/18,,,1,,,,1,,,12,10/31/18,30 - 35%,1/7/18,55 - 60%,,6,12,6,2.00E+11,2/16/18,3/17/18,29,7.06,UVHE 3 EAST,Lower abdominal pain,18,0.8,135,3.88,87,,116/67,,40 - 45%,,,,,1,,,2.00E+11,12/28/17,2/1/18,35,66.96,UVHE 4 NORTH,Small bowel ischemia,17,0.9,136,,78,30.7,105/57,,40 - 45%,,,,,,,,2.00E+11,12/28/17,2/1/18,35,66.96,UVHE 4 NORTH,Small bowel ischemia,17,0.9,136,,78,30.7,105/57,,40 - 45%,,,,,,,,12/29/17,17,66,29,46,38,,,,,,80.2,
Z515876,Male,10/4/62,2.00E+11,2/16/18,3/17/18,,,1,,,,1,,,12,10/31/18,30 - 35%,1/7/18,55 - 60%,,6,12,6,2.00E+11,2/16/18,3/17/18,29,7.06,UVHE 3 EAST,Lower abdominal pain,18,0.8,135,3.88,87,,116/67,,40 - 45%,,,,,1,,,2.00E+11,12/28/17,2/1/18,35,66.96,UVHE 4 NORTH,Small bowel ischemia,17,0.9,136,,78,30.7,105/57,,40 - 45%,,,,,,,,2.00E+11,12/28/17,2/1/18,35,66.96,UVHE 4 NORTH,Small bowel ischemia,17,0.9,136,,78,30.7,105/57,,40 - 45%,,,,,,,,12/29/17,17,66,29,46,38,,,,,,80.2,
Z868858,Male,8/20/69,2.00E+11,11/7/20,11/16/20,,,1,,,1,1,1,,3,11/7/20,15 - 20%,4/2/17,65 - 70%,6,,,3,2.00E+11,12/3/20,12/11/20,8,7.14,UVHE 4 WEST,Acute on chronic systolic heart failure,36,1.4,136,,113,37.3,103/64,,,,,,,1,,,2.00E+11,11/20/20,11/25/20,5,9.24,UVHE 4 CENTRAL CV,HFrEF (heart failure with reduced ejection fraction),36,1.1,134,2.55,126,,95/57,,15 - 20%,1,,,,1,,,2.00E+11,11/20/20,11/25/20,5,9.24,UVHE 4 CENTRAL CV,HFrEF (heart failure with reduced ejection fraction),36,1.1,134,2.55,126,,95/57,,15 - 20%,1,,,,1,,,,,,,,,,,,,,,
Z135845,Male,6/16/61,2.00E+11,6/2/17,6/8/17,1,,,,,1,1,,,2,6/3/17,<15%,6/3/17,<15%,2,,,,2.00E+11,6/2/17,6/8/17,6,5.95,UVHE 4 NORTH,Shock,41,2.4,138,0.77,114,42.4,95/69,,<15%,,,,,,,,10081880,11/27/03,11/28/03,1,,UVHE 5 CENTRAL,,14,1.2,135,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6/8/17
Z149771,Female,1/9/39,72364298,4/23/17,4/24/17,1,,,,,,1,,,,,,,,,,,,72364298,4/23/17,4/24/17,1,0.45,UVHE CORONARY CARE,Essential hypertension,36,1.3,142,0.95,130,,151/66,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4/24/17
Z256335,Male,11/7/34,2.00E+11,5/16/18,5/21/18,,,,,,1,,1,1,4,5/17/18,50-55%,8/29/19,60 - 65%,,,,4,2.00E+11,5/16/18,5/21/18,5,1.45,UVHE 5 WEST,Third degree heart block,22,1.1,137,2.44,114,,135/75,,50-55%,,,,,,,,7481410,5/20/01,5/22/01,2,,UVHE 4 EAST,,,,,,,,,,,,,,,,,,7900912,11/23/00,11/24/00,1,,UVHE 4 EAST,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z1705769,Male,2/21/60,2.00E+11,3/15/19,3/28/19,1,,,,,,1,1,,2,3/18/19,50-55%,5/1/17,60 - 65%,,,,2,2.00E+11,3/15/19,3/28/19,13,12.87,UVHE 3 NORTH,Encephalopathy,29,0.8,136,0.25,82,,65/41,,50-55%,,,,,,,,2.00E+11,8/7/17,8/10/17,3,,UVHE 4 WEST,Status post lung surgery,16,0.9,135,,,32.6,119/71,,,,,,,1,,,72822940,5/14/17,5/24/17,10,,UVHE 4 EAST,Waldenstrom macroglobulinemia,20,0.7,136,,96,32.9,176/85,,,,,,,1,,1,,,,,,,,,,,,,3/28/19
Z152584,Male,11/7/46,2.00E+11,11/1/20,11/23/20,,,1,,,1,,1,,4,10/18/20,15 - 20%,1/10/19,25 - 30%,3,1,,,2.00E+11,11/1/20,11/23/20,22,3.4,UVHE 4 CENTRAL CV,AKI (acute kidney injury),32,1.4,139,0.97,197,,97/53,,,,,,,,,,2.00E+11,10/16/20,10/26/20,10,,UVHE 4 EAST,Acute on chronic systolic heart failure,66,1.4,137,,224,24,97/61,,15 - 20%,,,1,,1,,,2.00E+11,12/16/19,12/21/19,5,,UVHE 4 EAST,Rhinovirus infection,39,1,143,,173,,97/51,,,,,1,,1,,,,,,,,,,,,,,,
Z553184,Male,10/7/61,2.00E+11,11/17/18,11/22/18,,1,1,,,1,1,1,1,7,11/10/18,15 - 20%,12/17/18,20 - 25%,14,,,,2.00E+11,11/29/18,12/19/18,20,21.6,UVHE 4 EAST,Shock,43,1.3,140,2.82,132,26.4,96/62,,20 - 25%,1,,,,,,,2.00E+11,11/17/18,11/22/18,5,5.38,UVHE 4 CENTRAL CV,Acute systolic heart failure,23,1.2,133,3.45,,26.6,93/61,,15 - 20%,1,,,,1,,,2.00E+11,11/17/18,11/22/18,5,5.38,UVHE 4 CENTRAL CV,Acute systolic heart failure,23,1.2,133,3.45,,26.6,93/61,,15 - 20%,1,,,,1,,1,,,,,,,,,,,,,
Z291149,Female,3/17/39,2.00E+11,1/9/18,1/22/18,,,,,,,,1,,2,1/12/18,25 - 30%,1/12/18,30 - 35%,,2,,,2.00E+11,1/9/18,1/22/18,13,7.96,UVHE 6 NORTH,"Fracture, intertrochanteric, right femur, closed, initial encounter",41,1.6,145,1.4,71,33,127/66,,30 - 35%,,,,,1,,,2.00E+11,10/12/17,10/20/17,8,,UVHE 3 WEST,Acute encephalopathy,30,1.8,136,,0,,140/68,,,,,,,1,,,2.00E+11,10/10/17,10/11/17,1,,UVHE 3 WEST,Encephalopathy acute,18,1.6,139,1.13,90,,183/80,,,,,,,1,,,1/15/18,12,46,26,35,27,86,3.96,2.05,,,54.3,
Z145396,Male,6/17/55,2.00E+11,12/21/17,1/1/18,1,1,1,,,,,1,,8,1/24/17,<15%,5/15/14,25 - 30%,7,1,,,2.00E+11,12/21/17,1/1/18,11,0.92,UVHE 4 CENTRAL CV,Cardiogenic shock,43,1.4,133,1.48,171,35,122/84,,,,,,,1,,1,2.00E+11,10/2/17,10/6/17,4,,UVHE 4 EAST,,22,1.1,138,,162,38.8,91/66,,,,,,,1,,1,72832777,5/15/17,5/23/17,8,,UVHE 4 CENTRAL CV,Acute on chronic systolic heart failure,35,1.3,136,0.67,138,,142/68,,,,,,,,,,,,,,,,,,,,,,4/15/20
Z934992,Male,10/5/42,2.00E+11,3/11/19,3/15/19,1,,,,,,,,,1,3/13/19,50-55%,3/13/19,50-55%,,,,1,2.00E+11,3/11/19,3/15/19,4,3.76,UVHE MEDICAL ICU,Cardiogenic shock,23,1.5,147,0.68,96,,127/61,,50-55%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3/15/19
Z919825,Female,9/2/98,2.00E+11,6/6/17,6/10/17,1,,,,,,,,,3,6/7/17,20 - 25%,6/11/17,35 - 40%,1,2,,,2.00E+11,6/6/17,6/10/17,4,3.99,UVHE ADMIT,"TBI (traumatic brain injury), with loss of consciousness of unspecified duration, initial encounter",12,0.6,160,0.75,84,,120/75,,25 - 30%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6/10/17
Z1078182,Male,10/29/57,2.00E+11,4/23/19,5/13/19,1,,1,,,1,,,,3,4/23/19,15 - 20%,11/18/19,20 - 25%,3,,,,2.00E+11,4/23/19,5/13/19,20,10.44,UVHE 4 EAST,SOB (shortness of breath),49,2.1,132,0.99,116,28.8,95/61,,15 - 20%,1,,,,1,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9/21/20
Z114276,Male,5/9/47,2.00E+11,12/4/17,1/25/18,1,,,,,1,,,,9,12/18/17,40 - 45%,12/11/17,65 - 70%,,,3,6,2.00E+11,12/4/17,1/25/18,52,42.85,UVHE 4 WEST,HIT (heparin-induced thrombocytopenia),94,2.5,136,0,123,29.9,98/62,,50-55%,,,,,,,,44960047,4/30/13,5/2/13,2,,UVHE 6 EAST,Hyperlipidemia,21,0.8,132,,,29.6,100/71,,,,,,,,,,44832685,4/19/13,4/20/13,1,,UVHE 6 EAST,Hyperlipidemia,30,1,140,,82,29.6,110/76,,,,,,,,,,11/6/17,4,24,8,15,7,98,4.62,2.29,5.43,2.69,70,2/4/18
Z614031,Female,1/11/37,2.00E+11,1/24/19,1/28/19,,,,,,,1,,,1,1/24/19,40 - 45%,1/24/19,40 - 45%,,,1,,2.00E+11,1/24/19,1/28/19,4,2.58,UVHE 4 CENTRAL CV,NSTEMI (non-ST elevated myocardial infarction),23,0.9,138,1.09,92,24.8,130/67,,40 - 45%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z615295,Male,1/25/54,2.00E+11,12/21/18,12/26/18,,,,,,1,,1,,2,9/11/20,40 - 45%,12/22/18,60 - 65%,,,1,1,2.00E+11,12/21/18,12/26/18,5,3.93,UVHE 6 EAST,Cardiogenic shock,29,8,136,,92,34.4,143/70,,60 - 65%,,,,,,,,5707943,3/9/02,3/16/02,7,,UVHE 6 CENTRAL,,34,10.3,138,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z371457,Female,9/19/53,2.00E+11,5/1/19,5/7/19,1,1,,1,,,,,,2,5/2/19,30 - 35%,2/15/19,50-55%,,1,,1,2.00E+11,5/1/19,5/7/19,6,4.17,UVHE CORONARY CARE,Cardiogenic shock,56,1.8,129,0.55,113,31.1,116/50,,30 - 35%,,,,,,,,2.00E+11,4/14/19,4/16/19,2,,UVHE 4 WEST,Cardiac amyloidosis,45,1.9,135,1.07,112,,102/57,,,,,,,,,,2.00E+11,2/18/19,2/21/19,3,,UVHE 4 EAST,Heart failure with preserved left ventricular function (HFpEF),26,1.5,137,,107,30.3,97/57,,,,,,,,,1,5/2/19,14, 15; 52; 64, 13; 38; 33, 14; 41; 43, 24; 24,93,3.05,1.6,3.63,1.9,51.4,5/7/19
Z868458,Female,5/30/04,2.00E+11,8/23/20,8/27/20,1,,,,,,,,,,,,,,,,,,2.00E+11,8/23/20,8/27/20,4,4.01,UVHE PICU 7NORTH,"Drowning, initial encounter",67,7,153,1.78,72,,100/55,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8/27/20
Z532266,Female,5/6/59,71752326,3/26/17,4/14/17,,,,,,,1,,,11,3/29/17,<15%,4/8/17,60 - 65%,4,5,,2,71752326,3/26/17,4/14/17,19,17.44,UVHE 4 EAST,Acute systolic heart failure,16,0.8,137,0.69,76,31.4,109/68,,60 - 65%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z1135557,Male,1/28/50,2.00E+11,7/1/18,7/16/18,,1,,,,,1,,,12,7/2/18,35 - 40%,11/6/18,60 - 65%,,2,3,7,2.00E+11,7/1/18,7/16/18,15,11.39,UVHE 4 WEST,S/P MVR (mitral valve repair),16,0.9,136,0.89,96,26.6,109/58,,55 - 60%,,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2099727,Female,12/18/55,2.00E+11,8/2/19,8/17/19,1,,,,,1,1,,,3,8/5/19,<15%,8/3/19,20 - 25%,3,,,,2.00E+11,8/2/19,8/17/19,15,14.73,UVHE CORONARY CARE,Shock,119,2.5,154,0.47,103,40.3,100/70,,<15%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8/17/19
Z2139003,Male,9/8/59,2.00E+11,7/12/18,7/25/18,,,1,,,1,1,1,,6,6/21/18,30 - 35%,7/30/20,50-55%,,4,1,1,2.00E+11,7/12/18,7/25/18,13,5.1,UVHE 4 WEST,S/P CABG x 3,60,2.2,133,,87,31.4,110/58,,30 - 35%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2245135,Male,4/23/59,2.00E+11,7/31/18,8/16/18,,,1,,,1,1,1,1,15,10/28/14,<15%,6/28/19,20 - 25%,15,,,,2.00E+11,7/31/18,8/16/18,16,7.2,UVHE 4 EAST,"Complication involving left ventricular assist device (LVAD), subsequent encounter",37,2.4,136,1.45,189,23.1,90/73,,,,,,,,,,2.00E+11,7/19/18,7/22/18,3,2.23,UVHE 4 EAST,,32,1.9,137,,126,23.3,64/0,,15 - 20%,,,,,,,,71013260,2/21/17,2/24/17,3,2.02,UVHE 4 EAST,LVAD (left ventricular assist device) present,34,2.1,136,1.05,126,23.5,115/73,,,,,,,,,,6/26/19,12,37,20,29,10,92,3.93,1.95,5.1,2.53,46.5,
Z2317848,Male,1/29/71,2.00E+11,9/11/17,10/17/17,,,1,,1,,1,1,,38,9/11/17,<15%,7/31/18,65 - 70%,20,,,18,2.00E+11,9/11/17,10/17/17,36,14.62,UVHE 4 EAST,NICM (nonischemic cardiomyopathy),18,1,138,0.88,154,32.8,94/65,,<15%,,,,,1,,1,69852159,1/1/17,1/4/17,3,,UVHE 4 CENTRAL CV,Syncope and collapse,31,1.5,135,1.76,156,,100/71,,15 - 20%,,1,,,1,,1,65562368,6/2/16,6/26/16,24,0.01,UVHE 4 EAST,,28,1.3,137,,146,34,109/69,,15 - 20%,,1,,,1,,1,9/13/17,14,46,27,35,23,72,2.53,1.3,3.6,1.85,45.7,
Z2331222,Female,7/28/96,2.00E+11,9/23/19,10/16/19,1,,,1,1,,1,1,,53,9/23/19,<15%,8/20/15,60 - 65%,39,15,15,90,2.00E+11,9/23/19,10/16/19,23,53.7,UVHE CORONARY CARE,Cardiac arrest,70,3.9,133,0,96,29,86/48,,50-55%,,,,,,,,2.00E+11,7/22/19,8/13/19,22,12.57,UVHE 4 WEST,Status post orthotopic heart transplant,26,1.5,141,0.22,88,30.4,108/71,,35 - 40%,1,,,,1,,,2.00E+11,5/13/19,6/10/19,28,63.36,UVHE 4 WEST,Acute rejection of cardiac transplant,30,1.4,138,0.36,100,32.4,117/85,,50-55%,1,,,,1,,,6/12/19,10,26,12,19,10,111,3.88,2.01,3.43,1.78,54.4,10/16/19
Z449528,Male,4/14/73,2.00E+11,11/13/18,11/26/18,,,1,,,1,,,,5,11/14/18,15 - 20%,11/6/19,35 - 40%,3,2,,,2.00E+11,11/13/18,11/26/18,13,6.76,UVHE 4 CENTRAL CV,Cardiogenic shock,29,0.8,134,2.94,103,28.8,101/66,,15 - 20%,1,,,,1,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,1/14/19,9,42,24,31, 17; 21,79,4.57,2.04,5.33,2.38,63.9,
Z291362,Female,3/17/61,2.00E+11,2/11/19,3/13/19,1,,1,,,1,1,,,1,2/12/19,15 - 20%,2/12/19,15 - 20%,1,,,,2.00E+11,2/11/19,3/13/19,30,11.38,UVHE CORONARY CARE,Acute systolic congestive heart failure,26,2.9,128,,138,29.6,85/52,,15 - 20%,,,,,,,,38637935,7/18/12,7/20/12,2,,UVHE 4 EAST,,12,0.6,134,1.82,86,29.9,102/56,,,1,,,,1,,,35726340,3/15/12,3/17/12,2,,UVHE 4 CENTRAL CV,,12,0.6,140,,72,29.3,141/74,,,,,,,,,,2/15/19,30,68,31,46,28,79,2.34,1.28,2.4,1.31,48.3,3/13/19
Z423233,Female,11/15/50,2.00E+11,10/9/18,10/11/18,1,,,,,1,1,1,,1,10/10/18,<15%,10/10/18,<15%,1,,,,2.00E+11,10/9/18,10/11/18,2,1.08,UVHE MEDICAL ICU,Abscess,75,3,140,0.37,76,,97/54,,<15%,,,,,,,,2.00E+11,8/16/18,8/21/18,5,,UVHE 3 CENTRAL,,57,2.6,135,,,,110/55,,,,,,,1,,,24323170,11/4/10,11/8/10,4,1.88,UVHE 5 WEST,,35,1.2,135,,,,,,,,,,,,,,,,,,,,,,,,,,10/10/18
Z390162,Female,10/1/62,2.00E+11,1/23/18,5/20/18,1,,,,1,,1,1,,32,5/8/17,<15%,5/10/18,>70%,29,,,3,2.00E+11,1/23/18,5/20/18,117,115.41,UVHE 4 NORTH,Cardiogenic shock,5,0.2,148,0.09,83,31.1,123/46,,55 - 60%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1/24/18,23,68,37,48,39,118,2.86,1.39,3.7,1.8,47.1,5/20/18
Z2179321,Female,10/18/70,2.00E+11,9/26/18,11/5/18,,1,,1,,,,1,,15,8/27/18,50-55%,10/19/18,60 - 65%,,,,15,2.00E+11,9/26/18,11/5/18,40,13.06,UVHE 4 EAST,Shock,26,3.1,135,0.84,96,26.1,92/56,,60 - 65%,1,,,,1,,,2.00E+11,8/26/18,8/31/18,5,,UVHE 4 EAST,Acute on chronic systolic congestive heart failure,35,1.6,136,,102,37.1,106/69,,50-55%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,8/28/18,14, 71; 72; 70, 36; 36; 29, 48; 48; 45,13,82,4.86,2.21,7.67,3.48,65.3,
Z2236833,Female,1/20/37,2.00E+11,11/26/18,12/5/18,1,,,,,1,,,,4,11/30/18,25 - 30%,11/28/18,55 - 60%,,1,2,1,2.00E+11,11/26/18,12/5/18,9,8.76,UVHE PERIOP,NSTEMI (non-ST elevated myocardial infarction),24,1,138,1.24,169,40.6,90/51,,40 - 45%,,,,,,,,2.00E+11,11/21/18,11/23/18,2,,UVHE 4 WEST,NSTEMI (non-ST elevated myocardial infarction),15,0.9,124,,83,,141/68,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12/5/18
Z2264952,Male,2/21/68,2.00E+11,3/30/18,4/6/18,,,,,,1,,,,2,3/31/18,15 - 20%,7/11/18,25 - 30%,1,1,,,2.00E+11,3/30/18,4/6/18,7,2.51,UVHE 4 EAST,Acute systolic heart failure,22,1.1,135,1.74,168,30.6,135/64,,15 - 20%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3/30/18,5, 35; 32, 19; 17, 24; 22,24,82,4.02,2.01,,,66,
Z2265707,Male,11/21/12,2.00E+11,9/24/19,9/25/19,1,,,,,,,,,,,,,,,,,,2.00E+11,9/24/19,9/25/19,1,0.95,UVHE PERIOP,"Drowned, initial encounter",45,1.8,146,1.68,,,79/51,,,,,,,,,,42805845,1/14/13,3/1/13,46,11.5,UVHE 7 WEST,Hypoxia,9,0.4,137,9.01,52,,94/54,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9/25/19
Z2374464,Male,5/19/69,2.00E+11,10/3/17,10/10/17,1,1,,,,,,1,,2,3/18/17,<15%,3/18/17,<15%,6,,,,2.00E+11,10/3/17,10/10/17,7,,UVHE 4 WEST,Acute decompensated heart failure,27,1.1,135,,100,,116/70,,,,,1,,1,,,2.00E+11,9/11/17,9/17/17,6,7.74,UVHE 3 CENTRAL,"Psychosis, unspecified psychosis type",53,1.4,137,1.21,102,,116/83,,,,,1,,1,,,2.00E+11,9/3/17,9/8/17,5,,UVHE 4 EAST,Acute on chronic systolic heart failure,33,1.9,133,,100,20.2,103/64,,,,,,,,,,3/17/17,18,48,29,37, 28; 32,94,3.42,1.63,4.53,2.16,42.4,5/7/18
Z2410547,Female,2/13/67,2.00E+11,12/9/20,12/24/20,,,1,,,,,,1,7,3/25/15,<15%,3/20/15,25 - 30%,6,1,,,2.00E+11,12/9/20,12/24/20,15,2.62,UVHE 4 EAST,Cardiogenic shock,24,0.8,133,,233,26.4,82/60,,,1,,,,1,,1,2.00E+11,11/27/20,12/5/20,8,,UVHE 4 EAST,Acute decompensated heart failure,32,1.1,129,,166,33.3,98/67,,<15%,1,,,,1,,1,69319750,12/3/16,12/5/16,2,,UVHE 6 CENTRAL,Multiple sclerosis exacerbation,22,1.2,139,,,32.4,95/60,,,1,,,,,,,12/15/20,3, 50; 50, 27; 26, 34; 34, 20; 20,79,2.31,1.36,2.5,1.47,54.2,
Z2423573,Female,10/16/68,2.00E+11,5/7/20,5/18/20,,,,,,,,,,3,5/7/20,20 - 25%,5/5/20,55 - 60%,1,,,2,2.00E+11,5/7/20,5/18/20,11,9.65,UVHE 3 CENTRAL,Acute hypoxemic respiratory failure,13,1.5,140,1.6,78,,117/86,,55 - 60%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2458326,Male,4/22/36,72754204,5/10/17,5/16/17,1,,,,,,,,,3,5/15/17,35 - 40%,5/10/17,60 - 65%,,1,,2,72754204,5/10/17,5/16/17,6,5.76,UVHE TCV POST OP,Acute coronary syndrome,25,1.2,147,,58,23.6,100/53,,35 - 40%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5/16/17
Z2554879,Female,5/20/39,2.00E+11,11/26/19,12/4/19,,,,,,,,,,3,2/3/17,60 - 65%,12/28/16,>70%,,,,6,2.00E+11,11/26/19,12/4/19,8,,UVHE 4 WEST,Acute on chronic respiratory failure with hypoxia,43,1.4,142,,,42.5,118/56,,60 - 65%,,,,,1,,,71107391,2/28/17,3/10/17,10,9.06,UVHE 4 EAST,Persistent atrial fibrillation,46,1.2,137,,90,33.6,116/57,,,,,,,1,,,70582676,2/2/17,2/11/17,9,9.38,UVHE 3 WEST,Acute respiratory failure with hypoxia,29,1.2,136,0.77,90,36.2,100/58,,60 - 65%,,,,,1,,,,,,,,,,,,,,,
Z2568794,Female,4/16/39,71632672,4/13/17,4/18/17,,,,,,,1,,,4,4/14/17,60 - 65%,4/14/17,60 - 65%,,,,4,71632672,4/13/17,4/18/17,5,1.91,UVHE 4 CENTRAL CV,Cardiogenic shock,15,0.7,136,1.17,103,24.7,117/58,,60 - 65%,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2572187,Female,2/24/17,71588287,3/17/17,5/1/17,,,,,,,,,,,,,,,,,,,71588287,3/17/17,5/1/17,45,20.19,UVHE 7NORTH ACUTE,Failure to thrive in childhood,17,0.2,134,3.6,83,10.9,73/45,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2578912,Male,12/10/44,72396468,4/25/17,4/26/17,,,,,,1,,,,9,1/28/19,55 - 60%,3/26/19,65 - 70%,,,,9,72396468,4/25/17,4/26/17,1,,UVHE 4 EAST,Coronary artery disease of native artery of native heart with stable angina pectoris,,,,,68,27.4,132/68,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2586002,Female,7/11/45,73092764,5/27/17,6/3/17,1,,,,,,,,,1,5/28/17,15 - 20%,5/28/17,15 - 20%,1,,,,73092764,5/27/17,6/3/17,7,6.92,UVHE CORONARY CARE,Cardiogenic shock,33,1.8,138,1.04,111,35.3,84/46,,15 - 20%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6/3/17
Z2593653,Female,9/12/73,2.00E+11,7/4/17,7/12/17,,,,,,1,,,,1,7/5/17,45 - 50%,7/5/17,45 - 50%,,,1,,2.00E+11,7/4/17,7/12/17,8,4.24,UVHE 4 WEST,Cardiogenic shock,11,0.8,138,,78,27.8,124/58,,45 - 50%,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2633636,Male,4/15/49,2.00E+11,12/23/17,1/16/18,,1,1,,,,,,,9,12/27/17,<15%,10/14/20,45 - 50%,5,1,3,,2.00E+11,12/23/17,1/16/18,24,16.83,UVHE 4 EAST,Cardiogenic shock,53,1.9,133,1.12,112,22.6,76/0,,<15%,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,12/26/17,9, 42; 48, 22; 22, 29; 31,20,98,4.32,2.37,3.73,2.05,68.2,
Z2650626,Male,1/24/92,2.00E+11,4/14/18,5/2/18,,1,1,,,,1,1,,2,4/15/18,15 - 20%,4/15/18,15 - 20%,2,,,,2.00E+11,4/14/18,5/2/18,18,10.88,UVHE 4 EAST,Cardiogenic shock,72,12.8,124,2.39,98,41.3,89/57,,15 - 20%,,,,,1,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,4/26/18,10,43,25,35,14,99,5.48,2.25,5.66,2.33,56.1,
Z2671521,Male,8/18/52,2.00E+11,5/4/18,5/26/18,1,,,,,,,,,2,5/4/18,<15%,5/21/18,25 - 30%,1,1,,,2.00E+11,5/4/18,5/26/18,22,22.15,UVHE 4 NORTH,Cardiogenic shock,39,1.3,143,0.42,157,23.5,93/54,,25 - 30%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5/26/18
Z2671630,Male,9/17/70,2.00E+11,4/21/19,5/8/19,,,,,1,,1,,,17,4/22/19,15 - 20%,4/25/19,60 - 65%,2,,,15,2.00E+11,4/21/19,5/8/19,17,9.22,UVHE 4 WEST,Heart transplant recipient,19,1.2,137,1.85,74,,137/86,,60 - 65%,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,5/6/19, 3; 2,14,7,10,6,90,5.13,2.47,5.03,2.42,63.2,
Z2692846,Male,6/3/40,2.00E+11,9/30/19,10/22/19,,,,,,1,,,,3,10/6/19,20 - 25%,10/4/19,30 - 35%,1,2,,,2.00E+11,9/30/19,10/22/19,22,7.14,UVHE 4 WEST,NSTEMI (non-ST elevation myocardial infarction),30,1.3,132,,80,31.9,110/57,,20 - 25%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2693162,Male,4/4/63,2.00E+11,7/21/18,7/30/18,1,,,,,,1,,,5,7/26/18,15 - 20%,7/23/18,45 - 50%,1,1,3,,2.00E+11,7/21/18,7/30/18,9,9.17,UVHE 4 NORTH,Shock,54,1.6,139,1.5,110,28.8,117/60,,15 - 20%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7/30/18
Z2699590,Female,4/27/75,2.00E+11,9/9/18,10/12/18,,,1,,,1,,,,14,9/25/18,<15%,3/16/19,20 - 25%,14,,,,2.00E+11,9/9/18,10/12/18,33,10.66,UVHE 4 EAST,Acute on chronic systolic heart failure,14,0.6,138,3.73,154,25.8,104/71,,15 - 20%,1,,,,1,,1,2.00E+11,8/26/18,8/31/18,5,,UVHE 4 WEST,LV (left ventricular) mural thrombus following MI,35,0.7,133,,152,,86/61,,,1,,,,1,,1,2.00E+11,8/6/18,8/14/18,8,1.58,UVHE 4 EAST,Tobacco abuse,26,0.8,133,3.28,145,,97/65,,15 - 20%,1,,,,1,,1,9/12/18,19,43,27,33,27,82,1.64,1,1.53,0.94,32.2,
Z2722866,Female,8/19/18,2.00E+11,9/27/18,10/27/18,,,,,,,,,,,,,,,,,,,2.00E+11,9/27/18,10/27/18,30,17.75,UVHE 7 WEST,Congenital stenosis of aortic valve,6,0.2,133,6.97,69,13.4,103/66,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2737970,Male,1/21/77,2.00E+11,11/30/18,2/4/19,,,,1,1,,1,1,,22,12/17/18,<15%,12/26/18,60 - 65%,2,,,20,2.00E+11,11/30/18,2/4/19,66,27,UVHE 4 WEST,Status post orthotopic heart transplant,21,1,136,1.48,107,26.2,121/56,,55 - 60%,,,,,,,,2.00E+11,11/20/18,11/27/18,7,,UVHE 4 EAST,NICM (nonischemic cardiomyopathy),30,1.8,129,0.99,101,,104/72,,15 - 20%,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2/1/19, 17; 19,44,21,32, 24; 22,97,6.69,3.32,7.77,3.85,58,
Z2782066,Male,12/11/56,2.00E+11,3/5/19,4/23/19,,,,,1,1,1,,,22,3/6/19,15 - 20%,4/9/19,60 - 65%,4,1,,17,2.00E+11,3/5/19,4/23/19,49,37.26,UVHE 4 WEST,S/P orthotopic heart transplant,43,2.5,136,0.31,118,32.4,105/67,,60 - 65%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4/23/19,15,36,19,27,19,81,7.37,3.07,7.57,3.15,57.8,
Z2785852,Male,8/4/64,2.00E+11,3/21/19,3/29/19,,,,,,,,,,1,3/21/19,<15%,3/21/19,<15%,1,,,,2.00E+11,3/21/19,3/29/19,8,8.43,UVHE CORONARY CARE,Cardiogenic shock,17,1,126,,98,,122/78,,<15%,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2803172,Female,11/25/60,2.00E+11,5/21/19,5/27/19,1,,,,,1,1,1,,2,5/21/19,<15%,5/21/19,<15%,2,,,,2.00E+11,5/21/19,5/27/19,6,5.91,UVHE 4 NORTH,Cardiogenic shock,111,4,145,0.77,83,,110/66,,<15%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5/27/19
Z2813851,Female,4/15/46,2.00E+11,6/23/19,6/26/19,,,,,,,,,,1,6/24/19,60 - 65%,6/24/19,60 - 65%,,,,1,2.00E+11,6/23/19,6/26/19,3,2.56,UVHE 3 NORTH,Shock circulatory,16,0.8,140,,79,,153/67,,60 - 65%,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2838708,Male,11/21/74,2.00E+11,8/22/19,11/14/19,,,1,,,1,,,,15,8/23/19,<15%,10/8/19,20 - 25%,15,,,,2.00E+11,8/22/19,11/14/19,84,62.16,UVHE 4 EAST,Cardiogenic shock,9,0.7,139,1.2,166,28.5,70/0,,15 - 20%,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/30/19,12,29,18,19,13,88,7.04,3.21,5.97,2.72,55.3,
Z2868183,Female,9/22/58,2.00E+11,11/10/19,11/16/19,1,,,,,,,,,1,11/12/19,<15%,11/12/19,<15%,1,,,,2.00E+11,11/10/19,11/16/19,6,3.52,UVHE SURG TRAM ICU,Necrotizing fasciitis,19,0.6,145,0,86,31.2,84/50,,<15%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11/16/19
Z2910448,Male,2/12/63,2.00E+11,3/5/20,4/7/20,1,,1,,,,,1,,4,3/12/20,25 - 30%,3/6/20,40 - 45%,,2,2,,2.00E+11,3/5/20,4/7/20,33,28.04,UVHE 4 NORTH,Cardiogenic shock,47,3.3,135,0.95,153,35.2,143/67,,25 - 30%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4/23/20
Z2930740,Male,9/19/57,2.00E+11,5/12/20,5/20/20,,,,,,,,,,1,5/13/20,20 - 25%,5/13/20,20 - 25%,1,,,,2.00E+11,5/12/20,5/20/20,8,1.48,UVHE 4 EAST,Acute systolic congestive heart failure,118,2.9,130,,134,25.5,89/60,,20 - 25%,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5/18/20,2, 46; 47, 25; 26, 32; 33, 26; 28,97,3.51,1.66,3.17,1.5,57.3,
Z2993709,Male,4/3/54,2.00E+11,10/1/20,12/2/20,1,,1,,,,,1,,2,10/1/20,15 - 20%,10/5/20,20 - 25%,2,,,,2.00E+11,10/1/20,12/2/20,62,23.82,UVHE 3 WEST,Acute hypercapnic respiratory failure,66,4.7,134,0.13,101,,102/66,,20 - 25%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/28/20,5, 42; 42, 22; 23, 29; 30, 16; 11,102,5.84,2.09,5.2,1.86,65.5,12/2/20
Z734588,Male,7/14/47,69924139,1/4/17,1/20/17,,,,,,,,,,2,1/7/17,25 - 30%,1/5/17,35 - 40%,,2,,,69924139,1/4/17,1/20/17,16,10.23,UVHE 4 EAST,Acute systolic congestive heart failure,68,2.6,135,0.81,92,35.8,115/61,,25 - 30%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z131814,Female,4/23/52,2.00E+11,6/6/17,6/10/17,1,,1,,,,,1,,5,3/22/15,<15%,6/2/16,15 - 20%,5,,,,2.00E+11,6/6/17,6/10/17,4,1.14,UVHE CORONARY CARE,"Acute on chronic congestive heart failure, unspecified congestive heart failure type",92,3.1,133,,227,21.6,121/77,,,,,,,,,,71787970,3/28/17,3/31/17,3,,UVHE 4 CENTRAL CV,"Sepsis, due to unspecified organism",70,2.4,137,0.62,170,,113/68,,,,,,,,,,71574888,3/18/17,3/24/17,6,3.28,UVHE 4 CENTRAL CV,Chronic systolic heart failure,83,1.9,136,0.36,190,23.8,94/60,,15 - 20%,,,,,,,,,,,,,,,,,,,,6/10/17
Z177998,Male,3/19/59,2.00E+11,7/12/18,8/3/18,1,1,,,,1,1,,1,10,10/11/18,25 - 30%,8/27/15,55 - 60%,,6,1,3,2.00E+11,7/12/18,8/3/18,22,4.58,UVHE 4 EAST,PAD (peripheral artery disease),14,1,136,,90,,102/52,,30 - 35%,,,,,,,,2.00E+11,4/24/18,4/26/18,2,,UVHE 4 CENTRAL CV,,15,0.8,137,,92,27.4,123/69,,,1,,,,1,,,2.00E+11,2/15/18,3/1/18,14,6.9,UVHE 4 EAST,Coronary artery disease involving native coronary artery of native heart with angina pectoris,12,0.8,138,,107,30.1,106/56,,35 - 40%,1,,,,1,,,,,,,,,,,,,,,10/15/18
Z686853,Male,10/17/60,2.00E+11,7/25/17,7/29/17,1,,,,,,,,,4,7/25/17,<15%,7/25/17,>70%,2,1,,1,2.00E+11,7/25/17,7/29/17,4,3.64,UVHE 4 NORTH,ST elevation myocardial infarction involving left circumflex coronary artery,24,2.6,137,1.27,97,,93/84,,25 - 30%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7/29/17
Z84781,Female,1/13/30,70298928,1/21/17,1/27/17,1,,1,,,,,,,3,9/7/17,15 - 20%,1/16/17,25 - 30%,2,1,,,70298928,1/21/17,1/27/17,6,3.11,UVHE 4 CENTRAL CV,Acute decompensated heart failure,31,0.9,137,,70,24.7,135/63,,20 - 25%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12/29/18
Z927126,Male,8/4/63,70626311,2/4/17,3/22/17,1,,1,,,,,1,1,9,2/8/17,<15%,1/2/19,15 - 20%,9,,,,70626311,2/4/17,3/22/17,46,9.69,UVHE 4 EAST,Acute on chronic systolic heart failure,21,1,140,0.45,110,27.2,91/0,,<15%,,1,,,1,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,2/7/17, 12; 12,42,24,30,24,,3.32,1.58,5.63,2.68,48,1/26/19
Z107856,Female,2/24/64,2.00E+11,9/14/18,11/8/18,1,,1,,,,,1,,3,9/15/18,15 - 20%,9/24/18,65 - 70%,2,,,1,2.00E+11,9/14/18,11/8/18,55,45.61,UVHE SURG TRAM ICU,Shock,16,0.4,136,0.16,91,36.4,193/106,,65 - 70%,,,,,,,,2.00E+11,8/8/18,8/11/18,3,,UVHE 5 WEST,Multiple sclerosis exacerbation,37,1,138,,,,148/80,,,,,,,,,,2.00E+11,4/12/18,4/14/18,2,,UVHE 6 CENTRAL,Ileus,15,0.8,139,,99,,146/72,,,,,,,,,,,,,,,,,,,,,,11/22/18
Z1171102,Female,4/30/50,2.00E+11,7/24/17,8/24/17,1,,,,,,,,,3,7/30/17,20 - 25%,8/6/17,50-55%,1,1,,1,2.00E+11,7/24/17,8/24/17,31,19.62,UVHE 4 WEST,Acute respiratory failure with hypoxemia,19,0.4,142,,79,23.8,127/65,,50-55%,,,,,,,,70096817,2/3/17,2/8/17,5,1.32,UVHE 6 NORTH,Squamous cell carcinoma,10,0.5,142,0.42,82,24.3,126/64,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8/25/18
Z236238,Male,10/2/54,2.00E+11,7/15/18,7/18/18,1,,,,,,,,,2,7/18/18,20 - 25%,5/27/18,60 - 65%,1,,,1,2.00E+11,7/15/18,7/18/18,3,0.36,UVHE SURG TRAM ICU,Acute coronary syndrome,15,0.7,133,0.84,100,15.8,91/57,,20 - 25%,,,,,,,,2.00E+11,6/28/18,7/5/18,7,,UVHE 5 WEST,Enteritis,9,0.7,132,,99,16.7,138/71,,,,,,,,,,2.00E+11,6/11/18,6/13/18,2,,UVHE 5 WEST,Small bowel obstruction due to adhesions,10,0.8,133,1.72,91,110.4,123/73,,,,,,,,,,,,,,,,,,,,,,7/18/18
Z1440064,Male,4/1/35,2.00E+11,9/25/19,10/15/19,1,,,,,1,1,,,3,9/26/19,45 - 50%,12/20/19,60 - 65%,,,1,2,2.00E+11,9/25/19,10/15/19,20,4.84,UVHE 4 EAST,Cardiogenic shock,31,1,144,1.05,94,18.9,107/53,,45 - 50%,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1/1/20
Z349613,Male,10/23/63,2.00E+11,2/29/20,3/11/20,,,,,,1,,,,7,3/1/20,15 - 20%,2/1/17,45 - 50%,6,,1,,2.00E+11,2/29/20,3/11/20,11,3.67,UVHE 4 WEST,ST elevation myocardial infarction involving left anterior descending (LAD) coronary artery,34,1.5,138,0.75,97,,107/60,,20 - 25%,,1,,,1,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,2/29/20,11,37,22,26,26,99,4.54,2,,,61,
Z169335,Male,5/13/47,2.00E+11,1/30/19,1/31/19,1,,,,,1,1,,,5,1/31/19,30 - 35%,12/28/18,60 - 65%,,3,1,1,2.00E+11,1/30/19,1/31/19,1,1.49,UVHE CORONARY CARE,NSTEMI (non-ST elevated myocardial infarction),25,2.3,136,1.15,171,37.2,150/45,,30 - 35%,,,,,,,,2.00E+11,12/21/18,1/9/19,19,6.95,UVHE 3 CENTRAL,PAD (peripheral artery disease),24,1.2,136,,107,,138/83,,60 - 65%,1,,,,,,,2.00E+11,11/1/18,11/4/18,3,,UVHE 3 WEST,,53,1.5,129,0.78,,37.6,126/66,,,1,,,,,,,,,,,,,,,,,,,1/31/19
Z1140320,Female,4/4/56,2.00E+11,3/19/18,3/29/18,1,,,,,,,,,1,3/20/18,25 - 30%,3/20/18,25 - 30%,,1,,,2.00E+11,3/19/18,3/29/18,10,9.92,UVHE CORONARY CARE,Microcytic anemia,10,1,135,,215,32.9,105/68,,25 - 30%,,,,,,,,30408267,7/14/11,7/20/11,6,,UVHE 4 EAST,,18,1,138,1.27,,,115/68,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3/22/18,19,54,24,38,36,86,4.2,2.02,3.27,1.57,63.5,3/29/18
Z677138,Male,4/22/49,2.00E+11,6/26/20,7/2/20,,1,,,,1,1,1,,6,6/23/19,20 - 25%,10/29/18,50-55%,2,4,,6,2.00E+11,6/26/20,7/2/20,6,,UVHE 4 CENTRAL CV,Cardiogenic shock,34,1.7,142,0.81,108,,117/56,,,,1,,,1,,,2.00E+11,12/10/19,12/15/19,5,2.3,UVHE 4 WEST,Hx of CABG,40,1.6,139,,108,31.5,124/58,,,,1,,,1,,,2.00E+11,6/21/19,7/15/19,24,31.8,UVHE 4 WEST,Coronary artery disease involving native coronary artery of native heart without angina pectoris,36,4.4,136,1.84,103,31.5,115/56,,30 - 35%,,1,,,1,,,6/23/19,13,64,25,43,30,77,3.08,1.46,3.43,1.63,51.3,
Z1017923,Male,6/7/56,2.00E+11,11/20/18,12/7/18,1,1,1,,,,1,1,,2,11/27/18,20 - 25%,10/10/15,45 - 50%,1,,1,,2.00E+11,11/20/18,12/7/18,17,0.59,UVHE 4 CENTRAL CV,Acute on chronic systolic heart failure,116,3.5,132,2.91,112,34.5,102/71,,20 - 25%,,,,,,,,60732435,10/3/15,10/12/15,9,,UVHE 8 WEST,Examination,34,2.4,138,0.87,,31.6,134/76,,45 - 50%,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,11/26/18,9,38,20,26,15,99,4.83,1.87,7.5,2.91,55.1,7/30/20
Z1288596,Female,12/8/39,2.00E+11,10/18/20,10/24/20,,,,,,,,,,2,10/18/20,>70%,10/18/20,>70%,,,,2,2.00E+11,10/18/20,10/24/20,6,5.71,UVHE CORONARY CARE,Acute systolic right heart failure,54,0.8,140,,116,,108/68,,>70%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/21/20,13,110,58,79,18,119,2.31,1.45,2.83,1.78,55.7,
Z1024230,Male,11/21/55,2.00E+11,4/6/18,4/19/18,,1,1,,,1,1,1,,6,4/12/18,35 - 40%,12/26/18,60 - 65%,,2,2,2,2.00E+11,4/6/18,4/19/18,13,10.38,UVHE 4 CENTRAL CV,Cardiogenic shock,20,0.9,130,2.23,115,25.9,93/56,,35 - 40%,,,,,,,,15437624,1/4/10,1/8/10,4,,UVHE 4 WEST,,16,1,132,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z137291,Female,1/2/50,2.00E+11,1/11/18,2/14/18,,,,1,1,1,,1,,25,3/9/14,15 - 20%,2/2/18,65 - 70%,4,,,21,2.00E+11,1/11/18,2/14/18,34,23.21,UVHE 4 WEST,Heart transplanted,25,0.6,135,0,74,26.5,104/56,,65 - 70%,,,,,,,,2.00E+11,6/26/17,7/11/17,15,,UVHE 4 EAST,Acute on chronic systolic congestive heart failure,60,2.3,133,,186,20.9,99/63,,15 - 20%,,,,,1,,,50703619,4/5/14,4/9/14,4,,UVHE 4 WEST,Neutropenia with fever,13,0.8,134,0.9,128,,98/59,,,,,,,,,,2/14/18,10,39,16,26,13,70,4.06,2.61,5.13,3.3,66.1,
Z522948,Female,2/23/45,70937094,2/17/17,3/7/17,1,,,1,,,,,,3,2/17/17,65 - 70%,2/17/17,65 - 70%,,,,6,72702949,5/9/17,5/18/17,9,17.9,UVHE MEDICAL ICU,Acute on chronic diastolic heart failure,115,2.6,140,0.24,97,,118/51,,65 - 70%,,,,,,,,70937094,2/17/17,3/7/17,18,21.52,UVHE 4 EAST,Pulmonary hypertension,59,1.6,140,0.56,88,41.4,101/55,,65 - 70%,1,,,,1,,,70937094,2/17/17,3/7/17,18,21.52,UVHE 4 EAST,Pulmonary hypertension,59,1.6,140,0.56,88,41.4,101/55,,65 - 70%,1,,,,1,,1,3/2/17,,97,37,62,21,87,4.18,2.28,4.07,2.21,59.4,5/18/17
Z605799,Female,1/12/49,2.00E+11,8/19/18,8/24/18,,,,,,,,,,2,7/15/15,55 - 60%,7/15/15,55 - 60%,,,,2,2.00E+11,8/19/18,8/24/18,5,3.91,UVHE 5 CENTRAL,Melena,7,0.9,141,0.62,84,,133/83,,,,1,,,1,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z680896,Male,12/12/85,2.00E+11,8/23/17,9/8/17,,,,,,1,,,,2,8/24/17,20 - 25%,9/2/17,30 - 35%,1,1,,,2.00E+11,8/23/17,9/8/17,16,11.42,UVHE 4 EAST,ST elevation myocardial infarction involving left anterior descending (LAD) coronary artery,19,1.6,136,2.67,109,38.7,130/77,,30 - 35%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9/6/17,2,23,8,15,10,109,6.62,2.63,5.7,2.26,54.9,
Z726238,Female,2/15/49,70959406,2/19/17,3/16/17,,,1,,,,1,,,3,2/20/17,20 - 25%,2/18/17,25 - 30%,1,2,,,70959406,2/19/17,3/16/17,25,10,UVHE 4 EAST,Acute on chronic systolic heart failure,18,0.9,127,0.63,104,,86/52,,25 - 30%,1,,,,1,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z198593,Male,12/19/39,2.00E+11,4/2/19,4/9/19,1,,1,,,1,,1,,1,3/5/19,15 - 20%,3/5/19,15 - 20%,1,,,,2.00E+11,4/2/19,4/9/19,7,6.38,UVHE CORONARY CARE,Cardiogenic shock,25,1.3,137,0.52,214,,88/53,,,,,,,,,,2.00E+11,2/24/19,3/16/19,20,8.75,UVHE 4 EAST,Shock,28,3.1,134,1.07,159,22.7,107/58,,15 - 20%,,,,,1,,,67114741,8/19/16,8/21/16,2,1.09,UVHE 4 CENTRAL CV,PVT (paroxysmal ventricular tachycardia),19,1.2,139,1.04,130,26.6,118/71,,,,1,,,,,,,,,,,,,,,,,,4/9/19
Z492964,Female,7/13/82,2.00E+11,1/24/19,2/25/19,,1,,1,1,,1,1,,44,5/27/16,20 - 25%,2/12/19,65 - 70%,3,2,,39,2.00E+11,1/24/19,2/25/19,32,20.68,UVHE 4 WEST,Status post orthotopic heart transplant,54,2.3,135,2.7,96,30.7,111/78,,65 - 70%,,,,,1,,1,2.00E+11,8/30/18,9/4/18,5,,UVHE 4 EAST,NICM (nonischemic cardiomyopathy),29,1.3,131,3.8,118,27.3,92/67,,,,,,,1,,1,2.00E+11,8/26/18,8/28/18,2,,UVHE 4 CENTRAL CV,Chronic systolic heart failure,34,1.4,135,,124,27.8,90/56,,,,,,,1,,1,2/25/19, 22; 24,46,26,35,25,92,5.17,2.59,4.1,2.06,53.7,
Z80966,Female,10/9/08,2.00E+11,6/1/20,8/24/20,,,,,1,,,,,,,,,,,,,,2.00E+11,6/1/20,8/24/20,84,75.58,UVHE 7 WEST,Heart transplanted,38,0.5,135,1.21,123,18.1,124/75,,,1,,,,,,1,16458445,11/16/08,11/19/08,3,,UVHE 7 WEST,,6,0.3,137,4.68,,,,,,,,,,,,1,15152871,10/9/08,10/11/08,2,,UVHE NEWBORN NURSERY,,,,,,,,,,,,,,,,,,8/11/20,20,44,26,33,20,,,,1.77,1.48,56.3,
Z338337,Female,9/5/64,2.00E+11,9/18/19,9/24/19,1,,,,,1,1,,,4,9/18/19,<15%,9/18/19,<15%,4,,,,2.00E+11,9/18/19,9/24/19,6,5.42,UVHE 4 NORTH,Atypical atrial flutter,21,1.4,132,1.08,148,33.4,74/32,,<15%,,,,,,,,19064234,2/19/10,2/20/10,1,15.41,UVHE 4 EAST,,15,0.9,137,0.84,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9/24/19
Z481671,Male,3/23/78,2.00E+11,4/16/20,4/25/20,,,1,,,,,,,5,4/17/20,<15%,10/14/20,50-55%,3,1,,1,2.00E+11,4/16/20,4/25/20,9,6.02,UVHE 4 EAST,Cardiogenic shock,23,1.3,137,1.22,96,20.2,100/69,,<15%,1,,,,1,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,6/4/20,5,29,13,21, 16; 14,67,3.24,1.92,4.27,2.53,64.4,
Z460701,Male,9/14/38,2.00E+11,11/24/18,11/26/18,1,1,1,1,,,1,1,,3,4/9/18,35 - 40%,2/11/14,60 - 65%,,1,,2,2.00E+11,11/24/18,11/26/18,2,2.05,UVHE CORONARY CARE,"Shock, cardiogenic",128,3.3,134,0.73,210,,105/58,,,,,,,,,,2.00E+11,7/9/18,7/13/18,4,2.97,UVHE 4 WEST,Complete heart block,78,3.1,135,0.85,168,,107/64,,,,,,,,,,2.00E+11,4/25/18,4/27/18,2,1.2,UVHE 4 WEST,Femoral artery pseudoaneurysm complicating cardiac catheterization,39,1.6,138,,165,22.9,117/59,,,,,,,,,,,,,,,,,,,,,,12/31/18
Z1148550,Male,1/12/55,2.00E+11,9/7/17,9/22/17,1,,,,,1,,,,8,9/15/17,<15%,9/7/17,15 - 20%,8,,,,2.00E+11,9/7/17,9/22/17,15,15.35,UVHE 4 NORTH,ST elevation myocardial infarction involving left anterior descending (LAD) coronary artery,65,2.8,139,0.2,107,26.5,76/65,,15 - 20%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9/22/17
Z2082184,Male,5/31/69,2.00E+11,6/12/19,6/20/19,,,1,,,1,1,,,2,5/19/16,<15%,5/19/16,<15%,2,,,,2.00E+11,6/12/19,6/20/19,8,0.84,UVHE 4 EAST,Chronic systolic heart failure,31,1.3,138,,97,20.4,101/64,,<15%,,1,,,1,,1,62123652,12/12/15,12/15/15,3,,UVHE 4 EAST,Acute systolic heart failure,50,1.3,130,,74,,99/83,,,1,,,,1,,1,,,,,,,,,,,,,,,,,,,,,,,,6/17/19,16,53,26,36,21,90,2.86,1.7,3.47,2.06,49.4,
Z2084789,Male,8/13/45,2.00E+11,6/26/20,6/27/20,1,,,,,,,,,2,6/29/20,20 - 25%,8/4/16,60 - 65%,1,,,1,2.00E+11,6/26/20,6/27/20,1,0.23,UVHE CORONARY CARE,,22,1.5,142,3.58,144,,131/88,,20 - 25%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6/27/20
Z2290682,Male,1/14/99,2.00E+11,9/24/18,12/12/18,,,1,,1,,1,,,24,10/6/18,<15%,10/16/18,45 - 50%,16,5,3,,2.00E+11,9/24/18,12/12/18,79,61.33,UVHE 4 EAST,Cardiogenic shock,36,1.7,136,2.55,81,22.6,121/78,,20 - 25%,1,,,,,,,47790323,10/14/13,10/18/13,4,,UVHE 7 NORTH,S/P orthotopic heart transplant,13,0.8,139,0.69,,22.5,129/76,,,,,,,,,,44726153,4/13/13,7/5/13,83,68.23,UVHE 7 CENTRAL,Cardiogenic shock,18,0.8,136,0.99,78,21.9,130/68,,,,,,,,,,11/26/18,14,38,22,29,22,102,7.06,3.7,5.53,2.9,52.8,
Z2334833,Male,12/10/42,70020491,1/10/17,1/27/17,,,1,,,,,,,,,,,,,,,,70424382,1/27/17,3/13/17,45,,TCIR TC2A,Acute respiratory failure with hypoxia and hypercapnia,32,0.8,141,1.32,132,,124/83,,,,,,,,,,70020491,1/10/17,1/27/17,17,31.98,UVHE TCV POST OP,Lung mass,51,1,145,,126,30.2,104/59,,,,,,,,,,70020491,1/10/17,1/27/17,17,31.98,UVHE TCV POST OP,Lung mass,51,1,145,,126,30.2,104/59,,,,,,,,,,,,,,,,,,,,,,
Z2334833,Male,12/10/42,70424382,1/27/17,3/13/17,,,1,,,,,,,,,,,,,,,,70424382,1/27/17,3/13/17,45,,TCIR TC2A,Acute respiratory failure with hypoxia and hypercapnia,32,0.8,141,1.32,132,,124/83,,,,,,,,,,70020491,1/10/17,1/27/17,17,31.98,UVHE TCV POST OP,Lung mass,51,1,145,,126,30.2,104/59,,,,,,,,,,70020491,1/10/17,1/27/17,17,31.98,UVHE TCV POST OP,Lung mass,51,1,145,,126,30.2,104/59,,,,,,,,,,,,,,,,,,,,,,
Z2412027,Male,12/24/56,2.00E+11,3/20/18,3/29/18,1,,,,,,,,,,,,,,,,,,2.00E+11,3/20/18,3/29/18,9,4.4,UVHE 4 NORTH,"Superficial femoral artery injury, right, subsequent encounter",12,0.8,157,0.17,73,18.8,98/62,,,,,,,,,,57000278,3/23/15,3/24/15,1,,UVHE 5 WEST,Abscess of abdominal cavity,3,0.7,139,,,,136/76,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3/29/18
Z2565038,Female,9/1/89,2.00E+11,6/5/17,7/28/17,,,,1,1,,1,,,44,6/28/17,<15%,6/21/18,65 - 70%,11,,,33,2.00E+11,6/5/17,7/28/17,53,18.04,UVHE 4 EAST,Acute on chronic systolic heart failure,0,0,0,1.51,86,26,97/71,,15 - 20%,,,,,,,,71853426,3/30/17,4/6/17,7,2.93,UVHE 4 CENTRAL CV,Chronic systolic heart failure,49,2.2,135,0.89,69,28.2,116/72,,15 - 20%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8/24/17,17,59,23,39, 20; 25,92,2.84,1.65,3.65,2.12,44.1,
Z2582690,Female,5/15/57,72726848,5/9/17,5/19/17,,,,,,1,,,,1,5/15/17,30 - 35%,5/15/17,30 - 35%,,1,,,72726848,5/9/17,5/19/17,10,9.76,UVHE CORONARY CARE,Peripheral arterial occlusive disease,42,1.5,132,1.37,113,42.4,115/53,,30 - 35%,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,5/10/17,27,57,31,44,33,98,,,7.23,3.26,71.2,
Z2613155,Male,7/14/46,2.00E+11,9/23/17,10/4/17,1,1,1,,,1,,,1,3,9/25/17,15 - 20%,9/24/17,20 - 25%,3,,,,2.00E+11,9/23/17,10/4/17,11,7.87,UVHE 4 CENTRAL CV,Perforated ulcer of intestine,14,1.2,136,1.5,134,25,155/87,,15 - 20%,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8/6/20
Z2630284,Male,8/28/62,2.00E+11,12/3/17,1/3/18,,,1,,,1,1,,,8,12/7/17,<15%,12/4/17,15 - 20%,8,,,,2.00E+11,12/3/17,1/3/18,31,16.55,UVHE 4 EAST,Left ventricular assist device present,28,0.9,134,1.41,151,28.6,99/70,,<15%,,,,,1,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,5/7/18,12,32,18,24,13,100,4.74,2.21,5.97,2.79,61.1,
Z2647218,Male,7/18/46,2.00E+11,2/13/18,2/26/18,,,,,,1,,,,4,2/17/18,20 - 25%,2/20/18,30 - 35%,2,2,,,2.00E+11,2/13/18,2/26/18,13,7.95,UVHE 4 WEST,Coronary artery disease of native artery of native heart with stable angina pectoris,28,1.4,133,,155,26.7,100/58,,30 - 35%,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2648853,Male,2/26/45,2.00E+11,2/7/20,3/12/20,,,1,,,1,,,,7,2/7/20,15 - 20%,2/15/20,25 - 30%,6,1,,,2.00E+11,2/7/20,3/12/20,34,13.85,UVHE 4 EAST,Acute systolic heart failure,31,1.4,136,0.76,103,20.8,90/57,,20 - 25%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2651874,Female,2/27/18,2.00E+11,8/27/18,10/12/18,,,,,1,,,,,,,,,,,,,,2.00E+11,8/27/18,10/12/18,46,26.99,UVHE 7 WEST,S/P orthotopic heart transplant,6,0.2,132,0.61,72,13.5,111/43,,,,,,,,,,2.00E+11,2/28/18,3/15/18,15,6.78,UVHE 7 CIMU,HLHS (hypoplastic left heart syndrome),9,0.3,141,3.67,66,14.6,77/47,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2667748,Male,9/14/54,2.00E+11,4/21/18,5/10/18,1,,1,,,1,,,,4,5/4/18,<15%,4/24/18,15 - 20%,4,,,,2.00E+11,4/21/18,5/10/18,19,15.51,UVHE 4 NORTH,Atrial fibrillation with RVR,37,1.4,138,1.45,92,31.2,84/79,,<15%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4/24/18,27,54,34,42,36,100,3.61,1.57,,,54.6,5/10/18
Z2711913,Male,10/16/69,2.00E+11,9/2/18,9/5/18,1,,,,,,,,,1,9/3/18,15 - 20%,9/3/18,15 - 20%,1,,,,2.00E+11,9/2/18,9/5/18,3,2.69,UVHE CORONARY CARE,Cardiogenic shock,12,1.2,132,1.9,182,34.6,149/69,,15 - 20%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9/5/18
Z2723046,Male,3/30/58,2.00E+11,9/29/18,1/14/19,,,,,1,,,,,23,10/24/18,<15%,12/14/18,60 - 65%,10,,,13,2.00E+11,9/29/18,1/14/19,107,66.17,UVHE 4 WEST,"Heart transplant, orthotopic, status",24,0.8,132,1.14,161,20.7,112/77,,60 - 65%,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1/10/19, 0; 0,15,3,8,2,94,5.3,3.02,4.47,2.54,68,
Z2726887,Male,8/10/69,2.00E+11,10/12/18,10/17/18,1,1,,,,,,,,2,10/12/18,15 - 20%,10/12/18,15 - 20%,2,,,,2.00E+11,10/12/18,10/17/18,5,3.64,UVHE 4 EAST,IVCD (intraventricular conduction defect),33,1.1,134,1.59,117,20.4,106/68,,15 - 20%,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/12/18,3,72,30,44,26,70,2.3,1.74,3.47,2.62,51.7,5/15/19
Z2737615,Male,5/2/49,2.00E+11,11/3/18,11/7/18,1,,,,,,,,,1,11/3/18,15 - 20%,11/3/18,15 - 20%,1,,,,2.00E+11,11/3/18,11/7/18,4,4.5,UVHE CORONARY CARE,,36,1.3,141,,113,,121/78,,15 - 20%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11/7/18
Z2768507,Male,7/14/43,2.00E+11,7/20/19,7/31/19,1,,,,,,,,,3,7/21/19,20 - 25%,7/20/19,60 - 65%,1,,,2,2.00E+11,7/20/19,7/31/19,11,11.3,UVHE 4 NORTH,Acute massive pulmonary embolism,99,1.7,151,0.72,103,,134/50,,55 - 60%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7/31/19
Z2775239,Male,5/15/65,2.00E+11,2/9/19,2/24/19,1,,,,,,,,,1,2/10/19,<15%,2/10/19,<15%,1,,,,2.00E+11,2/9/19,2/24/19,15,10.75,UVHE 3 EAST,Cardiogenic shock,90,3.3,128,0.14,146,,53/35,,<15%,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,2/13/19,20,47,29,39,36,101,5.4,2.25,3.73,1.56,51,2/25/19
Z2801311,Male,7/24/79,2.00E+11,5/13/19,5/24/19,,,,,,,,,,3,5/15/19,20 - 25%,5/16/19,25 - 30%,2,1,,,2.00E+11,5/13/19,5/24/19,11,5.57,UVHE 4 EAST,Cardiogenic shock,41,2.1,133,0.9,99,34.6,136/65,,20 - 25%,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5/16/19,20,58,44,49,44,103,2.64,1.21,3.37,1.55,37,
Z2820615,Male,12/17/37,2.00E+11,7/14/19,8/9/19,1,,,,,,,,,2,7/15/19,45 - 50%,7/15/19,45 - 50%,,,2,,2.00E+11,7/14/19,8/9/19,26,15.78,UVHE CORONARY CARE,Critical aortic valve stenosis,110,2.5,136,,160,32.4,128/65,,45 - 50%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7/23/19,,40,23,29,,98,3.68,1.66,,,53.1,8/11/19
Z2834869,Male,1/17/65,2.00E+11,8/24/19,9/26/19,,,1,,1,1,1,,1,18,8/26/19,<15%,9/11/19,60 - 65%,2,,2,14,2.00E+11,8/24/19,9/26/19,33,19.87,UVHE 4 WEST,Heart transplanted,34,1.4,135,1.34,88,26.6,131/69,,60 - 65%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/10/19, 7; 7,31,14,20,12,80,6.05,3.1,6,3.08,62.2,
Z2889760,Male,7/13/35,2.00E+11,12/31/19,1/6/20,1,,,,,,,,,1,12/31/19,35 - 40%,12/31/19,35 - 40%,,1,,,2.00E+11,12/31/19,1/6/20,6,2.99,UVHE 4 CENTRAL CV,,38,1,144,1.27,98,28.4,109/67,,35 - 40%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4/27/20
Z2983759,Male,3/17/77,2.00E+11,10/12/20,11/2/20,,,,,,,,,,5,10/12/20,<15%,10/19/20,15 - 20%,5,,,,2.00E+11,10/12/20,11/2/20,21,21.34,UVHE 4 NORTH,Cardiogenic shock,89,3,134,0.89,180,25.3,91/54,,<15%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/12/20, 22; 22; 22, 50; 46; 51; 49, 38; 44; 42; 42, 44; 44; 45; 43, 35; 40; 31; 39,119,3.15,1.49,4.07,1.93,38.6,
Z2561844,Male,9/28/64,2.00E+11,12/29/17,1/24/18,1,1,1,,,1,1,,1,10,4/25/17,<15%,9/18/19,20 - 25%,20,,,,2.00E+11,12/29/17,1/24/18,26,52.56,UVHE 4 NORTH,Cardiogenic shock,12,0.8,132,0.36,122,22.6,98/76,,<15%,,,,,,,,2.00E+11,7/2/17,7/5/17,3,2.06,UVHE 4 EAST,Acute on chronic systolic heart failure,14,1.3,137,0.84,138,26.4,110/62,,,,1,,,1,,,72366103,4/24/17,4/29/17,5,6.94,UVHE 4 EAST,Cardiogenic shock,37,1.3,132,0.94,128,,88/62,,<15%,,1,,,1,,,4/25/17,17,77,46,56,27,123,2.86,1.44,3.8,1.91,38.6,9/30/19
Z2586003,Male,11/1/50,73093085,5/26/17,6/25/17,,,1,,,,1,1,,5,5/27/17,<15%,9/26/18,30 - 35%,3,2,,,73093085,5/26/17,6/25/17,30,9.45,UVHE 4 EAST,Physical deconditioning,28,1.2,136,0.6,124,38.8,83/64,,<15%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6/6/17,14,53,20,38,29,112,5.24,2.44,5.53,2.58,53.3,
Z2616157,Male,12/13/55,2.00E+11,5/2/19,5/20/19,1,,1,,,,,,,6,5/4/19,<15%,12/28/17,15 - 20%,6,,,,2.00E+11,5/2/19,5/20/19,18,16.79,UVHE 4 NORTH,Cardiogenic shock,25,1.3,133,1.08,209,,102/63,,15 - 20%,,,,,,,,2.00E+11,2/26/19,2/28/19,2,,UVHE 4 EAST,"Cough, persistent",15,0.9,139,2,232,28.5,100/56,,15 - 20%,,,,,1,,,2.00E+11,4/25/18,4/26/18,1,,UVHE 4 CENTRAL CV,Cardiac syncope,18,1,140,2.47,226,,118/67,,,,,,,,,1,5/3/19,5,54,22,33,16,64,3.28,1.57,3.9,1.87,57,5/20/19
Z2618461,Female,8/22/83,2.00E+11,12/13/17,1/5/18,,,,,,,,1,,2,12/14/17,60 - 65%,12/14/17,60 - 65%,,,,2,2.00E+11,12/13/17,1/5/18,23,22.54,UVHE MEDICAL ICU,Ventilator dependence,77,2.5,133,1.08,88,,144/103,,60 - 65%,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2621183,Male,2/18/66,2.00E+11,10/25/17,11/7/17,,1,1,,,,,,,8,10/29/17,<15%,12/1/20,55 - 60%,4,1,2,1,2.00E+11,10/25/17,11/7/17,13,11.58,UVHE 4 EAST,Acute systolic heart failure,51,1.8,134,1.92,104,34.2,124/70,,20 - 25%,,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11/1/17,12,42,12,29,27,,,,,,77.2,
Z2626723,Male,2/8/80,2.00E+11,11/16/17,11/25/17,1,,,,,,,,,4,11/17/17,35 - 40%,11/19/17,65 - 70%,,1,,3,2.00E+11,11/16/17,11/25/17,9,9.1,UVHE 4 NORTH,Acute hypoxemic respiratory failure,96,1.7,146,0.31,74,21.9,103/53,,50-55%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11/25/17
Z2689562,Male,4/11/50,2.00E+11,11/21/19,11/21/19,1,,1,,,,,1,,6,7/19/18,30 - 35%,7/11/18,60 - 65%,,1,2,3,2.00E+11,11/21/19,11/21/19,0,0.32,UVHE MEDICAL ICU,Pleural effusion on left,29,2.4,143,1.73,148,,104/52,,55 - 60%,,,,,,,,2.00E+11,7/10/18,8/10/18,31,24.9,UVHE TCV POST OP,Non-rheumatic mitral regurgitation,94,3.6,134,1.53,108,56,120/57,,45 - 50%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11/21/19
Z2714424,Male,3/13/47,2.00E+11,9/11/18,9/24/18,1,1,1,,,1,,1,,9,9/11/18,<15%,11/2/18,25 - 30%,8,1,,,2.00E+11,9/11/18,9/24/18,13,9.65,UVHE 4 WEST,LV (left ventricular) mural thrombus following MI,84,2.1,136,1.81,68,,101/59,,<15%,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1/27/19
Z2719685,Male,5/31/47,2.00E+11,1/7/19,1/17/19,1,,1,,,,,,,1,1/8/19,<15%,1/8/19,<15%,1,,,,2.00E+11,1/7/19,1/17/19,10,8.13,UVHE 4 EAST,Cardiogenic shock,54,2.8,133,0.66,207,22.4,96/52,,<15%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1/17/19
Z2751474,Male,8/22/98,2.00E+11,12/28/19,5/18/20,1,,1,,1,,,,,8,12/28/19,<15%,5/18/20,>70%,1,,,7,2.00E+11,12/28/19,5/18/20,142,28.23,UVHE 4 NORTH,Mediastinitis,30,0.5,144,1.55,221,39.3,126/50,,>70%,,,,,,,,2.00E+11,11/13/19,11/26/19,13,5.24,UVHE 4 EAST,Right ventricular failure,23,0.9,138,1.07,71,44.2,116/89,,,,,,,1,,,2.00E+11,10/9/19,10/31/19,22,,UVHE 4 EAST,Acute on chronic left systolic heart failure,16,0.7,135,0.9,69,39.6,130/65,,,,,,,,,1,11/15/19,30,46,32,38,26,122,9.27,3.36,7.5,2.72,47.5,5/18/20
Z2759963,Male,4/2/62,2.00E+11,12/25/18,1/1/19,,1,1,,,,,,,3,12/25/18,15 - 20%,3/6/19,20 - 25%,3,,,,2.00E+11,12/25/18,1/1/19,7,1.32,UVHE 4 EAST,,14,0.8,129,1.1,99,21.7,108/69,,15 - 20%,1,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2767929,Male,8/10/57,2.00E+11,3/26/19,5/6/19,,,,,,1,1,1,,6,3/28/19,60 - 65%,4/14/19,>70%,,,,6,2.00E+11,3/26/19,5/6/19,41,17.04,UVHE 4 WEST,Cardiogenic shock,85,7.3,133,1.58,126,,115/70,,>70%,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3/26/19,19,46,22,32,20,86,3.69,1.67,3.73,1.68,57.2,
Z2803211,Male,6/23/41,2.00E+11,5/21/19,5/28/19,,,,,,1,,,,2,5/21/19,<15%,5/23/19,20 - 25%,2,,,,2.00E+11,5/21/19,5/28/19,7,6.1,UVHE 4 EAST,Cardiogenic shock,19,1.2,133,0.25,147,19.8,111/55,,20 - 25%,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2818721,Male,3/13/46,2.00E+11,7/5/19,7/11/19,,,1,,,1,1,1,,2,7/6/19,25 - 30%,7/6/19,25 - 30%,,2,,,2.00E+11,7/5/19,7/11/19,6,4.62,UVHE 4 EAST,Cardiogenic shock,51,1.9,139,0.49,92,,,,25 - 30%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2916430,Male,7/27/66,2.00E+11,3/28/20,4/17/20,,,1,,,1,,,,4,4/1/20,<15%,1/4/21,30 - 35%,3,1,,,2.00E+11,3/28/20,4/17/20,20,16.47,UVHE 4 EAST,Cardiogenic shock,12,1,137,1,98,33,104/61,,15 - 20%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2953027,Male,2/1/74,2.00E+11,7/15/20,7/17/20,1,,,,,,,,,1,7/15/20,15 - 20%,7/15/20,15 - 20%,1,,,,2.00E+11,7/15/20,7/17/20,2,2.23,UVHE CORONARY CARE,Cardiogenic shock,70,6.7,129,2.96,120,28.4,101/64,,15 - 20%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7/17/20
Z2976379,Male,12/12/31,2.00E+11,9/2/20,9/9/20,,,,,,1,,,,5,9/4/20,15 - 20%,9/4/20,35 - 40%,1,4,,,2.00E+11,9/2/20,9/9/20,7,4.99,UVHE CORONARY CARE,Atrial flutter with rapid ventricular response,32,1.1,133,0.98,131,26.2,113/64,,25 - 30%,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2977182,Female,3/31/47,2.00E+11,8/9/20,8/28/20,,,,,,,,,,2,8/17/20,60 - 65%,8/11/20,65 - 70%,,,,2,2.00E+11,8/9/20,8/28/20,19,8.45,UVHE 3 CENTRAL,Malignant pericardial effusion,20,0.5,140,0.97,109,,125/75,,60 - 65%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8/10/20, 24; 20, 38; 50; 57, 28; 25; 29, 32; 35; 35,28, 90; 100, 1.94; 3.9, 1.08; 2.17,,, 41; 65.5,
Z2986966,Male,7/8/67,2.00E+11,9/5/20,9/15/20,1,,,,,,,1,,2,9/5/20,<15%,9/5/20,<15%,2,,,,2.00E+11,9/5/20,9/15/20,10,10.38,UVHE 4 NORTH,Personal history of ECMO,11,2.2,138,0.88,106,,88/64,,<15%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9/15/20
Z1670395,Male,2/26/45,2.00E+11,8/15/20,8/29/20,1,1,,,,,,1,,6,8/25/20,25 - 30%,10/26/17,45 - 50%,,4,2,,2.00E+11,8/15/20,8/29/20,14,12.42,UVHE MEDICAL ICU,Acute respiratory failure with hypoxia,47,2.1,137,0.61,124,,105/40,,25 - 30%,,,,,,,,2.00E+11,10/25/17,10/28/17,3,0.52,UVHE 4 EAST,"Syncope, unspecified syncope type",22,1.4,138,0.82,146,45.8,149/74,,45 - 50%,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8/29/20
Z172070,Male,6/9/35,2.00E+11,9/24/17,9/25/17,1,1,1,,,1,,1,,7,10/13/16,15 - 20%,3/14/14,35 - 40%,3,4,,,2.00E+11,9/24/17,9/25/17,1,0.17,UVHE CORONARY CARE,Cardiogenic shock,67,3,135,1.88,174,,67/48,,,,,,,,,,2.00E+11,9/13/17,9/24/17,11,0.65,UVHE 4 WEST,Acute systolic congestive heart failure,56,2.2,136,3.68,206,24,109/59,,,1,,,,1,,,72761347,5/11/17,5/14/17,3,,UVHE 4 EAST,Acute decompensated heart failure,36,1.7,141,1.16,188,25.2,103/56,,15 - 20%,1,,,,1,,,,,,,,,,,,,,,9/25/17
Z566304,Male,7/24/45,2.00E+11,1/26/19,1/27/19,1,,,,,,,,,,,,,,,,,,2.00E+11,1/26/19,1/27/19,1,0.37,UVHE CORONARY CARE,Cardiogenic shock,30,1.4,137,4.05,167,28.3,137/54,,,,,,,,,,61798165,12/3/15,12/4/15,1,,UVHE 4 CENTRAL CV,"Endoleak post (EVAR) endovascular aneurysm repair, initial encounter",9,0.8,139,,,25.5,132/66,,,1,,,,1,,,57079621,5/26/15,5/28/15,2,,UVHE 4 WEST,S/P hip replacement,17,0.9,138,,144,26.2,117/57,,,1,,,,1,,,,,,,,,,,,,,,1/27/19
Z410544,Female,12/21/42,2.00E+11,5/21/18,5/22/18,1,,,,,1,,,,1,5/22/18,<15%,5/22/18,<15%,1,,,,2.00E+11,5/21/18,5/22/18,1,1.28,UVHE 4 NORTH,"Coronary artery disease involving native heart without angina pectoris, unspecified vessel or lesion type",25,1.7,148,4.63,122,,157/157,,<15%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5/22/18
Z964794,Male,8/18/55,72131522,4/12/17,4/27/17,1,,1,,,1,1,,,3,12/15/16,<15%,12/15/16,<15%,3,,,,72131522,4/12/17,4/27/17,15,3.94,UVHE 4 WEST,Acute on chronic systolic heart failure,61,2.2,122,,88,,90/61,,,,,,,,,1,71211021,3/1/17,3/6/17,5,,UVHE 4 WEST,Acute on chronic systolic heart failure,43,1.3,137,,92,,94/61,,,,,,,,,1,70512817,1/31/17,2/13/17,13,,UVHE 4 EAST,Chronic osteomyelitis of right foot,47,1.3,136,2.11,134,28,91/57,,<15%,1,,,,1,,,,,,,,,,,,,,,4/27/17
Z75684,Female,11/8/63,2.00E+11,8/22/18,8/31/18,1,1,1,,,1,,1,,11,5/5/20,<15%,1/9/19,25 - 30%,20,2,,,2.00E+11,8/10/20,9/1/20,22,18.56,UVHE CORONARY CARE,Cardiogenic shock,36,1.3,143,1.37,42,36.4,69/59,,<15%,,,,,,,,2.00E+11,6/6/20,7/23/20,47,22.86,UVHE 4 EAST,Chronic systolic heart failure,8,0.7,135,1.26,94,38,70/0,,<15%,1,,,,1,,,2.00E+11,5/4/20,5/13/20,9,,UVHE 4 EAST,Chronic systolic heart failure,23,1.4,140,,171,39.5,84/54,,<15%,1,,,,1,,,8/28/18,15, 37; 35, 18; 19, 25; 25,18,88,3.6,1.62,4.13,1.85,43.6,9/1/20
Z1160705,Male,1/20/51,2.00E+11,10/22/18,10/29/18,,,,,,,,,,3,9/21/18,60 - 65%,9/21/18,60 - 65%,,,,6,2.00E+11,10/22/18,10/29/18,7,14.88,UVHE 3 NORTH,Shock,27,0.7,149,0.71,96,,158/75,,,,,,,,,,2.00E+11,9/20/18,10/18/18,28,55.78,UVHE 3 NORTH,"Respiratory failure with hypercapnia, unspecified chronicity",42,1.1,146,1.35,86,,153/78,,60 - 65%,,,,,,,,2.00E+11,9/20/18,10/18/18,28,55.78,UVHE 3 NORTH,"Respiratory failure with hypercapnia, unspecified chronicity",42,1.1,146,1.35,86,,153/78,,60 - 65%,,,,,,,,,,,,,,,,,,,,
Z868858,Male,8/20/69,2.00E+11,12/3/20,12/11/20,,,1,,,1,1,1,,3,11/7/20,15 - 20%,4/2/17,65 - 70%,6,,,3,2.00E+11,12/3/20,12/11/20,8,7.14,UVHE 4 WEST,Acute on chronic systolic heart failure,36,1.4,136,,113,37.3,103/64,,,,,,,1,,,2.00E+11,11/20/20,11/25/20,5,9.24,UVHE 4 CENTRAL CV,HFrEF (heart failure with reduced ejection fraction),36,1.1,134,2.55,126,,95/57,,15 - 20%,1,,,,1,,,2.00E+11,11/20/20,11/25/20,5,9.24,UVHE 4 CENTRAL CV,HFrEF (heart failure with reduced ejection fraction),36,1.1,134,2.55,126,,95/57,,15 - 20%,1,,,,1,,,,,,,,,,,,,,,
Z1904624,Male,5/8/81,2.00E+11,4/9/19,4/16/19,,,,,,,,,,1,4/10/19,15 - 20%,4/10/19,15 - 20%,1,,,,2.00E+11,4/9/19,4/16/19,7,2.46,UVHE 4 EAST,Cardiogenic shock,48,1.7,128,1.36,114,27.9,120/70,,15 - 20%,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z161127,Male,10/24/65,2.00E+11,8/20/18,9/14/18,,1,1,,,1,,1,,2,8/21/18,20 - 25%,10/19/15,30 - 35%,1,1,,,2.00E+11,8/20/18,9/14/18,25,9.65,UVHE 4 EAST,Chronic systolic heart failure,33,1.4,140,0.13,109,18.3,98/66,,20 - 25%,,1,,,,,1,60965087,10/16/15,10/23/15,7,,UVHE 4 EAST,Acute on chronic systolic heart failure,24,1.3,139,0.5,116,26.1,103/59,,30 - 35%,,1,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,9/13/18,11,39,25,30,22,90,4.28,2.39,3.77,2.11,35,
Z531727,Female,4/5/66,2.00E+11,8/13/19,8/14/19,1,,1,,,,,,,2,1/24/19,25 - 30%,10/24/18,45 - 50%,,1,1,,2.00E+11,8/13/19,8/14/19,1,0.98,UVHE CORONARY CARE,Cardiogenic shock,89,2.3,146,0.63,,,135/80,,,,,,,,,,2.00E+11,7/13/19,7/17/19,4,1.73,UVHE 4 EAST,Personal history of atrial flutter,25,0.7,141,0.52,162,,100/73,,,,,,,1,,,2.00E+11,6/27/19,7/6/19,9,6.63,UVHE 4 EAST,Septic shock,14,0.6,141,1.13,146,16.8,110/66,,,,,,,,,,,,,,,,,,,,,,8/14/19
Z90715,Male,4/6/39,2.00E+11,8/29/17,9/3/17,1,,,,,,1,1,,7,6/12/18,55 - 60%,8/26/18,>70%,,,,7,2.00E+11,8/29/17,9/3/17,5,1.78,UVHE 3 CENTRAL,"Hypotension, unspecified hypotension type",15,1.5,141,0.44,79,,141/68,,,,,,,1,,,73123719,5/30/17,6/2/17,3,3.19,UVHE MEDICAL ICU,UGI bleed,45,1.8,138,,84,,103/56,,,,,,,,,,72912411,5/18/17,5/22/17,4,,UVHE 3 EAST,Generalized abdominal pain,32,1.7,135,0.78,94,,158/70,,60 - 65%,,,,,1,,,,,,,,,,,,,,,8/26/18
Z1099417,Female,7/27/81,2.00E+11,5/9/19,6/7/19,,,1,,,,,,,5,5/17/19,25 - 30%,5/9/19,65 - 70%,,2,1,2,2.00E+11,5/9/19,6/7/19,29,13.39,UVHE 4 WEST,PAD (peripheral artery disease),11,0.8,136,0.99,84,,92/51,,25 - 30%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5/13/19,32,58,34,44,21,111,3.39,2.06,,,52.5,
Z86358,Male,3/13/59,2.00E+11,4/6/20,5/14/20,,,1,,,,,,,15,4/8/20,<15%,11/26/14,45 - 50%,10,3,2,,2.00E+11,4/6/20,5/14/20,38,21.49,UVHE 4 EAST,Cardiogenic shock,16,0.8,133,0.86,33,,78/0,,<15%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z435863,Male,1/26/77,2.00E+11,6/15/19,6/29/19,,,,,,,,,,6,6/16/19,<15%,10/2/19,15 - 20%,6,,,,2.00E+11,6/15/19,6/29/19,14,1.99,UVHE 4 WEST,Acute on chronic systolic heart failure,42,1.7,136,1.64,103,22.7,97/65,,<15%,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,6/19/19,16,47,31,38, 29; 41,106,3.09,1.5,2.43,1.18,38.2,
Z346449,Female,11/3/39,2.00E+11,12/10/18,12/18/18,1,,,,,,1,,,3,12/10/18,<15%,5/17/17,50-55%,1,1,,1,2.00E+11,12/10/18,12/18/18,8,8.08,UVHE CORONARY CARE,Cardiogenic shock,15,1.4,127,,144,30,114/64,,25 - 30%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12/18/18
Z271614,Female,11/19/01,2.00E+11,12/31/17,2/5/18,,,,,,,,,,,,,,,,,,,2.00E+11,12/31/17,2/5/18,36,22.41,UVHE 7NORTH ACUTE,Cardiogenic shock,11,0.6,141,2.64,108,,124/65,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z725703,Male,10/28/81,2.00E+11,6/8/17,6/12/17,1,,,,,,,,,1,6/9/17,<15%,6/9/17,<15%,1,,,,2.00E+11,6/8/17,6/12/17,4,4.1,UVHE 4 NORTH,"ST elevation myocardial infarction (STEMI), unspecified artery",87,4.2,143,0.16,98,37.4,226/136,,<15%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6/8/17,,59,43,47,42,112,4.38,2.1,,,50.6,6/12/17
Z381101,Male,10/28/04,2.00E+11,9/28/20,10/16/20,,,,,,,,,,,,,,,,,,,2.00E+11,9/28/20,10/16/20,18,12.99,UVHE 7 CENTRAL,MIS-C associated with COVID-19,13,0.8,132,2.88,80,,112/56,,,,,,,,,,1566424,10/28/04,10/30/04,2,,UVHE 8 CENTRAL OB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z403080,Female,7/9/45,70785067,2/11/17,2/27/17,1,,,,,1,1,1,,3,2/11/17,25 - 30%,2/22/16,50-55%,,2,,1,70785067,2/11/17,2/27/17,16,14.67,UVHE 4 EAST,Respiratory arrest,98,1.9,152,1.54,92,41.1,93/55,,30 - 35%,,,,,,,,63443882,2/22/16,2/26/16,4,1.71,UVHE 4 EAST,,39,1.3,139,,62,41.1,142/63,,50-55%,,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2/27/17
Z113096,Female,7/6/77,2.00E+11,9/19/18,9/26/18,,,,,,1,1,1,,2,2/12/17,<15%,2/14/17,50-55%,2,,,2,2.00E+11,9/19/18,9/26/18,7,,UVHE 6 EAST,"CKD (chronic kidney disease), stage IV",62,3.5,138,,107,30.8,129/73,,,,1,,,,,,70791377,2/11/17,2/19/17,8,11.22,UVHE 4 WEST,ARDS (adult respiratory distress syndrome),45,2,136,,66,34.9,111/59,,50-55%,1,,,,1,,,70791377,2/11/17,2/19/17,8,11.22,UVHE 4 WEST,ARDS (adult respiratory distress syndrome),45,2,136,,66,34.9,111/59,,50-55%,1,,,,1,,,,,,,,,,,,,,,
Z77454,Female,8/13/42,72151715,4/13/17,4/14/17,1,,,,,,1,,,1,4/13/17,25 - 30%,4/13/17,25 - 30%,,1,,,72151715,4/13/17,4/14/17,1,0.88,UVHE MEDICAL ICU,Hypovolemic shock,44,3.7,154,0,100,,122/59,,25 - 30%,,,,,,,,39634075,8/30/12,8/31/12,1,,UVHE 4 EAST,,17,0.7,141,1.88,82,34,120/65,,,,,,,,,,35930796,3/26/12,3/26/12,0,,UVHE 6 CENTRAL,,21,0.8,143,,94,34.9,115/52,,,,,,,,,,,,,,,,,,,,,,4/14/17
Z370094,Male,1/29/59,72411232,4/25/17,5/17/17,,,,,1,,,,,23,3/7/16,<15%,7/20/17,60 - 65%,9,,,14,72411232,4/25/17,5/17/17,22,9.49,UVHE 4 WEST,Heart transplant candidate,26,1.3,134,1.02,68,26.4,109/73,,55 - 60%,,,,,1,,,69746172,12/23/16,1/3/17,11,,UVHE 4 EAST,"Anemia, unspecified",18,1,139,,202,24.5,95/70,,,,,,,1,,,67109679,8/19/16,8/25/16,6,,UVHE 4 EAST,,18,1,139,1.46,48,25.1,84/0,,20 - 25%,,,,,1,,,5/17/17,9,28,11,19,10,86,6.15,3.08,6.67,3.34,61.4,
Z124550,Female,3/9/60,2.00E+11,11/20/17,12/8/17,1,1,1,,,,,1,,14,2/3/18,<15%,10/18/17,50-55%,18,6,2,2,2.00E+11,11/20/17,12/8/17,18,22.06,UVHE 4 EAST,PAF (paroxysmal atrial fibrillation),82,2,131,,153,22.9,107/53,,15 - 20%,,,,,1,,,2.00E+11,10/16/17,11/16/17,31,61.2,UVHE 4 NORTH,Mitral valve disorder,94,1.7,146,0.24,140,20.7,118/55,,20 - 25%,,1,,,1,,,2.00E+11,10/16/17,11/16/17,31,61.2,UVHE 4 NORTH,Mitral valve disorder,94,1.7,146,0.24,140,20.7,118/55,,20 - 25%,,1,,,1,,1,12/4/17, 6; 6,35,16,24,13,80,2.4,1.53,3.97,2.53,51.3,6/25/18
Z86557,Male,2/17/61,2.00E+11,6/2/20,6/24/20,,,1,,1,,1,1,,20,7/27/17,<15%,12/12/13,60 - 65%,6,24,2,8,2.00E+11,6/2/20,6/24/20,22,,UVHE 4 EAST,"Uncontrolled type 2 diabetes mellitus with complication, with long-term current use of insulin",96,2.9,142,,133,46.7,116/62,,25 - 30%,,,,,1,,1,2.00E+11,10/3/18,10/12/18,9,,UVHE 4 EAST,Heart replaced by transplant,124,2.9,141,,152,41.6,115/67,,30 - 35%,,,,,1,,1,2.00E+11,10/3/18,10/12/18,9,,UVHE 4 EAST,Heart replaced by transplant,124,2.9,141,,152,41.6,115/67,,30 - 35%,,,,,1,,1,5/29/18,32,58,35,44,37,82,,,4.93,1.82,62.5,
Z459571,Female,10/19/35,2.00E+11,3/28/20,4/9/20,1,1,1,,,1,,,,6,3/29/20,<15%,1/4/19,20 - 25%,6,,,,2.00E+11,3/28/20,4/9/20,12,6.08,UVHE 3 EAST,NICM (nonischemic cardiomyopathy),82,1.4,143,,124,19.7,136/67,,<15%,,,,,,,,2.00E+11,1/3/19,1/5/19,2,,UVHE 4 WEST,Acute on chronic heart failure with reduced ejection fraction and diastolic dysfunction,16,0.9,136,,146,,110/58,,20 - 25%,,,,,1,,,2.00E+11,9/2/17,9/3/17,1,,UVHE 4 CENTRAL CV,Acute on chronic systolic congestive heart failure,8,0.9,139,,107,,138/74,,,1,,,,,,,,,,,,,,,,,,,4/9/20
Z347734,Female,10/5/60,2.00E+11,6/3/17,7/6/17,1,1,1,,,,,1,1,7,6/3/17,<15%,6/13/17,45 - 50%,3,3,1,,2.00E+11,6/3/17,7/6/17,33,13.93,UVHE 4 CENTRAL CV,Acute respiratory failure with hypoxia and hypercapnia,11,1.3,138,0.38,102,,149/67,,45 - 50%,,,,,,,,72057893,4/9/17,4/30/17,21,,UVHE 4 CENTRAL CV,Generalized abdominal pain,28,1.3,136,,76,21.1,168/58,,20 - 25%,1,,,,,,,71701108,3/30/17,3/31/17,1,,UVHE 4 CENTRAL CV,Middle aortic syndrome,52,2.2,131,,84,21.4,158/71,,,1,1,,,,,,,,,,,,,,,,,,3/30/20
Z2157157,Female,7/29/57,2.00E+11,1/2/18,1/26/18,,,1,,1,,1,,,26,1/9/18,<15%,7/9/18,60 - 65%,7,,6,13,2.00E+11,1/2/18,1/26/18,24,6.13,UVHE 4 EAST,Acute on chronic systolic congestive heart failure,16,1.2,138,,121,24.2,82/0,,<15%,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,1/3/18,7,36,21,27,12,66,1.88,1.04,2.6,1.44,46.3,
Z2211547,Male,8/29/42,2.00E+11,9/22/18,10/4/18,1,,1,,,,,,,2,9/25/18,<15%,9/24/18,15 - 20%,2,,,,2.00E+11,9/22/18,10/4/18,12,4.83,UVHE 4 WEST,Atrial fibrillation with RVR,21,1,142,0.56,139,29.1,132/60,,<15%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/4/18
Z2227437,Male,6/14/60,2.00E+11,6/21/19,9/6/19,,,1,1,1,,,1,1,30,7/2/19,<15%,11/3/19,65 - 70%,16,,,14,2.00E+11,6/21/19,9/6/19,77,60.74,UVHE 4 NORTH,Abscess of sternal region,9,0.7,128,1.29,99,24.3,97/77,,<15%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9/25/19,10, 47; 42, 24; 24, 31; 31,14,97,5.65,2.81,,,48.6,
Z2276981,Male,2/28/59,2.00E+11,11/20/17,11/25/17,,,1,,,,1,,,3,11/21/17,<15%,4/9/17,55 - 60%,4,,,2,2.00E+11,12/13/17,12/29/17,16,5.16,UVHE 4 EAST,Cardiogenic shock,31,0.8,132,1.57,106,21.5,114/73,,15 - 20%,,,,,,,,2.00E+11,11/20/17,11/25/17,5,6.12,UVHE 4 CENTRAL CV,Acute on chronic systolic heart failure,19,0.9,135,2.65,107,25.7,115/68,,<15%,1,,,,1,,,2.00E+11,11/20/17,11/25/17,5,6.12,UVHE 4 CENTRAL CV,Acute on chronic systolic heart failure,19,0.9,135,2.65,107,25.7,115/68,,<15%,1,,,,1,,,,,,,,,,,,,,,
Z2282795,Female,9/3/35,2.00E+11,3/26/19,3/28/19,1,,,,,,,1,,6,3/27/19,<15%,7/14/16,60 - 65%,1,1,,4,2.00E+11,3/26/19,3/28/19,2,1.75,UVHE CORONARY CARE,Cardiogenic shock,41,1.4,147,,158,25.4,105/85,,<15%,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3/26/19,13, 53; 54, 28; 30, 36; 38,26,,,,3.85,2.68,57.9,3/28/19
Z2507834,Female,4/27/16,70124787,1/13/17,3/23/17,1,,,,,,,1,,,,,,,,,,,70124787,1/13/17,3/23/17,69,22.95,UVHE 7 CIMU,Cardiogenic shock,11,0.4,136,2.12,,16.3,86/56,,,,,,,,,,67589563,9/21/16,12/19/16,89,60.68,UVHE 7NORTH ACUTE,"Respiratory failure, unspecified chronicity, unspecified whether with hypoxia or hypercapnia",2,0.2,138,3.37,106,19.6,106/58,,,,,,,,,,65598539,6/4/16,6/7/16,3,,UVHE 7 CENTRAL,,10,0.3,137,5.37,,11.9,84/39,,,,,,,,,,,,,,,,,,,,,,8/13/19
Z2568083,Male,2/16/44,71089873,2/24/17,2/24/17,1,,,,,,,,,1,2/24/17,<15%,2/24/17,<15%,1,,,,71089873,2/24/17,2/24/17,0,0.37,UVHE CORONARY CARE,Delay kidney tx func d/t ATN requiring acute dialysis,50,3.5,125,2.21,102,,92/52,,<15%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2/24/17
Z2578202,Male,3/17/59,72252919,4/18/17,6/12/17,,,,1,1,,1,,,37,4/19/17,<15%,7/4/20,65 - 70%,21,,,16,72252919,4/18/17,6/12/17,55,24.82,UVHE 4 EAST,Cardiogenic shock,15,0.9,132,1.31,90,28.4,116/88,,20 - 25%,1,,1,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4/27/17,5,50,18,31,15,61,5.65,2.35,5.07,2.11,72,
Z2618602,Male,12/2/47,2.00E+11,10/16/17,10/16/17,1,,,,,,,,,1,10/16/17,<15%,10/16/17,<15%,1,,,,2.00E+11,10/16/17,10/16/17,0,0.21,UVHE CORONARY CARE,Cardiac arrest,16,1.5,137,2.46,106,,118/67,,<15%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/16/17
Z2638855,Male,4/5/99,2.00E+11,1/14/18,1/17/18,1,,,,,,,,,,,,,,,,,,2.00E+11,1/14/18,1/17/18,3,2.85,UVHE PEDIATRIC ICU,Receiving inotropic medication,109,0.5,134,1.6,124,,73/52,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1/17/18
Z2647236,Female,12/12/46,2.00E+11,6/4/18,6/20/18,1,,,,,,,,,8,6/6/18,<15%,6/17/18,50-55%,5,1,1,1,2.00E+11,6/4/18,6/20/18,16,15.86,UVHE 4 NORTH,Upper GI bleed,32,0.6,135,0.78,123,26.7,93/74,,<15%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6/20/18
Z2752878,Male,11/30/18,2.00E+11,12/15/18,1/28/19,,,,,,,,,,,,,,,,,,,2.00E+11,12/15/18,1/28/19,44,28.45,UVHE 7 WEST,Pneumatosis intestinalis,7,0.3,141,4.71,60,11.4,104/57,,,,,,,,,,2.00E+11,12/5/18,12/9/18,4,3.5,UVHE NEWBORN ICU,Respiratory distress syndrome in neonate,19,0.8,136,,,13.5,82/48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2786826,Female,12/19/64,2.00E+11,3/26/19,4/7/19,1,,,,,1,1,,,5,3/26/19,<15%,4/1/19,15 - 20%,5,,,,2.00E+11,3/26/19,4/7/19,12,12.36,UVHE 4 NORTH,Personal history of extracorporeal membrane oxygenation (ECMO),109,3,144,3.82,81,41.4,97/56,,15 - 20%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4/7/19
Z2792235,Male,5/10/18,2.00E+11,9/26/20,9/30/20,1,,,,,,,,,,,,,,,,,,2.00E+11,9/26/20,9/30/20,4,3.32,UVHE PERIOP,Cardiogenic shock,6,0.3,144,1.3,68,,103/56,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9/28/20
Z2791762,Male,9/25/73,2.00E+11,4/12/19,4/26/19,,,1,,,1,,,,6,4/13/19,15 - 20%,4/25/19,20 - 25%,12,,,,2.00E+11,3/9/20,3/24/20,15,,UVHE 4 WEST,Cardiogenic shock,21,1.6,137,,157,29.9,135/71,,20 - 25%,,1,1,,1,,,2.00E+11,12/12/19,12/15/19,3,,UVHE 4 CENTRAL CV,LV (left ventricular) mural thrombus,15,1.3,139,,138,,105/58,,,,1,,,1,,,2.00E+11,6/21/19,6/30/19,9,,UVHE 4 EAST,NSTEMI (non-ST elevated myocardial infarction),30,1.1,135,,,27.3,98/62,,15 - 20%,1,,,,1,,1,3/20/20,11,68,31,45, 30; 33,75,3.9,1.88,4.03,1.95,52.5,
Z2791762,Male,9/25/73,2.00E+11,3/9/20,3/24/20,,,1,,,1,,,,6,4/13/19,15 - 20%,4/25/19,20 - 25%,12,,,,2.00E+11,3/9/20,3/24/20,15,,UVHE 4 WEST,Cardiogenic shock,21,1.6,137,,157,29.9,135/71,,20 - 25%,,1,1,,1,,,2.00E+11,12/12/19,12/15/19,3,,UVHE 4 CENTRAL CV,LV (left ventricular) mural thrombus,15,1.3,139,,138,,105/58,,,,1,,,1,,,2.00E+11,6/21/19,6/30/19,9,,UVHE 4 EAST,NSTEMI (non-ST elevated myocardial infarction),30,1.1,135,,,27.3,98/62,,15 - 20%,1,,,,1,,1,3/20/20,11,68,31,45, 30; 33,75,3.9,1.88,4.03,1.95,52.5,
Z2883604,Female,2/2/43,2.00E+11,12/10/19,12/20/19,1,,,,,,,1,,1,12/11/19,60 - 65%,12/11/19,60 - 65%,,,,1,2.00E+11,12/10/19,12/20/19,10,6.9,UVHE 4 WEST,Cardiogenic shock,85,1.3,147,2.37,102,22.2,124/69,,60 - 65%,1,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,12/11/19,9,31,22,25,22,90,1.99,1.17,,,57.7,12/20/19
Z2885417,Female,1/5/63,2.00E+11,12/5/19,12/12/19,,,,,,,,1,,4,12/6/19,55 - 60%,12/6/19,>70%,,,,4,2.00E+11,12/5/19,12/12/19,7,6.76,UVHE 4 NORTH,Nonrheumatic mitral valve stenosis,21,0.7,134,0,131,31.9,102/55,,55 - 60%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2941614,Male,9/9/96,2.00E+11,6/13/20,7/6/20,,,,,,,,,,7,6/13/20,<15%,6/19/20,60 - 65%,5,,,2,2.00E+11,6/13/20,7/6/20,23,11.01,UVHE 4 CENTRAL CV,"Viral myocarditis, unspecified chronicity",22,0.9,135,1.88,103,,109/69,,55 - 60%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z3005933,Female,5/17/79,2.00E+11,11/13/20,12/14/20,,,1,,,,,,,3,11/24/20,20 - 25%,11/14/20,25 - 30%,2,1,,,2.00E+11,11/13/20,12/14/20,31,11.7,UVHE 4 EAST,Cardiogenic shock,21,1.5,141,,122,19.9,108/74,,20 - 25%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12/10/20,13, 30; 38, 21; 17, 28; 28, 21; 22; 20,105,2.05,1.51,1.87,1.37,38.7,
Z457581,Male,5/11/53,2.00E+11,10/15/18,11/2/18,,,,,,1,,,,5,10/15/18,<15%,10/15/18,40 - 45%,3,1,1,,2.00E+11,10/15/18,11/2/18,18,12.24,UVHE 4 WEST,S/P MVR (mitral valve replacement),38,1.5,134,,112,24.9,93/52,,30 - 35%,,1,,,,,,57132549,4/2/15,4/5/15,3,,UVHE 5 CENTRAL,,33,1.3,135,,,22.3,114/74,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z327533,Male,4/12/48,2.00E+11,3/24/20,3/26/20,1,,,,,,,,,,,,,,,,,,2.00E+11,3/24/20,3/26/20,2,0.62,UVHE NEUR ICU,Acute leukemia not having achieved remission,17,1,137,0,100,,108/64,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3/26/20
Z2150479,Female,12/5/80,2.00E+11,11/30/19,12/7/19,1,,1,1,1,,1,,,40,3/16/16,<15%,4/28/19,55 - 60%,21,8,3,8,2.00E+11,11/30/19,12/7/19,7,6.69,UVHE 4 NORTH,Cardiogenic shock,36,1.6,145,0,114,32.1,52/25,,<15%,,,,,,,,2.00E+11,11/16/19,11/20/19,4,3.17,UVHE 4 WEST,Heart transplant recipient,47,1.5,138,,102,,141/92,,,,,,,1,,,2.00E+11,10/12/19,10/31/19,19,8.09,UVHE 4 EAST,Cardiac transplant rejection,77,2.9,136,0.28,106,35.5,122/87,,30 - 35%,,,,,1,,,12/2/19,15,47,26,35,22,125,6.88,3.49,5.6,2.84,70.9,12/7/19
Z2244044,Female,4/20/49,71423140,3/10/17,3/11/17,1,,,,,,,,,,,,,,,,,,71423140,3/10/17,3/11/17,1,0.46,UVHE CORONARY CARE,Cardiogenic shock,32,3,138,,,,70/62,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3/10/17,23,38,23,29,25,80,3.69,1.7,,,45.6,3/11/17
Z2276981,Male,2/28/59,2.00E+11,12/13/17,12/29/17,,,1,,,,1,,,3,11/21/17,<15%,4/9/17,55 - 60%,4,,,2,2.00E+11,12/13/17,12/29/17,16,5.16,UVHE 4 EAST,Cardiogenic shock,31,0.8,132,1.57,106,21.5,114/73,,15 - 20%,,,,,,,,2.00E+11,11/20/17,11/25/17,5,6.12,UVHE 4 CENTRAL CV,Acute on chronic systolic heart failure,19,0.9,135,2.65,107,25.7,115/68,,<15%,1,,,,1,,,2.00E+11,11/20/17,11/25/17,5,6.12,UVHE 4 CENTRAL CV,Acute on chronic systolic heart failure,19,0.9,135,2.65,107,25.7,115/68,,<15%,1,,,,1,,,,,,,,,,,,,,,
Z2338479,Female,11/27/44,2.00E+11,8/9/17,9/5/17,,,,,,,,,1,3,8/12/17,50-55%,8/9/17,55 - 60%,,,,3,2.00E+11,8/9/17,9/5/17,27,20.95,UVHE 4 WEST,Bradycardia,53,4.3,135,0.72,112,43.6,132/61,,50-55%,,,,,,,,49038753,1/7/14,1/13/14,6,1.7,UVHE 4 WEST,Aortic valve disease,19,0.7,137,,76,40.1,110/55,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2371274,Male,1/6/64,2.00E+11,8/5/17,8/5/17,1,,1,,,,,,,1,3/20/17,<15%,3/20/17,<15%,1,,,,2.00E+11,8/5/17,8/5/17,0,0.2,UVHE 3 NORTH,Acute respiratory failure with hypoxemia,29,3.2,129,0.88,,,88/52,,,,,,,,,,73088881,5/25/17,5/28/17,3,,UVHE 3 CENTRAL,Multifocal pneumonia,9,1.2,138,0.74,146,,108/64,,,1,,,,1,,,72889219,5/17/17,5/20/17,3,,UVHE 4 CENTRAL CV,Syncope and collapse,22,1.3,139,,128,,98/61,,,1,,,,1,,1,3/22/17,6,39,20,26,13,73,3.92,2.15,,,61.1,8/5/17
Z2374464,Male,5/19/69,2.00E+11,7/13/17,8/4/17,1,1,,,,,,1,,2,3/18/17,<15%,3/18/17,<15%,6,,,,2.00E+11,10/3/17,10/10/17,7,,UVHE 4 WEST,Acute decompensated heart failure,27,1.1,135,,100,,116/70,,,,,1,,1,,,2.00E+11,9/11/17,9/17/17,6,7.74,UVHE 3 CENTRAL,"Psychosis, unspecified psychosis type",53,1.4,137,1.21,102,,116/83,,,,,1,,1,,,2.00E+11,9/3/17,9/8/17,5,,UVHE 4 EAST,Acute on chronic systolic heart failure,33,1.9,133,,100,20.2,103/64,,,,,,,,,,3/17/17,18,48,29,37, 28; 32,94,3.42,1.63,4.53,2.16,42.4,5/7/18
Z2374464,Male,5/19/69,2.00E+11,9/3/17,9/8/17,1,1,,,,,,1,,2,3/18/17,<15%,3/18/17,<15%,6,,,,2.00E+11,10/3/17,10/10/17,7,,UVHE 4 WEST,Acute decompensated heart failure,27,1.1,135,,100,,116/70,,,,,1,,1,,,2.00E+11,9/11/17,9/17/17,6,7.74,UVHE 3 CENTRAL,"Psychosis, unspecified psychosis type",53,1.4,137,1.21,102,,116/83,,,,,1,,1,,,2.00E+11,9/3/17,9/8/17,5,,UVHE 4 EAST,Acute on chronic systolic heart failure,33,1.9,133,,100,20.2,103/64,,,,,,,,,,3/17/17,18,48,29,37, 28; 32,94,3.42,1.63,4.53,2.16,42.4,5/7/18
Z2432824,Female,9/13/98,2.00E+11,8/12/20,8/27/20,1,,1,,,,,,,10,8/13/20,<15%,7/8/20,65 - 70%,1,5,2,2,2.00E+11,8/12/20,8/27/20,15,14.89,UVHE CORONARY CARE,Cardiogenic shock,35,1.2,145,0.42,89,38.7,99/53,,<15%,,,,,,,,2.00E+11,7/6/20,7/17/20,11,2.02,UVHE 4 EAST,Chronic systolic heart failure,7,0.8,139,1.94,74,43.3,100/52,,65 - 70%,,,,,1,,,2.00E+11,11/21/18,11/24/18,3,,UVHE 8 NORTH OB,Postpartum state,6,0.5,137,1.85,90,39,121/70,,45 - 50%,1,,,,,,,7/14/20,22,48,30,35, 32; 30,96,3.63,1.71,3,1.41,44,8/27/20
Z2458948,Male,9/18/65,2.00E+11,1/30/20,2/20/20,,,1,,,1,1,1,,9,1/30/20,<15%,8/7/18,15 - 20%,9,,,,2.00E+11,1/30/20,2/20/20,21,15.37,UVHE 4 EAST,"Heart failure, unspecified HF chronicity, unspecified heart failure type",30,1.7,135,2.24,100,,99/74,,<15%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1/30/20,24,66,36,47,34,109,2.04,1.07,3.1,1.62,29.7,
Z2560230,Female,6/30/80,70190395,1/17/17,1/22/17,1,,,,,,,,,1,1/18/17,60 - 65%,1/18/17,60 - 65%,,,,1,70190395,1/17/17,1/22/17,5,4.81,UVHE CORONARY CARE,Cardiogenic shock,53,4.3,141,0.31,86,35.4,106/52,,60 - 65%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1/22/17
Z2573981,Male,2/11/62,2.00E+11,8/15/20,8/24/20,,,1,,,,,,,1,8/17/20,25 - 30%,8/17/20,25 - 30%,,1,,,2.00E+11,8/15/20,8/24/20,9,5.97,UVHE 3 WEST,Squamous cell carcinoma of hypopharynx,17,0.7,136,0,111,,113/79,,25 - 30%,1,,,,1,,,2.00E+11,6/5/20,6/14/20,9,0.34,UVHE 6 EAST,,17,0.7,135,0.92,107,,142/62,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2773033,Male,1/30/19,2.00E+11,1/30/19,4/18/19,1,,,,,,,,,,,,,,,,,,2.00E+11,1/30/19,4/18/19,78,77.31,UVHE PICU 7NORTH,TAPVR (total anomalous pulmonary venous return),18,0.4,143,0.56,58,12,74/46,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4/18/19
Z2776349,Female,9/20/58,2.00E+11,2/14/19,3/8/19,,,,,,,,,,4,2/15/19,<15%,3/4/19,45 - 50%,3,,1,,2.00E+11,2/14/19,3/8/19,22,15.29,UVHE 4 EAST,Cardiogenic shock,10,2.1,132,0.8,73,18.8,106/68,,45 - 50%,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2798951,Female,8/15/79,2.00E+11,5/1/19,5/20/19,,,,,,,,,,5,5/2/19,35 - 40%,5/11/19,60 - 65%,,1,2,2,2.00E+11,5/1/19,5/20/19,19,18.71,UVHE TCV POST OP,Personal history of extracorporeal membrane oxygenation (ECMO),39,0.7,144,2.45,75,29,105/68,,45 - 50%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2840137,Male,12/3/43,2.00E+11,9/7/19,9/25/19,1,,,,,,,,,3,9/11/19,20 - 25%,9/12/19,40 - 45%,1,1,1,,2.00E+11,9/7/19,9/25/19,18,15.02,UVHE 4 NORTH,Cardiogenic shock,17,0.9,140,0,179,27.3,111/59,,35 - 40%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9/25/19
Z2908749,Male,8/19/58,2.00E+11,11/23/20,12/23/20,,,1,,,,,,,1,11/25/20,<15%,11/25/20,<15%,1,,,,2.00E+11,11/23/20,12/23/20,30,9.6,UVHE 4 EAST,Cardiogenic shock,62,1.1,131,0.97,98,15.9,98/75,,<15%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2926277,Male,7/12/54,2.00E+11,4/30/20,5/15/20,,,1,,,,,,,2,5/1/20,30 - 35%,5/9/20,40 - 45%,,1,1,,2.00E+11,4/30/20,5/15/20,15,10.09,UVHE 4 CENTRAL CV,Cardiogenic shock,21,0.9,136,1.09,156,34.3,115/68,,40 - 45%,1,,,,1,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,5/1/20,14,45,23,30,15,71,7.05,3.05,6.5,2.82,81,
Z2979861,Male,12/9/66,2.00E+11,8/16/20,8/21/20,,,,,,,,,,2,8/20/20,35 - 40%,11/23/20,40 - 45%,,1,1,,2.00E+11,8/16/20,8/21/20,5,3.82,UVHE 4 EAST,"Acute MI, anterior wall, initial episode of care",13,0.8,136,1.55,144,29.4,94/60,,35 - 40%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8/16/20,9, 31; 42, 22; 22, 26; 30,19,110,5.13,2.39,,,65.3,
Z3006101,Female,4/29/46,2.00E+11,11/13/20,11/21/20,,,1,,,,,,1,1,11/14/20,15 - 20%,11/14/20,15 - 20%,1,,,,2.00E+11,11/13/20,11/21/20,8,5.4,UVHE 4 EAST,Cardiogenic shock,21,0.7,141,1.61,127,38.1,100/55,,15 - 20%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z334221,Male,10/6/42,71695333,3/28/17,4/10/17,,,1,1,,1,1,1,,3,3/29/17,40 - 45%,3/31/17,50-55%,,,2,1,71695333,3/28/17,4/10/17,13,8.93,UVHE 4 WEST,Acute on chronic systolic heart failure,96,2.3,139,,128,31.4,106/59,,50-55%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z358106,Male,8/13/44,2.00E+11,12/23/17,12/27/17,1,,,,,,,,,2,12/26/17,<15%,12/24/17,20 - 25%,2,,,,2.00E+11,12/23/17,12/27/17,4,3.76,UVHE CORONARY CARE,Cardiogenic shock,54,3.1,131,1.08,134,41.4,108/56,,<15%,,,,,,,,8969450,4/14/01,4/15/01,1,,UVHE 6 WEST,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12/27/17
Z212654,Female,6/4/46,2.00E+11,9/4/18,9/6/18,1,,,1,,1,1,1,,11,9/6/18,15 - 20%,6/20/16,60 - 65%,1,1,1,8,2.00E+11,9/4/18,9/6/18,2,2,UVHE MEDICAL ICU,Melena,41,4.6,141,1.38,136,32,73/58,,15 - 20%,,,,,,,,2.00E+11,8/6/18,8/16/18,10,,UVHE 4 EAST,Syncope and collapse,41,5.9,130,0.96,160,32.9,119/55,,25 - 30%,,,,,1,,,2.00E+11,4/11/18,4/13/18,2,,UVHE 3 EAST,"Upper respiratory tract infection, unspecified type",31,3.8,136,1,161,,138/64,,50-55%,,,,,1,,,,,,,,,,,,,,,9/6/18
Z277858,Female,4/5/31,2.00E+11,7/12/17,8/9/17,,,,,,1,,,,9,7/14/17,50-55%,7/16/17,65 - 70%,,,,9,2.00E+11,7/12/17,8/9/17,28,25.7,UVHE CORONARY CARE,S/P CABG x 2,58,0.9,149,0.84,103,28.5,103/51,,60 - 65%,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z138856,Male,1/27/61,2.00E+11,9/9/20,9/11/20,1,,,,,,1,,,1,9/10/20,<15%,9/10/20,<15%,1,,,,2.00E+11,9/9/20,9/11/20,2,0.82,UVHE CORONARY CARE,"ST elevation myocardial infarction (STEMI), unspecified artery",20,1.1,131,1.05,183,,72/51,,<15%,,,,,,,,2.00E+11,5/17/18,5/20/18,3,1.74,UVHE 5 CENTRAL,Bacteremia due to Escherichia coli,15,1.1,134,0.24,85,,127/71,,,,,,,,,,66490745,7/20/16,7/21/16,1,,UVHE 5 WEST,"Incisional hernia, without obstruction or gangrene",13,1,133,,,24.4,133/75,,,,,,,,,,9/10/20,12,52,34,39,29,130,2.92,1.65,4.37,2.47,51.3,9/11/20
Z304771,Male,3/20/22,73123400,5/30/17,6/4/17,1,,1,,,1,1,,,3,5/30/17,15 - 20%,6/30/17,35 - 40%,1,2,,,73123400,5/30/17,6/4/17,5,4.32,UVHE 4 EAST,"ST elevation myocardial infarction (STEMI), unspecified artery",45,1.4,139,2.45,105,,142/63,,15 - 20%,,1,,,1,,,51020569,4/23/14,4/26/14,3,,UVHE 6 EAST,Humeral surgical neck fracture,26,1,140,0.71,,,140/80,,,,,,,1,,,38069264,6/22/12,6/24/12,2,1.46,UVHE 4 CENTRAL CV,,21,0.9,138,2.39,126,,139/68,,,,1,,,1,,,,,,,,,,,,,,,9/25/19
Z75684,Female,11/8/63,2.00E+11,8/10/20,9/1/20,1,1,1,,,1,,1,,11,5/5/20,<15%,1/9/19,25 - 30%,20,2,,,2.00E+11,8/10/20,9/1/20,22,18.56,UVHE CORONARY CARE,Cardiogenic shock,36,1.3,143,1.37,42,36.4,69/59,,<15%,,,,,,,,2.00E+11,6/6/20,7/23/20,47,22.86,UVHE 4 EAST,Chronic systolic heart failure,8,0.7,135,1.26,94,38,70/0,,<15%,1,,,,1,,,2.00E+11,5/4/20,5/13/20,9,,UVHE 4 EAST,Chronic systolic heart failure,23,1.4,140,,171,39.5,84/54,,<15%,1,,,,1,,,8/28/18,15, 37; 35, 18; 19, 25; 25,18,88,3.6,1.62,4.13,1.85,43.6,9/1/20
Z295030,Male,2/2/64,2.00E+11,4/11/18,4/21/18,1,,1,,,,,1,,12,9/17/20,15 - 20%,3/7/14,60 - 65%,12,6,2,4,2.00E+11,4/11/18,4/21/18,10,11.16,UVHE 3 WEST,Delirium tremens,16,1.9,135,1.36,146,,145/80,,20 - 25%,,,,,1,,,2.00E+11,2/22/18,2/24/18,2,,UVHE 3 WEST,Acute systolic heart failure,31,2.3,133,,151,,106/65,,,,,,,1,,,2.00E+11,2/5/18,2/10/18,5,,UVHE 3 CENTRAL,Acute hepatitis,30,2.3,132,1.09,154,,89/52,,20 - 25%,,,,,1,,,11/28/17,31,58,27,42,28,71,5.09,2.5,3.87,1.9,61.6,10/1/20
Z437836,Female,3/9/46,2.00E+11,2/10/18,2/14/18,1,1,1,,,1,1,1,,3,2/11/18,<15%,10/13/17,15 - 20%,3,,,,2.00E+11,2/10/18,2/14/18,4,1.23,UVHE 4 EAST,Cardiogenic shock,64,2.9,138,,193,20.8,101/63,,<15%,,,,,1,,,2.00E+11,1/10/18,1/16/18,6,,UVHE 4 CENTRAL CV,Acute on chronic systolic congestive heart failure,39,2.8,139,0.85,189,,91/54,,,,1,,,,,,2.00E+11,10/12/17,10/23/17,11,1.97,UVHE 4 EAST,"Acute on chronic congestive heart failure, unspecified congestive heart failure type",32,2.7,139,,218,19.9,100/65,,15 - 20%,,1,,,,,,10/18/17,16,68,34,49,40,69,2.04,1.19,2.33,1.36,36.3,11/17/18
Z372345,Female,1/1/75,2.00E+11,9/19/19,9/25/19,,,1,,,1,1,,,8,10/14/19,20 - 25%,4/16/14,50-55%,1,6,,1,2.00E+11,9/19/19,9/25/19,6,1.31,UVHE 4 CENTRAL CV,NSTEMI (non-ST elevated myocardial infarction),25,0.6,136,3.44,98,29.2,102/56,,25 - 30%,1,,,,1,,1,2.00E+11,8/20/19,8/23/19,3,,UVHE 4 WEST,NSTEMI (non-ST elevated myocardial infarction),12,0.5,137,,97,28.3,90/55,,25 - 30%,1,,,,1,,1,2.00E+11,5/8/19,5/13/19,5,2.17,UVHE 4 EAST,NSTEMI (non-ST elevated myocardial infarction),13,0.5,135,3,100,29.2,94/52,,25 - 30%,1,,,,1,,,9/19/19,12,47,25,34,25,86,4.82,2.58,5.67,3.04,72.1,
Z1782145,Male,5/20/51,2.00E+11,6/23/20,6/29/20,,,1,,,1,1,1,,7,5/31/19,<15%,10/21/20,35 - 40%,3,4,,,2.00E+11,6/23/20,6/29/20,6,2.1,UVHE 4 EAST,Normocytic anemia,16,1.2,141,1.09,157,21.6,157/76,,20 - 25%,,,,,,,1,2.00E+11,12/17/19,12/26/19,9,1.18,UVHE 6 CENTRAL,"Hypertension, unspecified type",38,1.5,140,0.59,161,,172/89,,30 - 35%,1,,,,,,1,2.00E+11,7/8/19,7/11/19,3,1.01,UVHE 4 WEST,Stage 3 chronic kidney disease,28,1.6,137,,165,22.9,121/69,,,,,,,,,,,,,,,,,,,,,,
Z844946,Male,1/31/42,2.00E+11,9/7/18,9/12/18,1,,,,,,,,,,,,,,,,,,2.00E+11,9/7/18,9/12/18,5,4.98,UVHE CORONARY CARE,"Acute renal failure, unspecified acute renal failure type",55,1.7,143,1.51,84,26,63/42,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9/12/18
Z101592,Male,7/3/38,2.00E+11,4/13/18,4/19/18,1,1,1,,,1,,,1,4,12/31/15,15 - 20%,3/31/17,20 - 25%,4,,,,2.00E+11,4/13/18,4/19/18,6,3.93,UVHE 4 WEST,Cardiogenic shock,51,1.4,145,0.73,121,19.3,100/54,,20 - 25%,,,,,,,,2.00E+11,9/15/17,9/18/17,3,,UVHE 3 EAST,Other specified hypotension,18,0.9,137,1.85,120,18.3,90/52,,,,,,,,,,2.00E+11,8/15/17,8/23/17,8,,UVHE 4 EAST,Acute cystitis without hematuria,17,0.8,139,0.93,119,21.1,118/60,,,1,,,,,,1,,,,,,,,,,,,,6/8/18
Z988224,Male,5/8/98,2.00E+11,10/19/17,11/27/17,,,1,1,1,,1,,,43,9/14/17,50-55%,11/6/17,>70%,,,,43,2.00E+11,10/19/17,11/27/17,39,17.85,UVHE 4 WEST,Status post orthotopic heart transplant,10,0.7,136,0.89,118,23,120/78,,>70%,,,,,1,,,2.00E+11,9/11/17,9/15/17,4,,UVHE 4 WEST,Heart replaced by transplant,18,1.2,139,0.53,132,,109/64,,50-55%,,,,,,,,2.00E+11,6/23/17,6/28/17,5,,UVHE 4 EAST,Acute on chronic diastolic heart failure,17,1.1,137,,131,,101/64,,,,,,,,,,11/21/17,8,20,12,15,8,,,,3,1.68,,
Z672892,Male,8/1/41,2.00E+11,1/21/18,1/27/18,1,,,,,,,,,4,1/21/18,<15%,1/21/18,<15%,4,,,,2.00E+11,1/21/18,1/27/18,6,6.58,UVHE 4 NORTH,Cardiogenic shock,32,1.8,135,1.18,88,,91/66,,<15%,,,,,,,,8967814,4/2/01,4/6/01,4,,UVHE 6 WEST,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1/27/18
Z93161,Male,7/26/46,2.00E+11,1/15/18,1/20/18,1,1,,,,1,,,1,2,12/28/17,25 - 30%,12/28/17,25 - 30%,,2,,,2.00E+11,1/15/18,1/20/18,5,3.39,UVHE 4 EAST,Acute systolic heart failure,42,1,129,0.63,,,128/73,,25 - 30%,1,,,,,,,2.00E+11,12/27/17,1/5/18,9,1.88,UVHE 4 EAST,Coronary artery disease involving native coronary artery of native heart with angina pectoris,22,0.9,126,0.92,97,17.3,128/60,,25 - 30%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1/2/18,,28,17,21,14,78,2.84,1.65,2.57,1.49,55.1,3/2/18
Z76310,Male,8/19/93,2.00E+11,12/8/17,6/7/18,1,,1,,1,,,1,,36,12/13/17,<15%,7/28/16,60 - 65%,8,15,8,5,2.00E+11,12/8/17,6/7/18,181,179.65,UVHE 4 NORTH,ESRD (end stage renal disease),46,2,136,0.85,103,19.9,93/52,,45 - 50%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6/6/18,10,30,15,20,14,88,4.29,2.55,3.77,2.24,52.4,6/3/19
Z251151,Male,4/12/31,2.00E+11,7/1/17,7/3/17,1,,,1,,,,,,2,7/2/17,20 - 25%,4/4/17,55 - 60%,1,,,1,2.00E+11,7/1/17,7/3/17,2,1.6,UVHE CORONARY CARE,SIRS (systemic inflammatory response syndrome),48,3,137,0.55,127,26.7,108/65,,20 - 25%,,,,,,,,71933865,4/3/17,4/7/17,4,,UVHE 4 WEST,"Fracture, proximal femur, right, closed, initial encounter",31,1.6,135,,,27.5,118/56,,55 - 60%,,,,,,,,1920158,3/7/05,3/11/05,4,,UVHE 4 WEST,,31,1.1,137,,,,,,,,,,,,,,,,,,,,,,,,,,7/4/17
Z314921,Male,11/2/33,2.00E+11,11/25/17,12/6/17,1,,1,,,,,,,2,11/25/17,30 - 35%,11/25/17,30 - 35%,,2,,,2.00E+11,11/25/17,12/6/17,11,5.56,UVHE 4 CENTRAL CV,Palliative care patient,134,3.2,154,0.28,96,,92/63,,30 - 35%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12/6/17
Z733645,Female,3/13/60,2.00E+11,9/27/19,10/9/19,1,,1,,,1,1,1,1,2,9/29/19,20 - 25%,9/29/19,20 - 25%,2,,,,2.00E+11,9/27/19,10/9/19,12,9.99,UVHE 4 EAST,Peripheral polyneuropathy,57,2.8,134,1.09,120,37.5,98/50,,20 - 25%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/4/19,14,76,31,51,28,74,4.32,2.23,,,73.7,2/3/20
Z239069,Male,3/17/52,2.00E+11,7/9/19,7/16/19,1,,1,,,1,1,1,,4,4/16/19,15 - 20%,7/2/17,30 - 35%,2,2,,,2.00E+11,7/9/19,7/16/19,7,6.33,UVHE CORONARY CARE,Cardiogenic shock,27,1.3,148,,81,35.3,,,15 - 20%,,,,,,,,2.00E+11,7/2/17,7/9/17,7,4.27,UVHE 5 WEST,Septic shock due to undetermined organism,44,1.9,142,0.31,85,36,125/60,,30 - 35%,1,,,,1,,,3333171,2/5/07,2/7/07,2,,UVHE 8 WEST,,10,0.9,140,,,,,,,,,,,,,,,,,,,,,,,,,,7/16/19
Z165476,Female,12/18/89,70587802,2/2/17,2/10/17,,,,,,,,,,10,1/26/15,50-55%,5/23/19,65 - 70%,,,,10,70587802,2/2/17,2/10/17,8,5.84,UVHE 4 EAST,Acute on chronic systolic right heart failure,20,0.8,134,2.61,90,28.6,97/56,,55 - 60%,,,,,,,,62500150,1/5/16,1/18/16,13,9.22,UVHE 4 CENTRAL CV,Septic shock,11,0.7,135,1.6,78,25.5,117/64,,55 - 60%,,,,,,,,47437184,10/16/13,10/19/13,3,,UVHE 4 EAST,S/P cardiac catheterization,10,0.7,137,,72,24.1,110/54,,,,,,,,,,2/9/17,0, 92; 96, 27; 33, 56; 57,25,,,,5.28,3.34,,
Z314907,Female,9/7/57,2.00E+11,11/8/20,11/15/20,,,,,,,,,1,2,11/6/20,15 - 20%,11/6/20,15 - 20%,2,,,,2.00E+11,11/8/20,11/15/20,7,3.03,UVHE 4 CENTRAL CV,Cardiogenic shock,14,0.7,139,1.22,99,21.9,110/55,,15 - 20%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z181980,Female,5/24/59,70242422,1/31/17,3/2/17,,,,,,,,,,2,2/2/17,20 - 25%,2/21/17,65 - 70%,1,,,1,70242422,1/31/17,3/2/17,30,28.28,UVHE 5 NORTH,Acute respiratory failure with hypoxemia,26,0.7,132,,78,25.5,103/77,,65 - 70%,,,,,,,,67260517,9/6/16,10/25/16,49,16.62,UVHE 5 CENTRAL,Post-op pain,10,1.2,132,0.42,74,23.7,96/65,,,,,,,,,,65193529,5/14/16,5/29/16,15,,UVHE 5 CENTRAL,Post-op pain,7,0.6,140,5.62,82,23.3,123/71,,,,,,,,,,,,,,,,,,,,,,
Z465369,Female,10/10/48,70465587,1/29/17,2/7/17,1,,1,,1,1,1,1,,11,1/14/16,30 - 35%,10/29/13,55 - 60%,,5,3,3,70465587,1/29/17,2/7/17,9,3.63,UVHE 4 CENTRAL CV,Cardiogenic shock,21,1.7,137,1.21,100,28.1,,,40 - 45%,1,,,,,,,63469232,2/22/16,3/1/16,8,,UVHE 4 EAST,HSV (herpes simplex virus) infection,30,1.6,139,0.93,104,,120/75,,35 - 40%,1,,,,,,,62539830,1/14/16,1/19/16,5,,UVHE 4 CENTRAL CV,Cardiac allograft vasculopathy,26,1.3,137,,111,28.8,126/78,,30 - 35%,,,,,,,,1/31/17,9,37,12,25,17,,4.96,2.7,5.41,2.94,58,11/26/19
Z2277105,Male,12/28/57,2.00E+11,1/4/18,1/12/18,1,,,,,,1,1,,10,1/4/18,20 - 25%,6/8/15,65 - 70%,1,,,9,2.00E+11,1/4/18,1/12/18,8,7.56,UVHE 3 WEST,Shock,39,1.1,147,,72,,129/85,,60 - 65%,1,,,,1,,,2.00E+11,12/22/17,12/27/17,5,,UVHE 3 WEST,PEG (percutaneous endoscopic gastrostomy) adjustment/replacement/removal,20,1,136,,,,157/98,,,,,,,,,,71647617,3/21/17,3/27/17,6,,UVHE 3 CENTRAL,"Hyperglycemia, drug-induced",37,0.9,133,0.76,81,22.4,133/89,,,,,,,,,,,,,,,,,,,,,,3/9/19
Z2346920,Female,12/9/75,71006977,2/21/17,6/16/17,,,,1,1,,,,,64,10/12/16,<15%,6/2/17,65 - 70%,25,2,,37,71006977,2/21/17,6/16/17,115,109.63,UVHE 4 WEST,"Dry eye syndrome, bilateral",35,1.8,139,0.8,70,18.3,129/59,,60 - 65%,,,,,1,,1,64216447,3/29/16,4/22/16,24,6.24,UVHE 4 EAST,LVAD (left ventricular assist device) present,12,0.8,136,,,21.8,76/0,,20 - 25%,,,,,,,1,63829927,3/9/16,3/14/16,5,,UVHE 4 CENTRAL CV,"Anemia, unspecified type",39,1.7,135,,164,24.3,98/56,,25 - 30%,,,,,1,,1,6/19/17, 13; 13,36,13,22,16,46,4.42,2.82,3.8,2.42,67.8,
Z2426619,Male,2/24/70,2.00E+11,9/19/18,10/20/18,1,1,1,,,,,1,,2,9/20/18,<15%,9/20/18,<15%,4,,,,2.00E+11,10/30/18,11/4/18,5,11,UVHE CORONARY CARE,Cardiogenic shock,13,1.5,139,1.48,199,47.5,76/44,,<15%,,,,,,,,2.00E+11,9/19/18,10/20/18,31,34.18,UVHE 4 WEST,PAF (paroxysmal atrial fibrillation),50,3.5,129,0.88,133,46.8,121/81,,<15%,1,,,,1,,,2.00E+11,9/19/18,10/20/18,31,34.18,UVHE 4 WEST,PAF (paroxysmal atrial fibrillation),50,3.5,129,0.88,133,46.8,121/81,,<15%,1,,,,1,,1,10/31/18,33,67,46,52,37,133,5.05,1.91,,,38.9,11/4/18
Z2426619,Male,2/24/70,2.00E+11,10/30/18,11/4/18,1,1,1,,,,,1,,2,9/20/18,<15%,9/20/18,<15%,4,,,,2.00E+11,10/30/18,11/4/18,5,11,UVHE CORONARY CARE,Cardiogenic shock,13,1.5,139,1.48,199,47.5,76/44,,<15%,,,,,,,,2.00E+11,9/19/18,10/20/18,31,34.18,UVHE 4 WEST,PAF (paroxysmal atrial fibrillation),50,3.5,129,0.88,133,46.8,121/81,,<15%,1,,,,1,,,2.00E+11,9/19/18,10/20/18,31,34.18,UVHE 4 WEST,PAF (paroxysmal atrial fibrillation),50,3.5,129,0.88,133,46.8,121/81,,<15%,1,,,,1,,1,10/31/18,33,67,46,52,37,133,5.05,1.91,,,38.9,11/4/18
Z2461115,Male,10/26/46,2.00E+11,3/30/18,4/7/18,1,,1,,,1,1,1,,22,9/3/15,<15%,9/21/15,15 - 20%,22,,,,2.00E+11,3/30/18,4/7/18,8,7.49,UVHE CORONARY CARE,Septic shock,41,2.1,149,0.73,77,,89/51,,<15%,,,,,,,,2.00E+11,3/7/18,3/16/18,9,,UVHE 4 EAST,"Hypervolemia, unspecified hypervolemia type",65,2.4,136,0.18,175,31.7,60/0,,<15%,,,,,1,,,2.00E+11,1/15/18,1/19/18,4,0.68,UVHE 4 EAST,Dehydration,37,2,140,0.26,153,,98/64,,<15%,,,,,1,,,,,,,,,,,,,,,4/7/18
Z2470379,Female,7/16/65,2.00E+11,7/26/17,9/5/17,1,,1,,,1,1,,1,5,2/22/16,<15%,2/22/16,<15%,5,,,,2.00E+11,7/26/17,9/5/17,41,15.46,UVHE CORONARY CARE,Subacute bacterial endocarditis,28,1.1,136,2.36,144,35.4,110/0,,<15%,,,,,,,,73079935,5/25/17,5/28/17,3,,UVHE 4 EAST,,22,0.7,135,,140,41,90/0,,<15%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9/5/17
Z2483092,Female,9/27/46,71043111,2/22/17,2/24/17,1,,1,,,,1,,,2,12/28/16,15 - 20%,12/28/16,15 - 20%,2,,,,71043111,2/22/17,2/24/17,2,1401.98,UVHE CORONARY CARE,Cardiogenic shock,57,2.6,151,1.43,162,21.8,92/55,,15 - 20%,,,,,,,,69783815,12/28/16,1/3/17,6,2.93,UVHE 4 EAST,Severe protein-calorie malnutrition,35,1,134,0.98,174,,106/54,,15 - 20%,,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2/24/17
Z2331222,Female,7/28/96,2.00E+11,5/13/19,6/10/19,1,,,1,1,,1,1,,53,9/23/19,<15%,8/20/15,60 - 65%,39,15,15,90,2.00E+11,9/23/19,10/16/19,23,53.7,UVHE CORONARY CARE,Cardiac arrest,70,3.9,133,0,96,29,86/48,,50-55%,,,,,,,,2.00E+11,7/22/19,8/13/19,22,12.57,UVHE 4 WEST,Status post orthotopic heart transplant,26,1.5,141,0.22,88,30.4,108/71,,35 - 40%,1,,,,1,,,2.00E+11,5/13/19,6/10/19,28,63.36,UVHE 4 WEST,Acute rejection of cardiac transplant,30,1.4,138,0.36,100,32.4,117/85,,50-55%,1,,,,1,,,6/12/19,10,26,12,19,10,111,3.88,2.01,3.43,1.78,54.4,10/16/19
Z2348605,Male,10/14/53,2.00E+11,2/19/18,3/1/18,1,1,1,,,,,1,,4,2/20/18,<15%,2/21/14,15 - 20%,4,,,,2.00E+11,2/19/18,3/1/18,10,3.74,UVHE 4 EAST,Paroxysmal atrial fibrillation,105,2.1,131,1.26,139,,113/56,,<15%,1,,,,,,1,62404991,12/29/15,1/6/16,8,,UVHE 4 CENTRAL CV,Acute on chronic combined systolic and diastolic heart failure,32,2.1,134,,120,33,99/62,,15 - 20%,1,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5/6/20
Z2442086,Male,5/22/40,71776033,3/27/17,4/7/17,,,1,,,,,,,1,3/29/17,<15%,3/29/17,<15%,1,,,,71776033,3/27/17,4/7/17,11,,UVHE 4 CENTRAL CV,Acute on chronic systolic heart failure,40,1.7,128,0.95,112,27.4,91/57,,<15%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4/6/17, 9; 10,44,22,32, 27; 32767,73,6.06,2.72,5.03,2.26,65,
Z2582960,Male,6/23/58,72968608,5/21/17,6/16/17,,,,1,1,,1,,,28,9/17/17,<15%,2/27/19,65 - 70%,5,,,23,72968608,5/21/17,6/16/17,26,6.26,UVHE 4 CENTRAL CV,Acute on chronic combined systolic and diastolic heart failure,81,1.6,133,1.35,102,,102/64,,15 - 20%,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6/14/17,11,52,31,36,22,94,3.99,2,5.63,2.83,51,
Z2630256,Male,12/11/49,2.00E+11,12/2/17,12/12/17,,,,,,1,,,1,1,1/15/18,25 - 30%,1/15/18,25 - 30%,,1,,,2.00E+11,12/2/17,12/12/17,10,2.89,UVHE 4 WEST,S/P CABG x 2,21,0.8,135,1.62,108,,130/63,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2639016,Female,8/17/39,2.00E+11,2/9/18,2/21/18,1,1,1,,,,1,1,,6,1/29/18,20 - 25%,2/10/18,40 - 45%,1,4,1,,2.00E+11,2/9/18,2/21/18,12,8.73,UVHE 4 CENTRAL CV,"Acute renal failure, unspecified acute renal failure type",77,2.6,135,1.2,161,29.6,110/58,,40 - 45%,,,,,1,,,2.00E+11,1/15/18,2/1/18,17,,UVHE 4 EAST,Non-rheumatic mitral regurgitation,81,3,135,,212,30.2,118/66,,35 - 40%,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6/21/18
Z2647295,Male,7/4/35,2.00E+11,2/13/18,2/19/18,1,,,,,,,,,2,2/14/18,<15%,2/14/18,<15%,2,,,,2.00E+11,2/13/18,2/19/18,6,5.89,UVHE CORONARY CARE,,48,1.8,140,1.11,144,,118/68,,<15%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2/14/18,8, 32; 36, 18; 16, 23; 24, 15; 16,74,4.73,2.17,4.77,2.19,63.1,2/19/18
Z2650526,Male,1/12/71,2.00E+11,12/16/19,3/2/20,,1,,1,,,1,1,,15,12/28/19,15 - 20%,12/31/19,>70%,1,,,14,2.00E+11,12/16/19,3/2/20,77,61.87,UVHE 4 WEST,Sarcoid,27,1.3,137,0,86,32.2,115/82,,60 - 65%,,,,,1,1,1,2.00E+11,11/19/19,11/26/19,7,,UVHE 4 EAST,Acute on chronic right heart failure,25,1.5,140,0.95,104,37,114/75,,,,,,,,,1,2.00E+11,2/23/18,3/6/18,11,4.21,UVHE 4 EAST,Acute on chronic right heart failure,37,1,140,0.64,89,32.1,135/86,,55 - 60%,,,,,,,,12/17/19,29,92,37,57,24,64,6.21,2.58,5.07,2.1,70.8,
Z2673792,Male,9/29/69,2.00E+11,5/13/18,5/25/18,1,,,,,,,,,5,5/14/18,<15%,5/26/18,55 - 60%,2,,1,2,2.00E+11,5/13/18,5/25/18,12,11.32,UVHE 4 NORTH,Cardiogenic shock,71,3.3,143,2.25,71,,134/65,,55 - 60%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5/24/18
Z2673388,Female,11/19/50,2.00E+11,9/10/18,10/4/18,1,,1,,,,1,,,25,5/11/18,<15%,10/20/18,25 - 30%,48,2,,,2.00E+11,9/10/18,10/4/18,24,2.78,UVHE 4 EAST,Gastrointestinal hemorrhage with melena,10,0.7,138,,49,29.5,111/69,,15 - 20%,,1,,,,,,2.00E+11,8/6/18,8/14/18,8,,UVHE 4 EAST,Chronic systolic heart failure,11,0.7,138,3.54,57,29.7,104/71,,15 - 20%,,,,,1,,,2.00E+11,5/10/18,7/27/18,78,70.96,UVHE 4 EAST,LVAD (left ventricular assist device) present,16,0.6,140,2.04,66,29.8,94/54,,20 - 25%,,,,,1,,,8/13/18,5,37,8,19,5,74,3.46,2.02,4.27,2.49,63,10/26/19
Z2702622,Male,2/28/44,2.00E+11,8/13/18,8/28/18,1,,,,,1,,,1,6,8/17/18,30 - 35%,8/13/18,40 - 45%,,4,2,,2.00E+11,8/13/18,8/28/18,15,14.21,UVHE TCV POST OP,"Coronary artery disease of native heart with stable angina pectoris, unspecified vessel or lesion type",25,1,146,3.29,97,28,101/59,,40 - 45%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8/27/18
Z2723048,Male,6/18/76,2.00E+11,9/28/18,11/3/18,,,1,,,1,1,,,18,10/5/18,<15%,9/23/20,60 - 65%,7,1,3,7,2.00E+11,9/28/18,11/3/18,36,8.11,UVHE 4 EAST,"Gastroesophageal reflux disease, esophagitis presence not specified",15,0.8,137,,88,23.7,101/69,,15 - 20%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/12/18,5,21,10,14,7,88,4.74,2.34,3.83,1.89,69,
Z2735215,Male,2/1/62,2.00E+11,10/24/18,12/22/18,1,,1,,,1,1,,,14,11/5/18,<15%,11/25/18,25 - 30%,12,2,,,2.00E+11,10/24/18,12/22/18,59,44.53,UVHE 4 EAST,Cardiogenic shock,20,1.6,133,0.63,74,26.6,88/66,,15 - 20%,1,,,,1,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,10/25/18,13,50,23,33,24,97,4.78,2.55,4.73,2.52,61.8,5/3/19
Z2759861,Male,9/5/55,2.00E+11,12/23/18,1/4/19,,,1,,,1,1,,,2,12/24/18,15 - 20%,12/28/18,20 - 25%,2,,,,2.00E+11,12/23/18,1/4/19,12,8.19,UVHE 4 EAST,Cardiogenic shock,41,1.8,130,2.88,105,27.5,83/55,,20 - 25%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2801292,Male,11/27/59,2.00E+11,5/11/19,5/19/19,,,1,,,1,1,1,,2,5/14/19,<15%,5/16/19,20 - 25%,2,,,,2.00E+11,5/11/19,5/19/19,8,7.66,UVHE 4 NORTH,Acute combined systolic and diastolic heart failure,81,1.3,152,,,,100/46,,20 - 25%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2819277,Female,3/25/00,2.00E+11,7/9/19,7/16/19,,,,,,,,,,6,7/9/19,40 - 45%,7/16/19,60 - 65%,,,3,3,2.00E+11,7/9/19,7/16/19,7,6.03,UVHE 6 CENTRAL,Myocarditis due to infectious agent,9,0.7,143,3.01,46,26.3,117/65,,60 - 65%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2853614,Female,1/9/88,2.00E+11,9/25/19,12/3/19,,,1,,,,,,,21,10/1/19,20 - 25%,8/14/20,60 - 65%,5,8,3,5,2.00E+11,9/25/19,12/3/19,69,59.59,UVHE 4 EAST,LVAD (left ventricular assist device) present,6,0.6,137,0.42,86,22.1,89/54,,20 - 25%,,,,,1,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,9/26/19,12,59,30,40,18,115,4.43,2.56,5.6,3.24,50.6,
Z2919181,Female,12/9/75,2.00E+11,6/16/20,7/31/20,,,,1,1,,,,,11,6/16/20,<15%,7/23/20,60 - 65%,2,,,9,2.00E+11,6/16/20,7/31/20,45,33.37,UVHE 4 WEST,Heart transplant recipient,19,0.9,138,2.43,99,29.9,94/57,,60 - 65%,,,,,1,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,7/23/20,10, 32; 36, 12; 12, 22; 22,15,78,5.06,2.74,5.23,2.83,58.5,
Z1349930,Female,6/25/41,2.00E+11,1/21/18,2/8/18,1,1,1,,,1,1,1,,8,9/12/18,20 - 25%,1/5/18,55 - 60%,3,2,2,1,2.00E+11,1/21/18,2/8/18,18,15.99,UVHE 4 CENTRAL CV,Angina at rest,19,1.3,142,1.14,84,25,115/55,,40 - 45%,,1,,,,,,2.00E+11,1/2/18,1/10/18,8,1.45,UVHE 4 CENTRAL CV,Essential hypertension,29,1.3,139,,89,,130/65,,45 - 50%,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6/15/20
Z685436,Male,3/5/47,2.00E+11,1/8/19,1/15/19,,,,,,,,,1,2,3/7/16,55 - 60%,1/8/19,65 - 70%,,,,2,2.00E+11,1/8/19,1/15/19,7,5.65,UVHE MEDICAL ICU,Melena,10,1,139,1.3,96,32,115/53,,65 - 70%,,,,,,,,63004512,1/29/16,1/30/16,1,,UVHE 4 EAST,"Atrial fibrillation, unspecified type",9,0.9,137,,78,28.8,134/77,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z159162,Male,6/10/53,2.00E+11,12/5/19,12/23/19,,,,,,,,,1,2,9/15/14,60 - 65%,12/18/19,65 - 70%,,,,2,2.00E+11,12/5/19,12/23/19,18,3.45,UVHE 4 CENTRAL CV,Other acute osteomyelitis of right foot,9,1.1,138,1.46,94,31.6,157/70,,65 - 70%,,,,,,,,53622979,9/13/14,9/15/14,2,,UVHE 6 CENTRAL,Stroke,14,0.8,139,2.15,82,38.8,136/62,,60 - 65%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z1699308,Male,2/8/43,2.00E+11,9/18/17,9/20/17,1,,1,,,1,,,,6,6/10/18,<15%,6/23/16,40 - 45%,6,4,2,,2.00E+11,6/8/18,6/22/18,14,,UVHE 4 EAST,Ischemic cardiomyopathy,86,3.3,125,1.22,153,20.4,85/53,,<15%,,,,,,,,2.00E+11,9/18/17,9/20/17,2,,UVHE 4 CENTRAL CV,Coronary artery disease involving native coronary artery of native heart without angina pectoris,21,1.1,140,,186,21.2,118/74,,,,,,,1,,,2.00E+11,9/18/17,9/20/17,2,,UVHE 4 CENTRAL CV,Coronary artery disease involving native coronary artery of native heart without angina pectoris,21,1.1,140,,186,21.2,118/74,,,,,,,1,,,6/19/18,1, 32; 26, 1; 6, 12; 12,4,84,4.12,2.4,4.23,2.47,64.3,11/20/18
Z139848,Female,2/17/55,2.00E+11,12/5/19,12/23/19,1,,1,,,1,1,1,,5,1/19/17,20 - 25%,10/17/14,30 - 35%,4,1,,,2.00E+11,12/5/19,12/23/19,18,8.55,UVHE 6 CENTRAL,Acute ischemic right MCA stroke,31,0.8,137,,93,31.7,114/68,,20 - 25%,,,,,1,,1,2.00E+11,10/30/19,11/1/19,2,,UVHE 3 WEST,Pyelonephritis,12,0.9,140,3,101,,146/92,,,,,,,1,,1,2.00E+11,6/1/18,6/4/18,3,,UVHE 6 CENTRAL,Left genital labial abscess,8,0.8,134,2.64,98,,111/64,,,,,,,1,,,,,,,,,,,,,,,10/7/20
Z216497,Male,7/31/59,2.00E+11,11/6/19,11/8/19,1,,,,,,,,,1,11/7/19,20 - 25%,11/7/19,20 - 25%,1,,,,2.00E+11,11/6/19,11/8/19,2,0.95,UVHE 3 NORTH,Syncope and collapse,64,3.5,140,0.29,111,,109/66,,20 - 25%,,,,,,,,11044486,8/17/98,8/21/98,4,,UVHE 5 CENTRAL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11/8/19
Z121216,Female,3/10/48,2.00E+11,1/11/18,1/20/18,,1,1,,,1,1,,,13,3/5/18,<15%,3/24/19,35 - 40%,18,8,,,2.00E+11,3/23/18,5/9/18,47,57.58,UVHE 4 EAST,Cardiogenic shock,17,1.2,137,1.87,114,29,92/58,,20 - 25%,,,,,1,,,2.00E+11,1/11/18,1/20/18,9,8.24,UVHE 4 CENTRAL CV,Acute on chronic systolic heart failure,54,2.3,134,,92,29,107/61,,15 - 20%,,1,,,1,,,2.00E+11,1/11/18,1/20/18,9,8.24,UVHE 4 CENTRAL CV,Acute on chronic systolic heart failure,54,2.3,134,,92,29,107/61,,15 - 20%,,1,,,1,,,3/27/18,25,54,33,41,26,88,2.26,1.21,3,1.61,34.3,
Z868858,Male,8/20/69,2.00E+11,11/20/20,11/25/20,,,1,,,1,1,1,,3,11/7/20,15 - 20%,4/2/17,65 - 70%,6,,,3,2.00E+11,12/3/20,12/11/20,8,7.14,UVHE 4 WEST,Acute on chronic systolic heart failure,36,1.4,136,,113,37.3,103/64,,,,,,,1,,,2.00E+11,11/20/20,11/25/20,5,9.24,UVHE 4 CENTRAL CV,HFrEF (heart failure with reduced ejection fraction),36,1.1,134,2.55,126,,95/57,,15 - 20%,1,,,,1,,,2.00E+11,11/20/20,11/25/20,5,9.24,UVHE 4 CENTRAL CV,HFrEF (heart failure with reduced ejection fraction),36,1.1,134,2.55,126,,95/57,,15 - 20%,1,,,,1,,,,,,,,,,,,,,,
Z147196,Female,5/25/59,2.00E+11,12/31/18,1/5/19,,,1,,,1,1,,,2,1/2/19,20 - 25%,1/2/19,20 - 25%,2,,,,2.00E+11,12/31/18,1/5/19,5,1.95,UVHE 4 EAST,"Type 2 diabetes mellitus with hyperglycemia, without long-term current use of insulin",14,0.7,132,3.46,104,,114/71,,20 - 25%,,1,,,,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z888391,Male,6/15/41,2.00E+11,12/17/17,12/27/17,1,,1,,,,,,,7,2/15/14,<15%,11/20/14,55 - 60%,3,2,,2,2.00E+11,12/17/17,12/27/17,10,9.77,UVHE CORONARY CARE,Hypoxia,32,1.5,138,2.27,111,61.5,90/46,,,,,,,,,,54989874,12/1/14,1/6/15,36,,TCIR TC2B,Obesity hypoventilation syndrome,34,1.1,137,2.27,106,54.1,129/57,,55 - 60%,,,,,1,,,54705620,11/11/14,12/1/14,20,10.9,UVHE 5 WEST,Sepsis,19,1,139,1.53,120,,111/73,,55 - 60%,,,,,,,,12/20/17,24,50,36,41,28,94,4.73,1.57,,,50.1,12/27/17
Z71364,Male,8/1/80,2.00E+11,8/7/20,9/9/20,,,1,,,,,,,6,8/7/20,<15%,8/28/20,15 - 20%,6,,,,2.00E+11,8/7/20,9/9/20,33,14.19,UVHE 4 EAST,Hyperthermia,11,0.8,135,0.86,111,,124/83,,<15%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8/7/20,,33,21,27,15,91,6.18,2.68,,,70.4,
Z553184,Male,10/7/61,2.00E+11,11/29/18,12/19/18,,1,1,,,1,1,1,1,7,11/10/18,15 - 20%,12/17/18,20 - 25%,14,,,,2.00E+11,11/29/18,12/19/18,20,21.6,UVHE 4 EAST,Shock,43,1.3,140,2.82,132,26.4,96/62,,20 - 25%,1,,,,,,,2.00E+11,11/17/18,11/22/18,5,5.38,UVHE 4 CENTRAL CV,Acute systolic heart failure,23,1.2,133,3.45,,26.6,93/61,,15 - 20%,1,,,,1,,,2.00E+11,11/17/18,11/22/18,5,5.38,UVHE 4 CENTRAL CV,Acute systolic heart failure,23,1.2,133,3.45,,26.6,93/61,,15 - 20%,1,,,,1,,1,,,,,,,,,,,,,
Z1369779,Male,8/27/53,2.00E+11,11/17/19,12/1/19,1,,,,,,,,1,2,11/17/19,30 - 35%,11/17/19,30 - 35%,,2,,,2.00E+11,11/17/19,12/1/19,14,8.11,UVHE 4 EAST,NSTEMI (non-ST elevation myocardial infarction),56,2.1,134,0.56,112,31.8,98/62,,30 - 35%,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12/3/19
Z719418,Male,9/29/53,2.00E+11,2/18/19,3/29/19,,,1,,1,1,,1,,8,2/21/19,<15%,2/21/19,<15%,8,,,,2.00E+11,2/18/19,3/29/19,39,15.05,UVHE 4 EAST,Acute on chronic systolic heart failure,14,1.2,133,0.69,157,39.8,104/77,,<15%,,,,,1,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,3/5/19,17,76,38,53,36,92,5.32,2.23,5.63,2.36,49.6,
Z1024990,Male,1/25/59,2.00E+11,1/29/18,2/1/18,1,,,,,,,,,1,1/31/18,15 - 20%,1/31/18,15 - 20%,1,,,,2.00E+11,1/29/18,2/1/18,3,2.71,UVHE CORONARY CARE,Cardiogenic shock,30,1.7,137,1.38,93,26.2,126/56,,15 - 20%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1/30/18,12, 51; 51, 33; 33, 39; 39,31,115,6.3,3,5.67,2.7,47.5,2/1/18
Z305862,Male,12/22/68,2.00E+11,8/8/20,11/4/20,,,,,,,,,,1,3/5/20,55 - 60%,3/5/20,55 - 60%,,,,1,2.00E+11,8/8/20,11/4/20,88,51.06,UVHE 3 WEST,COVID-19 virus infection,10,0.4,139,0.6,99,43.2,132/80,,,,,,,,,,2.00E+11,7/31/20,8/5/20,5,,UVHE 8 WEST,Acute leukemia not having achieved remission,17,0.6,137,0.19,,,167/100,,,1,,,,1,,,2.00E+11,6/30/20,7/8/20,8,,UVHE 8 NORTH ONC,Intra-abdominal infection,7,0.6,141,0.74,113,46.3,165/82,,,1,,,,1,,,,,,,,,,,,,,,
Z1347653,Female,5/16/49,2.00E+11,11/5/17,12/2/17,1,,1,,,1,1,1,1,5,11/5/17,15 - 20%,1/6/16,60 - 65%,1,3,,1,2.00E+11,11/5/17,12/2/17,27,13.04,UVHE 4 EAST,NSTEMI (non-ST elevated myocardial infarction),32,4.6,134,1.1,112,39.6,146/65,,25 - 30%,,,,,,,,64911554,5/2/16,5/8/16,6,,UVHE 5 WEST,"Constipation, unspecified constipation type",33,4.8,136,,,39.2,134/60,,,,,,,1,,,62363266,12/28/15,2/2/16,36,,TCIR TC2B,ESRD on hemodialysis,30,4.8,139,2.67,76,,154/62,,60 - 65%,,,,,,,,11/6/17,19,66,35,45,35,90,4.38,2.2,,,65.5,7/11/19
Z767034,Female,1/28/39,2.00E+11,5/8/20,5/15/20,1,,,,,1,,,,2,5/15/20,50-55%,5/14/20,65 - 70%,,,,2,2.00E+11,5/8/20,5/15/20,7,3.63,UVHE 4 NORTH,Coronary artery disease involving native coronary artery of native heart with unstable angina pectoris,24,1.6,145,,76,32,128/63,,50-55%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5/15/20
Z175536,Male,6/19/61,2.00E+11,1/7/18,1/10/18,1,1,1,,,1,,1,,8,1/26/18,<15%,1/8/15,20 - 25%,16,,,,2.00E+11,1/24/18,1/28/18,4,7.44,UVHE CORONARY CARE,Delirium,54,2.3,135,0.7,162,27.3,130/59,,<15%,,,,,,,,2.00E+11,1/16/18,1/22/18,6,,UVHE 4 WEST,Acute on chronic systolic heart failure,36,2,131,,180,,96/60,,,1,,,,,,,2.00E+11,1/7/18,1/10/18,3,3.14,UVHE 4 WEST,"Laceration of spleen, initial encounter",29,1.9,128,1.12,196,,130/85,,,1,,,,,,,,,,,,,,,,,,,1/28/18
Z242085,Male,2/11/42,2.00E+11,7/28/17,8/27/17,1,,,,,,1,,,10,8/1/17,50-55%,8/8/17,65 - 70%,,,,10,2.00E+11,7/28/17,8/27/17,30,25.87,UVHE 4 NORTH,S/P TVR (tricuspid valve repair),58,0.7,136,1.06,143,30.4,122/59,,50-55%,,,,,,,,4448945,4/18/07,4/25/07,7,,UVHE 4 WEST,,34,1.3,142,,,,,,,,,,,,,,681239,8/11/05,8/15/05,4,,UVHE 4 WEST,,21,1,136,,,,,,,,,,,,,,,,,,,,,,,,,,8/27/17
Z425855,Male,2/2/63,72303478,4/20/17,4/28/17,1,,1,,,1,1,1,,4,7/3/17,15 - 20%,4/20/17,20 - 25%,4,,,,72303478,4/20/17,4/28/17,8,5.98,UVHE 4 EAST,,11,1.3,135,,102,,130/60,,20 - 25%,1,,,,,,,44027818,3/5/13,3/12/13,7,,UVHE 5 WEST,Gangrene of foot,32,3.5,130,1.35,100,26.8,133/65,,,,1,,,,,,20508907,4/19/10,4/27/10,8,,UVHE 5 WEST,,19,1.1,130,,,,,,,,,,,,,,,,,,,,,,,,,,7/27/18
Z145807,Female,8/23/42,2.00E+11,11/11/20,11/18/20,,,,,,1,,1,1,2,11/11/20,55 - 60%,11/11/20,55 - 60%,,,,2,2.00E+11,11/11/20,11/18/20,7,3.79,UVHE 4 WEST,Coronary artery disease involving native coronary artery of native heart without angina pectoris,23,1.3,135,,95,27.4,150/63,,55 - 60%,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z392942,Female,3/7/64,2.00E+11,11/10/19,12/11/19,,,,,,,,,,4,11/11/19,15 - 20%,8/11/20,60 - 65%,2,,1,1,2.00E+11,11/10/19,12/11/19,31,31.04,UVHE 3 NORTH,Acute respiratory failure with hypoxia and hypercapnia,33,0.8,142,0,78,33,139/81,,40 - 45%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z1136379,Female,11/12/38,2.00E+11,2/11/20,2/15/20,1,1,,1,,,,,1,4,2/11/20,25 - 30%,5/19/18,50-55%,,1,1,2,2.00E+11,2/11/20,2/15/20,4,4.06,UVHE MEDICAL ICU,Acute respiratory failure with hypoxia and hypercapnia,45,1.3,139,0.29,85,,111/61,,25 - 30%,,,,,,,,2.00E+11,8/15/18,8/20/18,5,,UVHE 4 WEST,Acute on chronic diastolic heart failure,19,0.9,140,1.68,108,,128/60,,40 - 45%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2/15/20
Z2069558,Female,11/18/55,70722143,2/8/17,3/29/17,1,,1,,,,,,,18,2/9/17,<15%,2/26/17,60 - 65%,17,,,1,70722143,2/8/17,3/29/17,49,18.66,UVHE 4 EAST,Cardiogenic shock,24,0.8,137,0.65,198,25.9,80/0,,15 - 20%,,,,,,1,1,20888042,5/26/10,5/31/10,5,1,UVHE 4 WEST,,23,0.8,136,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,2/23/17,2, 32; 33, 11; 12, 21; 22,13,,3.8,2.36,5.43,3.37,55,1/23/19
Z2105005,Male,12/27/52,2.00E+11,11/27/17,12/4/17,1,,,,,,1,1,1,6,11/27/17,20 - 25%,7/9/14,40 - 45%,1,2,3,,2.00E+11,11/27/17,12/4/17,7,6.62,UVHE 4 EAST,Cardiogenic shock,72,1.4,155,1.9,157,42.1,165/72,,20 - 25%,,,,,,,,2.00E+11,8/14/17,8/25/17,11,,UVHE 4 WEST,"Morbid obesity, unspecified obesity type",50,1.4,135,,156,51.1,101/60,,,,,,,1,,,70970485,2/20/17,2/22/17,2,,UVHE 4 CENTRAL CV,"Acute congestive heart failure, unspecified congestive heart failure type",27,1.1,137,0.9,146,50.8,111/59,,,,,,,1,,1,,,,,,,,,,,,,12/4/17
Z2185662,Female,7/12/47,71262690,3/3/17,3/7/17,1,,1,,,1,1,1,,1,3/4/17,15 - 20%,3/4/17,15 - 20%,1,,,,71262690,3/3/17,3/7/17,4,4.01,UVHE MEDICAL ICU,,109,5.2,135,1.15,116,,101/58,,15 - 20%,,,,,,,,40710981,10/23/12,10/24/12,1,,UVHE 4 WEST,Dyslipidemia,,,,,,24.7,101/55,,,1,,,,,,,32024629,9/28/11,10/21/11,23,13.44,UVHE 4 EAST,,25,0.9,134,1.17,106,31.1,96/54,,,,,,,,,,,,,,,,,,,,,,3/9/17
Z2310159,Male,4/6/46,2.00E+11,10/10/17,10/14/17,,,,,,1,,,,7,10/10/17,15 - 20%,12/17/14,60 - 65%,2,1,2,2,2.00E+11,10/10/17,10/14/17,4,2.56,UVHE 4 EAST,"ST elevation myocardial infarction (STEMI), unspecified artery",18,1,139,1.79,157,,111/68,,15 - 20%,,1,,,,,,46033741,7/2/13,7/4/13,2,0.98,UVHE 4 EAST,NSTEMI (non-ST elevated myocardial infarction),15,1.1,135,1.33,88,35.2,111/59,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,10/11/17,4,23,14,18,5,73,3.23,1.44,3.3,1.47,57.5,
Z2331222,Female,7/28/96,2.00E+11,7/3/17,1/1/18,1,,,1,1,,1,1,,53,9/23/19,<15%,8/20/15,60 - 65%,39,15,15,90,2.00E+11,9/23/19,10/16/19,23,53.7,UVHE CORONARY CARE,Cardiac arrest,70,3.9,133,0,96,29,86/48,,50-55%,,,,,,,,2.00E+11,7/22/19,8/13/19,22,12.57,UVHE 4 WEST,Status post orthotopic heart transplant,26,1.5,141,0.22,88,30.4,108/71,,35 - 40%,1,,,,1,,,2.00E+11,5/13/19,6/10/19,28,63.36,UVHE 4 WEST,Acute rejection of cardiac transplant,30,1.4,138,0.36,100,32.4,117/85,,50-55%,1,,,,1,,,6/12/19,10,26,12,19,10,111,3.88,2.01,3.43,1.78,54.4,10/16/19
Z2475861,Male,6/24/79,2.00E+11,8/9/17,9/11/17,1,1,1,,,,,,,9,7/12/17,<15%,8/28/17,15 - 20%,9,,,,2.00E+11,8/9/17,9/11/17,33,20.35,UVHE 4 EAST,Cardiogenic shock,17,0.9,131,1.62,135,22.9,90/64,,15 - 20%,1,,,,,,1,2.00E+11,8/1/17,8/6/17,5,,UVHE 4 CENTRAL CV,Chronic systolic heart failure,27,1.2,122,,199,,104/68,,,1,,,,,,1,2.00E+11,7/12/17,7/19/17,7,,UVHE 4 CENTRAL CV,Acute on chronic systolic heart failure,20,1,127,,168,24.5,115/68,,<15%,1,,,,,,1,8/21/17,16,36,16,24,18,88,4.11,2.23,,,57.7,11/27/18
Z185178,Female,4/4/86,2.00E+11,5/14/18,5/27/18,1,1,1,,,,,,,4,5/16/18,15 - 20%,7/3/14,40 - 45%,1,2,1,,2.00E+11,5/14/18,5/27/18,13,10.12,UVHE CORONARY CARE,Cardiogenic shock,18,0.9,137,2.7,172,27.3,97/63,,15 - 20%,1,,,,1,,1,2.00E+11,2/9/18,2/12/18,3,1.06,UVHE 6 CENTRAL,Acute ischemic left ICA stroke,10,0.7,140,,177,31.9,128/72,,35 - 40%,1,,,,,,1,46718108,8/19/13,8/22/13,3,,UVHE 4 EAST,Atrial fibrillation,14,0.8,138,,114,,112/64,,,1,,,,,1,,,,,,,,,,,,,,8/22/18
Z1230070,Male,2/18/52,2.00E+11,2/27/19,3/12/19,,,1,,,1,1,,,1,2/28/19,<15%,2/28/19,<15%,1,,,,2.00E+11,2/27/19,3/12/19,13,7.83,UVHE 4 WEST,Permanent atrial fibrillation,53,1.6,133,0.36,148,,84/58,,<15%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z533768,Male,8/23/26,2.00E+11,11/23/18,11/23/18,1,,,,,,,,,1,6/18/18,35 - 40%,6/18/18,35 - 40%,,1,,,2.00E+11,11/23/18,11/23/18,0,0.18,UVHE CORONARY CARE,Cardiogenic shock,75,4.9,130,,213,,90/47,,,,,,,,,,2.00E+11,6/15/18,6/18/18,3,,UVHE 5 WEST,"Mediastinal hematoma, initial encounter",32,1.6,135,,138,21.6,137/63,,35 - 40%,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11/23/18
Z1801451,Male,5/31/37,2.00E+11,7/9/18,7/12/18,1,1,1,,,,1,,,4,3/13/15,20 - 25%,6/8/15,25 - 30%,1,3,,,2.00E+11,7/9/18,7/12/18,3,2.58,UVHE 4 CENTRAL CV,Cardiogenic shock,23,1.3,130,1.59,141,21.1,118/77,,,,,,,,,,2.00E+11,4/25/18,4/27/18,2,,UVHE 3 EAST,FTT (failure to thrive) in adult,40,1.5,130,,114,,,,,,,,,,,,2.00E+11,2/15/18,2/17/18,2,,UVHE 4 CENTRAL CV,Decreased strength,48,1.2,134,1.35,108,27.4,81/59,,25 - 30%,,1,,,1,,1,,,,,,,,,,,,,8/21/18
Z101721,Male,10/13/57,2.00E+11,10/31/17,11/11/17,1,,1,,,1,1,,,4,11/6/17,20 - 25%,5/30/17,40 - 45%,1,1,2,,2.00E+11,10/31/17,11/11/17,11,10.13,UVHE 4 NORTH,"Non-ST elevation myocardial infarction (NSTEMI), type 2",42,1.4,137,,115,,83/73,,20 - 25%,,,,,,,,2.00E+11,10/16/17,10/18/17,2,,UVHE 4 EAST,Near syncope,14,0.8,139,,101,29,,,,1,,,,,,,73121215,5/29/17,6/7/17,9,,UVHE 6 CENTRAL,"Cerebrovascular accident (CVA), unspecified mechanism",13,0.7,137,,107,31.8,145/70,,40 - 45%,1,,,,1,,1,,,,,,,,,,,,,11/11/17
Z665575,Male,4/2/62,2.00E+11,7/27/18,8/6/18,,1,1,,,1,,,,2,7/28/18,15 - 20%,11/19/18,25 - 30%,1,1,,,2.00E+11,7/27/18,8/6/18,10,4.95,UVHE 4 EAST,Cardiogenic shock,33,1,133,3.78,84,18.3,110/71,,15 - 20%,1,,,,1,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z123342,Male,11/2/45,2.00E+11,12/29/17,1/3/18,1,1,1,,,1,1,,1,3,1/14/15,15 - 20%,12/1/13,25 - 30%,2,1,,,2.00E+11,12/29/17,1/3/18,5,,UVHE 4 CENTRAL CV,"Congestive heart failure, unspecified congestive heart failure chronicity, unspecified congestive heart failure type",30,1.9,133,0.92,168,,115/64,,15 - 20%,1,,,,1,,,72089230,4/11/17,4/12/17,1,,UVHE 4 CENTRAL CV,"Acute renal failure, unspecified acute renal failure type",31,1.9,139,,197,,121/74,,,1,,,,1,,,71150552,2/27/17,2/28/17,1,,UVHE 5 WEST,Pain of upper abdomen,13,1.2,138,1.35,170,,123/58,,,1,,,,1,,,,,,,,,,,,,,,5/24/18
Z415863,Male,11/22/62,2.00E+11,6/24/20,8/14/20,,,1,,,,1,,,8,6/27/20,20 - 25%,10/3/18,60 - 65%,1,6,,1,2.00E+11,6/24/20,8/14/20,51,24.1,UVHE 4 EAST,S/P ICD (internal cardiac defibrillator) procedure,17,1.3,141,1.59,109,31.7,102/71,,30 - 35%,1,,,,,,,2.00E+11,10/2/18,10/5/18,3,1.59,UVHE 6 CENTRAL,"Cerebrovascular accident (CVA), unspecified mechanism",10,0.9,138,,,,174/79,,60 - 65%,1,,,,,,,2.00E+11,12/17/17,12/17/17,0,,UVHE EMERGENCY DEPT,Burn,12,1,130,1.82,77,32.8,104/65,,,,,,,,,,9/25/20,12, 59; 62, 27; 27, 39; 40, 19; 21; 25,57,4.35,2.2,3.83,1.94,44.4,
Z87463,Female,5/24/50,2.00E+11,11/29/18,2/9/19,1,1,,1,,1,1,1,,12,9/26/14,60 - 65%,12/19/17,>70%,,,,12,2.00E+11,11/29/18,2/9/19,72,18.12,UVHE 4 EAST,Cardiogenic shock,35,2.7,134,0.49,132,21.3,106/56,,60 - 65%,,,,,,,,2.00E+11,9/2/18,9/12/18,10,2.18,UVHE 5 CENTRAL,Rectal bleeding,27,1.3,139,1.03,116,,125/54,,,,,,,1,,,2.00E+11,1/8/18,1/17/18,9,,UVHE 5 CENTRAL,Hematochezia,26,1.2,139,,,,117/56,,,,,,,1,,1,12/27/18,6,82,26,45, 21; 20; 18,90,2.44,1.34,3.13,1.72,42.3,10/7/19
Z295030,Male,2/2/64,2.00E+11,11/21/17,12/14/17,1,,1,,,,,1,,12,9/17/20,15 - 20%,3/7/14,60 - 65%,12,6,2,4,2.00E+11,4/11/18,4/21/18,10,11.16,UVHE 3 WEST,Delirium tremens,16,1.9,135,1.36,146,,145/80,,20 - 25%,,,,,1,,,2.00E+11,2/22/18,2/24/18,2,,UVHE 3 WEST,Acute systolic heart failure,31,2.3,133,,151,,106/65,,,,,,,1,,,2.00E+11,2/5/18,2/10/18,5,,UVHE 3 CENTRAL,Acute hepatitis,30,2.3,132,1.09,154,,89/52,,20 - 25%,,,,,1,,,11/28/17,31,58,27,42,28,71,5.09,2.5,3.87,1.9,61.6,10/1/20
Z70778,Female,7/20/65,2.00E+11,3/4/18,4/3/18,,1,1,,,,,,,6,10/23/17,<15%,1/15/16,35 - 40%,4,2,,,2.00E+11,3/4/18,4/3/18,30,9.71,UVHE 4 EAST,"Acute congestive heart failure, unspecified congestive heart failure type",29,1,139,1.72,84,39.7,96/58,,<15%,,,,,,,,2.00E+11,12/12/17,12/18/17,6,,UVHE 4 WEST,Acute on chronic systolic congestive heart failure,31,0.9,141,,96,,122/73,,,,1,,,1,,,2.00E+11,10/20/17,10/28/17,8,,UVHE 4 WEST,Acute on chronic systolic congestive heart failure,25,1,143,1.69,100,,157/79,,<15%,,1,,,1,,,,,,,,,,,,,,,
Z1160705,Male,1/20/51,2.00E+11,9/20/18,10/18/18,,,,,,,,,,3,9/21/18,60 - 65%,9/21/18,60 - 65%,,,,6,2.00E+11,10/22/18,10/29/18,7,14.88,UVHE 3 NORTH,Shock,27,0.7,149,0.71,96,,158/75,,,,,,,,,,2.00E+11,9/20/18,10/18/18,28,55.78,UVHE 3 NORTH,"Respiratory failure with hypercapnia, unspecified chronicity",42,1.1,146,1.35,86,,153/78,,60 - 65%,,,,,,,,2.00E+11,9/20/18,10/18/18,28,55.78,UVHE 3 NORTH,"Respiratory failure with hypercapnia, unspecified chronicity",42,1.1,146,1.35,86,,153/78,,60 - 65%,,,,,,,,,,,,,,,,,,,,
Z1164798,Female,5/3/34,2.00E+11,9/24/20,9/30/20,1,,,,,,,,,2,9/25/20,20 - 25%,9/27/20,35 - 40%,1,1,,,2.00E+11,9/24/20,9/30/20,6,5.43,UVHE CORONARY CARE,Complete heart block,62,3.3,132,1.18,147,,110/42,,35 - 40%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9/24/20,13,42,20,29,17,85,3.65,2.22,,,72.3,9/30/20
Z121216,Female,3/10/48,2.00E+11,3/23/18,5/9/18,,1,1,,,1,1,,,13,3/5/18,<15%,3/24/19,35 - 40%,18,8,,,2.00E+11,3/23/18,5/9/18,47,57.58,UVHE 4 EAST,Cardiogenic shock,17,1.2,137,1.87,114,29,92/58,,20 - 25%,,,,,1,,,2.00E+11,1/11/18,1/20/18,9,8.24,UVHE 4 CENTRAL CV,Acute on chronic systolic heart failure,54,2.3,134,,92,29,107/61,,15 - 20%,,1,,,1,,,2.00E+11,1/11/18,1/20/18,9,8.24,UVHE 4 CENTRAL CV,Acute on chronic systolic heart failure,54,2.3,134,,92,29,107/61,,15 - 20%,,1,,,1,,,3/27/18,25,54,33,41,26,88,2.26,1.21,3,1.61,34.3,
Z70413,Male,10/10/69,2.00E+11,5/10/20,6/8/20,,,1,,,1,1,,,3,5/11/20,25 - 30%,2/12/19,40 - 45%,,2,1,,2.00E+11,5/10/20,6/8/20,29,1.58,UVHE 4 CENTRAL CV,ST elevation myocardial infarction involving right coronary artery,47,1.7,136,4.81,115,,135/74,,25 - 30%,1,,,,1,,1,2.00E+11,2/11/19,2/13/19,2,1.96,UVHE MEDICAL ICU,Status post below knee amputation of left lower extremity,19,0.8,131,2.87,,,140/86,,40 - 45%,1,,,,,,1,2.00E+11,3/29/18,3/31/18,2,,UVHE 3 WEST,Hypoglycemia,15,0.6,133,2.07,79,,102/65,,,1,,,,,,,5/14/20,20,62,34,46,34,78,3.28,1.61,2.77,1.36,50.6,
Z1333562,Female,7/22/48,2.00E+11,8/18/18,10/2/18,1,,,,,1,1,1,,12,8/20/18,15 - 20%,5/14/15,60 - 65%,1,2,5,4,2.00E+11,8/18/18,10/2/18,45,11.71,UVHE 3 WEST,Cardiogenic shock,36,3.7,136,8.07,121,22.7,92/52,,35 - 40%,,,,,,,,58433841,6/4/15,7/9/15,35,,TCIR TC2B,AKI (acute kidney injury),65,3.1,134,5.36,,,104/51,,,,,,,,,,57673834,4/23/15,6/4/15,42,39.67,UVHE 4 NORTH,Atrial flutter,53,1.5,134,6.09,62,28.9,133/54,,60 - 65%,1,,,,1,,,,,,,,,,,,,,,11/16/18
Z325361,Male,2/27/46,2.00E+11,3/6/18,3/9/18,,,,,,1,,,,9,8/9/18,<15%,6/9/20,20 - 25%,9,,,,2.00E+11,3/6/18,3/9/18,3,1.64,UVHE 4 EAST,VT (ventricular tachycardia),37,1.9,139,,123,28.1,114/77,,15 - 20%,,,,,,,,2.00E+11,2/24/18,2/28/18,4,1.94,UVHE 4 EAST,VT (ventricular tachycardia),31,2,142,0.73,124,40.6,95/63,,15 - 20%,1,,,,,,,2.00E+11,10/21/17,10/25/17,4,2.98,UVHE 4 CENTRAL CV,Complete heart block,21,1,137,0.78,136,31.4,117/74,,,1,,,,,,,,,,,,,,,,,,,
Z1846382,Male,3/20/70,2.00E+11,7/20/17,7/31/17,,,,,1,,,,,28,10/26/13,<15%,7/10/19,60 - 65%,12,3,4,9,2.00E+11,7/20/17,7/31/17,11,6.79,UVHE 4 EAST,Chronic systolic heart failure,27,1.2,137,1,133,29.8,109/62,,15 - 20%,,,,,,,1,72433183,4/26/17,4/27/17,1,1.25,UVHE CORONARY CARE,"Left ventricular assist device (LVAD) complication, initial encounter",19,1,139,,114,,101/81,,,,,,,,,1,55415540,12/26/14,12/27/14,1,,UVHE 4 EAST,Left ventricular assist device (LVAD) complication,18,0.9,138,1.82,124,,84/0,,,1,,,,,,1,12/7/17, 7; 5, 30; 30, 19; 16, 22; 23,11,80,4.59,2.08,5.9,2.67,59.2,
Z228560,Female,11/21/80,2.00E+11,3/30/19,5/10/19,,1,1,,,,1,,,8,6/25/18,<15%,8/8/17,15 - 20%,8,,,,2.00E+11,3/30/19,5/10/19,41,9.2,UVHE 4 EAST,Severe nausea and vomiting that has lasted a long time,12,0.8,137,2.44,129,46.3,70/0,,15 - 20%,,1,,,1,,1,2.00E+11,6/22/18,6/26/18,4,,UVHE 4 EAST,NICM (nonischemic cardiomyopathy),34,1.1,133,2.47,148,,90/53,,<15%,,1,,,,,1,2.00E+11,12/15/17,12/23/17,8,,UVHE 4 EAST,Acute on chronic systolic heart failure,30,1.2,131,3.66,142,46.7,104/63,,,,1,,,,,1,9/24/18,10,44,28,35,17,86,3.53,1.46,4.63,1.91,58,
Z1002839,Male,2/25/59,2.00E+11,8/7/17,8/13/17,1,,,,,,,,,4,8/13/17,15 - 20%,8/8/17,55 - 60%,1,,1,2,2.00E+11,8/7/17,8/13/17,6,1.66,UVHE CORONARY CARE,Acute systolic heart failure,36,2.2,135,1.04,93,,91/49,,15 - 20%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8/13/17
Z414739,Male,2/26/53,2.00E+11,5/30/19,6/14/19,,,,,,,,,,5,6/5/19,25 - 30%,6/4/19,60 - 65%,,2,,3,2.00E+11,5/30/19,6/14/19,15,11.4,UVHE 4 WEST,S/P MVR (mitral valve repair),49,1.3,137,0.79,144,23.7,127/64,,55 - 60%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z946846,Female,5/29/77,2.00E+11,4/30/20,5/6/20,,,,,,,,,,2,4/30/20,30 - 35%,5/4/20,55 - 60%,,1,,1,2.00E+11,4/30/20,5/6/20,6,4.73,UVHE 5 WEST,"Acute renal failure, unspecified acute renal failure type",38,2.6,138,1.7,76,,130/65,,55 - 60%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z652429,Male,11/26/66,2.00E+11,1/8/20,1/17/20,1,,1,,,,1,,,5,1/8/20,<15%,2/12/16,25 - 30%,4,1,,,2.00E+11,1/8/20,1/17/20,9,9.59,UVHE CORONARY CARE,Shock,24,1.3,146,1.17,112,37,106/56,,<15%,,,,,,,,2.00E+11,6/14/17,6/17/17,3,,UVHE 3 WEST,Acute combined systolic and diastolic HF (heart failure),18,1.2,135,2.27,82,34.4,112/64,,,,1,,,1,,,68722272,11/8/16,11/10/16,2,,UVHE 6 EAST,"Closed fracture of distal end of right radius with delayed healing, unspecified fracture morphology, subsequent encounter",17,1,140,,,35.7,137/80,,,,1,,,1,,,,,,,,,,,,,,,1/17/20
Z396846,Male,11/21/47,2.00E+11,11/18/17,2/15/18,1,,1,,,1,1,,1,18,11/24/17,<15%,11/19/17,20 - 25%,18,,,,2.00E+11,11/18/17,2/15/18,89,88.95,UVHE TCV POST OP,Chronic systolic heart failure,77,0.8,143,0.48,124,27.3,86/60,,15 - 20%,,,,,,,,2.00E+11,7/5/17,7/9/17,4,,UVHE 4 WEST,Acute on chronic systolic heart failure,19,1.1,142,1.97,133,,100/71,,,,,,,1,,,2.00E+11,6/9/17,6/19/17,10,4.06,UVHE 4 CENTRAL CV,Acute combined systolic and diastolic HF (heart failure),34,1.4,136,,128,,93/59,,,,,,,1,,,11/20/17,20,48,25,33,23,73,2.49,1.26,2,1.01,45.4,3/11/18
Z142517,Male,4/28/58,2.00E+11,10/4/20,10/10/20,1,,,,,,1,,,2,8/14/20,40 - 45%,10/5/20,55 - 60%,,,1,1,2.00E+11,10/4/20,10/10/20,6,5.59,UVHE CORONARY CARE,Shock,82,5.2,155,2.3,93,,135/50,,55 - 60%,,,,,,,,2.00E+11,1/10/20,1/15/20,5,,UVHE 5 WEST,"Type 2 diabetes mellitus with hyperglycemia, with long-term current use of insulin",23,1,140,,,24.8,150/84,,,1,,,,,,,2.00E+11,8/13/19,8/16/19,3,,UVHE 6 WEST,Acute prostatitis,10,0.9,138,,,,124/79,,,1,,,,,,,,,,,,,,,,,,,10/10/20
Z826542,Male,8/7/43,2.00E+11,2/13/18,2/20/18,,1,1,,,,,,,4,2/14/18,15 - 20%,4/19/18,45 - 50%,2,1,1,,2.00E+11,2/13/18,2/20/18,7,4.92,UVHE 4 EAST,Nonrheumatic aortic valve stenosis,19,1.1,135,2.06,92,31.8,90/57,,20 - 25%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2/14/18,26,46,30,37,29,120,2.89,1.35,,,35.2,
Z113096,Female,7/6/77,70791377,2/11/17,2/19/17,,,,,,1,1,1,,2,2/12/17,<15%,2/14/17,50-55%,2,,,2,2.00E+11,9/19/18,9/26/18,7,,UVHE 6 EAST,"CKD (chronic kidney disease), stage IV",62,3.5,138,,107,30.8,129/73,,,,1,,,,,,70791377,2/11/17,2/19/17,8,11.22,UVHE 4 WEST,ARDS (adult respiratory distress syndrome),45,2,136,,66,34.9,111/59,,50-55%,1,,,,1,,,70791377,2/11/17,2/19/17,8,11.22,UVHE 4 WEST,ARDS (adult respiratory distress syndrome),45,2,136,,66,34.9,111/59,,50-55%,1,,,,1,,,,,,,,,,,,,,,
Z82474,Male,9/16/63,71301409,3/6/17,3/6/17,1,,,,,,,,,3,5/22/14,60 - 65%,5/22/14,60 - 65%,,,,3,71301409,3/6/17,3/6/17,0,0.05,UVHE MEDICAL ICU,Cardiogenic shock,90,2.7,131,0.93,103,,102/46,,,,,,,,,,61479034,11/11/15,11/18/15,7,,UVHE 5 CENTRAL,,6,0.5,137,0.89,60,27.3,110/61,,60 - 65%,,,,,,1,,60538497,9/24/15,9/25/15,1,,UVHE 3 WEST,Melena,8,0.5,138,0.77,52,,119/74,,,,,,,,1,,,,,,,,,,,,,,3/6/17
Z277512,Male,2/27/75,2.00E+11,8/23/18,9/8/18,,,,,,,,,,1,8/24/18,65 - 70%,8/24/18,65 - 70%,,,,1,2.00E+11,8/23/18,9/8/18,16,10.84,UVHE 3 WEST,VF (ventricular fibrillation),29,4.2,137,1,94,32.8,129/81,,65 - 70%,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z124550,Female,3/9/60,2.00E+11,10/16/17,11/16/17,1,1,1,,,,,1,,14,2/3/18,<15%,10/18/17,50-55%,18,6,2,2,2.00E+11,11/20/17,12/8/17,18,22.06,UVHE 4 EAST,PAF (paroxysmal atrial fibrillation),82,2,131,,153,22.9,107/53,,15 - 20%,,,,,1,,,2.00E+11,10/16/17,11/16/17,31,61.2,UVHE 4 NORTH,Mitral valve disorder,94,1.7,146,0.24,140,20.7,118/55,,20 - 25%,,1,,,1,,,2.00E+11,10/16/17,11/16/17,31,61.2,UVHE 4 NORTH,Mitral valve disorder,94,1.7,146,0.24,140,20.7,118/55,,20 - 25%,,1,,,1,,1,12/4/17, 6; 6,35,16,24,13,80,2.4,1.53,3.97,2.53,51.3,6/25/18
Z406988,Male,12/23/68,2.00E+11,11/28/17,12/8/17,,1,,,,,,,,1,11/29/17,20 - 25%,11/29/17,20 - 25%,1,,,,2.00E+11,11/28/17,12/8/17,10,,UVHE 4 EAST,Essential hypertension,23,2.1,137,0.24,99,27.7,157/87,,20 - 25%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12/4/17,9, 51; 51, 25; 25, 34; 35, 15; 18,92,7.31,3.38,7.33,3.39,57.3,
Z2307669,Female,6/8/58,2.00E+11,6/12/18,6/29/18,1,,,1,,,,1,,17,8/11/15,40 - 45%,2/1/19,65 - 70%,,,2,15,2.00E+11,6/12/18,6/29/18,17,13.2,UVHE 4 WEST,ESRD (end stage renal disease),20,4.8,136,,122,31.1,95/52,,55 - 60%,,,,,,,,2.00E+11,7/4/17,7/15/17,11,1.87,UVHE 4 EAST,ESRD (end stage renal disease),35,6.2,132,,121,31.6,96/55,,60 - 65%,,,,,,,,57959943,5/20/15,5/25/15,5,2.7,UVHE 4 WEST,Mitral regurgitation,46,4.8,128,,80,29.8,131/63,,,,1,,,1,,,,,,,,,,,,,,,2/12/20
Z2410584,Female,12/21/51,2.00E+11,9/17/19,9/17/19,1,,,,,,,,1,1,12/4/14,60 - 65%,12/4/14,60 - 65%,,,,1,2.00E+11,9/17/19,9/17/19,0,0.16,UVHE CORONARY CARE,Cardiogenic shock,65,2.3,145,0.75,124,20.2,165/101,,,,,,,,,,55031347,12/3/14,12/15/14,12,2.93,UVHE 4 WEST,Aortic stenosis,17,0.8,134,2.72,68,17.9,129/56,,60 - 65%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9/17/19
Z2492441,Male,10/6/41,2.00E+11,6/30/17,7/6/17,1,,,,,,,,,1,7/1/17,15 - 20%,7/1/17,15 - 20%,1,,,,2.00E+11,6/30/17,7/6/17,6,6.02,UVHE CORONARY CARE,Cardiogenic shock,55,1.7,131,0.09,115,,86/57,,15 - 20%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7/12/17
Z2518126,Male,12/18/65,2.00E+11,9/14/17,10/8/17,,,,,,1,1,,,8,10/25/16,55 - 60%,7/14/17,60 - 65%,,,,8,2.00E+11,9/14/17,10/8/17,24,7,UVHE 4 WEST,Paroxysmal atrial fibrillation,65,3,133,2.76,140,35.4,126/80,,60 - 65%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2554875,Female,9/28/55,2.00E+11,10/1/17,10/16/17,1,,,1,1,,,,,17,1/22/18,50-55%,10/12/17,60 - 65%,,,,17,2.00E+11,10/1/17,10/16/17,15,13.66,UVHE 4 WEST,Heart transplanted,27,1.2,130,0.69,91,29.7,127/60,,55 - 60%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/9/17,14,41,17,25,15,89,3.95,2.05,5,2.6,50.2,7/21/19
Z2678380,Male,12/3/78,2.00E+11,6/25/18,8/3/18,1,,1,,,,,,,7,6/26/18,<15%,7/8/18,15 - 20%,7,,,,2.00E+11,6/25/18,8/3/18,39,24.37,UVHE 4 EAST,Chronic systolic congestive heart failure,12,0.8,136,0.76,178,27.7,80/0,,<15%,1,,,,1,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,6/29/18,29,64,40,50,40,92,5.01,2.11,5.8,2.45,41.8,5/16/19
Z2678901,Female,7/17/97,2.00E+11,2/5/19,2/18/19,,,,,,,,,,7,2/6/19,<15%,2/10/19,50-55%,3,2,,2,2.00E+11,2/5/19,2/18/19,13,9.99,UVHE 4 EAST,Cardiogenic shock,11,0.6,137,1.02,78,18.9,100/67,,50-55%,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2680925,Female,12/8/49,2.00E+11,6/13/18,6/26/18,,,1,,,,,,,1,6/14/18,15 - 20%,6/14/18,15 - 20%,1,,,,2.00E+11,6/13/18,6/26/18,13,7.85,UVHE 4 EAST,Cardiogenic shock,23,1.2,137,,97,20.2,118/76,,15 - 20%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2697921,Male,8/2/18,2.00E+11,10/10/18,10/29/18,,,,,,,,,,,,,,,,,,,2.00E+11,10/10/18,10/29/18,19,6.11,UVHE 7 WEST,Double outlet right ventricle,18,0.3,131,4.32,58,11.8,96/42,,,,,,,,,1,2.00E+11,8/2/18,9/20/18,49,49.02,UVHE NEWBORN ICU,Double outlet right ventricle,5,0.2,140,5.33,,9.5,80/50,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2723573,Female,7/30/43,2.00E+11,10/3/18,10/11/18,1,,,,,,,,,1,10/3/18,60 - 65%,10/3/18,60 - 65%,,,,1,2.00E+11,10/3/18,10/11/18,8,0.77,UVHE CORONARY CARE,Non-rheumatic mitral regurgitation,36,1.9,135,1.28,154,,,,60 - 65%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/11/18
Z2728857,Male,4/23/45,2.00E+11,3/8/19,3/19/19,1,1,,,,,,,,6,12/20/18,15 - 20%,10/18/18,20 - 25%,6,,,,2.00E+11,3/8/19,3/19/19,11,7.89,UVHE 4 EAST,Cardiogenic shock,131,5.5,140,,103,31.8,71/46,,15 - 20%,,,,,1,,,2.00E+11,1/20/19,1/28/19,8,,UVHE 4 EAST,"Acute on chronic congestive heart failure, unspecified heart failure type",46,1.9,136,,100,34.2,107/66,,15 - 20%,,,,,1,,,2.00E+11,1/11/19,1/15/19,4,,UVHE 4 EAST,Paroxysmal atrial fibrillation,36,1.7,135,1.43,107,33.6,93/55,,15 - 20%,1,,,,1,,,3/11/19,12,59,20,38,29,64,7.23,3.25,,,69.7,3/23/19
Z2745440,Male,2/10/49,2.00E+11,11/19/18,1/5/19,1,,1,,,1,,,,7,12/7/18,15 - 20%,11/20/18,25 - 30%,5,2,,,2.00E+11,11/19/18,1/5/19,47,32.77,UVHE 4 EAST,Coronary artery disease involving native coronary artery of native heart without angina pectoris,10,1.1,133,0.25,0,26.6,86/0,,20 - 25%,1,,,,1,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/26/20
Z2772726,Female,5/2/49,2.00E+11,1/29/19,2/17/19,1,,,,,,,,,3,2/1/19,20 - 25%,2/16/19,60 - 65%,1,1,,1,2.00E+11,1/29/19,2/17/19,19,18.41,UVHE CORONARY CARE,Cardiogenic shock,8,1.2,138,1.84,129,48,126/74,,60 - 65%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2/17/19
Z2862133,Male,4/4/32,2.00E+11,10/16/19,11/20/19,,,,,,1,,1,,8,10/21/19,<15%,11/3/19,60 - 65%,1,2,2,3,2.00E+11,10/16/19,11/20/19,35,33.61,UVHE 4 NORTH,S/P TAVR (transcatheter aortic valve replacement),41,1.1,141,0.51,81,25.8,102/58,,35 - 40%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2979355,Male,5/1/45,2.00E+11,8/13/20,8/14/20,1,,,,,,,,,1,8/14/20,15 - 20%,8/14/20,15 - 20%,1,,,,2.00E+11,8/13/20,8/14/20,1,0.93,UVHE CORONARY CARE,Shock,33,1.6,127,0.61,119,33.5,79/58,,15 - 20%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8/14/20
Z3006570,Male,9/19/75,2.00E+11,11/30/20,12/7/20,1,,1,,,1,1,,,2,12/1/20,<15%,12/1/20,<15%,2,,,,2.00E+11,11/30/20,12/7/20,7,1.72,UVHE 4 NORTH,Cardiogenic shock,45,2,141,0.4,124,35.8,98/54,,<15%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12/7/20
Z248509,Male,11/23/69,2.00E+11,9/20/19,11/9/19,,,,,,,,,,9,9/24/19,45 - 50%,9/25/19,60 - 65%,,,1,8,2.00E+11,9/20/19,11/9/19,50,16.06,UVHE 4 WEST,Paroxysmal atrial fibrillation,52,1.1,140,0,102,27.5,95/58,,55 - 60%,,,,,,,,37474329,6/15/12,6/16/12,1,,UVHE 6 WEST,,16,0.9,135,,,33.7,106/59,,,,,,,1,,,15237884,2/2/09,2/6/09,4,,UVHE 4 CENTRAL CV,,16,0.8,137,0.68,,,,,,,,,,,,,,,,,,,,,,,,,
Z1191606,Male,10/9/68,2.00E+11,6/8/20,6/28/20,1,1,1,,,1,,,,9,5/27/20,<15%,10/4/18,15 - 20%,9,,,,2.00E+11,6/8/20,6/28/20,20,18.7,UVHE 4 NORTH,Chronic systolic heart failure,56,2.3,135,1.2,102,30.7,100/73,,<15%,,,,,,,,2.00E+11,3/23/18,3/28/18,5,,UVHE 4 EAST,,27,1.3,135,2.83,115,29.6,109/72,,,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6/28/20
Z84203,Male,12/21/42,2.00E+11,12/10/20,1/5/21,1,,,,,1,1,,,6,12/15/20,40 - 45%,11/18/20,55 - 60%,,,1,5,2.00E+11,12/10/20,1/5/21,26,26.23,UVHE 4 NORTH,Coronary artery disease involving native coronary artery of native heart with angina pectoris,35,1,134,0.27,142,29.5,109/50,,50-55%,,,,,,,,34531485,1/24/12,1/26/12,2,,UVHE 6 EAST,Fracture of ankle,13,0.9,132,,,26.6,138/65,,,,,,,,,,8901324,11/20/03,11/23/03,3,,UVHE 5 WEST,,69,12.2,138,,,,,,,,,,,,,,11/20/20,20,53,26,38, 28; 27,56,3.77,1.93,3.67,1.87,57.15,1/5/21
Z132915,Male,11/26/45,2.00E+11,4/1/18,4/11/18,1,,1,,,1,,,1,3,3/8/18,15 - 20%,3/11/14,20 - 25%,3,,,,2.00E+11,4/1/18,4/11/18,10,5.26,UVHE CORONARY CARE,"Atrial flutter, unspecified type",46,2.5,135,0.63,177,21.4,97/50,,15 - 20%,,,,,1,,,2.00E+11,3/23/18,3/28/18,5,,UVHE 4 CENTRAL CV,Status post below knee amputation of right lower extremity,16,1,138,,158,23.9,119/69,,,1,,,,1,,,2.00E+11,3/8/18,3/11/18,3,1,UVHE 4 EAST,Paroxysmal atrial fibrillation,18,1.1,137,,130,,116/59,,15 - 20%,,,,,,,,,,,,,,,,,,,,7/2/18
Z74090,Female,7/22/51,2.00E+11,5/4/19,5/21/19,,1,1,,,1,1,1,,6,12/28/18,30 - 35%,10/9/20,45 - 50%,,3,3,,2.00E+11,5/4/19,5/21/19,17,5.88,UVHE 4 EAST,Heart block,24,1.6,138,1.51,151,52.9,143/63,,35 - 40%,1,,,,,,,2.00E+11,4/10/19,4/14/19,4,,UVHE 4 EAST,Systolic heart failure,40,2.3,140,,176,55.2,113/57,,,1,,,,,,,2.00E+11,1/18/19,1/22/19,4,,UVHE 4 EAST,"Acute on chronic congestive heart failure, unspecified heart failure type",46,1.8,139,,172,55.2,126/57,,,1,,,,1,,,5/10/19,10,31,16,21,12,92,6.47,2.59,6.83,2.74,60.8,
Z225789,Female,1/4/54,2.00E+11,5/18/18,6/2/18,,1,1,,,1,,,,5,5/20/18,20 - 25%,11/9/18,35 - 40%,3,2,,,2.00E+11,5/18/18,6/2/18,15,4.84,UVHE 4 CENTRAL CV,Cardiogenic shock,24,0.9,125,,105,,109/58,,20 - 25%,,,,,,,,38249240,7/2/12,7/6/12,4,,UVHE 4 CENTRAL CV,Acute kidney injury,15,0.8,137,1.68,104,28.6,129/68,,,1,,,,1,,,34982454,2/10/12,2/14/12,4,2.95,UVHE 4 CENTRAL CV,,10,0.7,138,1.63,78,25.1,122/67,,,,,,,,,,,,,,,,,,,,,,
Z1699308,Male,2/8/43,2.00E+11,6/8/18,6/22/18,1,,1,,,1,,,,6,6/10/18,<15%,6/23/16,40 - 45%,6,4,2,,2.00E+11,6/8/18,6/22/18,14,,UVHE 4 EAST,Ischemic cardiomyopathy,86,3.3,125,1.22,153,20.4,85/53,,<15%,,,,,,,,2.00E+11,9/18/17,9/20/17,2,,UVHE 4 CENTRAL CV,Coronary artery disease involving native coronary artery of native heart without angina pectoris,21,1.1,140,,186,21.2,118/74,,,,,,,1,,,2.00E+11,9/18/17,9/20/17,2,,UVHE 4 CENTRAL CV,Coronary artery disease involving native coronary artery of native heart without angina pectoris,21,1.1,140,,186,21.2,118/74,,,,,,,1,,,6/19/18,1, 32; 26, 1; 6, 12; 12,4,84,4.12,2.4,4.23,2.47,64.3,11/20/18
Z747583,Male,12/13/55,2.00E+11,10/24/17,11/6/17,,1,1,,,,,,,5,10/24/17,<15%,11/1/18,55 - 60%,3,,,2,2.00E+11,10/24/17,11/6/17,13,0.95,UVHE 4 CENTRAL CV,Cardiogenic shock,17,1.1,138,2.01,93,35.7,101/76,,<15%,1,,,,1,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,11/1/17,21,49,25,37,27,56,4.43,1.79,,,54.9,
Z178410,Female,6/25/37,2.00E+11,4/5/19,4/19/19,,,,,,1,,,,3,4/5/19,30 - 35%,4/10/19,45 - 50%,,2,1,,2.00E+11,4/5/19,4/19/19,14,8.81,UVHE 4 EAST,Cardiogenic shock,17,1.1,133,1.47,116,26.2,101/67,,45 - 50%,,,,,,,,52377921,7/7/14,7/11/14,4,2.24,UVHE 6 WEST,Pneumocephalus,14,0.7,138,1.01,82,,113/55,,,,,,,,,,10101335,11/12/03,11/15/03,3,,UVHE 4 CENTRAL CV,,14,0.8,138,,,,,,,,,,,,,,,,,,,,,,,,,,
Z145779,Female,12/20/57,2.00E+11,11/15/17,11/26/17,,1,1,,,,,1,,5,11/15/17,20 - 25%,9/14/15,40 - 45%,2,1,2,,2.00E+11,11/15/17,11/26/17,11,7.05,UVHE 4 EAST,Hypokalemia,39,0.9,138,0.51,148,35.9,109/57,,20 - 25%,1,,,,,,1,60319817,9/14/15,9/16/15,2,,UVHE 4 WEST,ACS (acute coronary syndrome),10,0.7,140,1.55,120,36.4,121/58,,40 - 45%,,,,,,,1,30378440,7/20/11,7/23/11,3,,UVHE 8 WEST,S/P TAH-BSO,6,0.7,138,,,37.7,135/79,,,,,,,,,,,,,,,,,,,,,,
Z135203,Female,9/16/40,2.00E+11,9/7/17,9/10/17,1,,1,,,1,,1,1,2,9/1/15,15 - 20%,9/1/15,15 - 20%,2,,,,2.00E+11,9/7/17,9/10/17,3,2.57,UVHE CORONARY CARE,Ischemic cardiomyopathy,38,1.9,135,2.11,113,27.7,98/56,,,,,,,,,,2.00E+11,8/10/17,8/11/17,1,,UVHE 4 WEST,,56,2.3,137,4.2,110,,92/54,,,1,,,,1,,,68173243,10/10/16,10/11/16,1,,UVHE 6 CENTRAL,"Atrial flutter, unspecified type",21,1.7,138,,168,,112/56,,15 - 20%,1,,,,1,,1,,,,,,,,,,,,,9/10/17
Z104044,Male,9/18/52,2.00E+11,5/13/18,5/18/18,1,1,1,,,1,1,1,1,17,6/13/14,20 - 25%,2/18/14,60 - 65%,7,7,2,1,2.00E+11,5/13/18,5/18/18,5,4.9,UVHE 3 NORTH,Shock,45,1.8,137,1.15,142,,116/56,,20 - 25%,,,,,,,,2.00E+11,3/2/18,3/5/18,3,,UVHE 3 WEST,Encephalopathy acute,36,1.8,141,0.86,174,,149/84,,,,,,,1,,,2.00E+11,2/9/18,2/11/18,2,,UVHE 3 EAST,AKI (acute kidney injury),50,1.8,138,0.74,175,,119/66,,,,,,,1,,,,,,,,,,,,,,,5/18/18
Z280774,Female,3/1/63,2.00E+11,5/14/18,6/13/18,,1,,,,,1,1,,23,9/8/14,35 - 40%,5/25/18,60 - 65%,,1,4,18,2.00E+11,5/14/18,6/13/18,30,25.21,UVHE 4 WEST,Non-rheumatic mitral regurgitation,14,1.2,133,0.87,84,35.9,115/65,,50-55%,,,,,,,,2.00E+11,3/31/18,4/11/18,11,,UVHE 4 EAST,SOB (shortness of breath),18,1.3,136,,105,38.5,128/62,,50-55%,,,,,1,,,2.00E+11,1/27/18,2/3/18,7,,UVHE 3 CENTRAL,"Community acquired pneumonia, unspecified laterality",29,1.2,136,0.18,66,38.5,137/87,,55 - 60%,,,,,1,,,4/9/18, 11; 11,62,34,42, 17; 15,71,2.24,1.15,3.1,1.59,44,
Z443978,Female,1/21/43,2.00E+11,12/13/18,12/17/18,1,,1,,,,1,,,7,10/9/17,40 - 45%,12/16/18,65 - 70%,,,1,6,2.00E+11,12/13/18,12/17/18,4,2.65,UVHE CORONARY CARE,Cardiogenic shock,35,1.5,142,0,101,,128/58,,65 - 70%,,,,,,,,2.00E+11,10/18/17,10/22/17,4,,UVHE 3 EAST,"Knee pain, unspecified chronicity, unspecified laterality",14,0.6,141,,,,150/71,,,1,,,,1,,,54760156,11/15/14,12/30/14,45,,TCIR TC2B,Other severe protein-calorie malnutrition,7,0.5,136,3.93,,,132/59,,,,,,,,,,,,,,,,,,,,,,12/17/18
Z573719,Female,12/29/43,2.00E+11,9/4/17,9/18/17,,,,,,1,1,,,4,9/5/17,25 - 30%,9/7/17,30 - 35%,,4,,,2.00E+11,9/4/17,9/18/17,14,10.33,UVHE 4 WEST,S/P CABG x 2,19,0.9,134,2.01,100,35.1,116/69,,25 - 30%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9/6/17,14,51,22,32,23,61,5.17,2.82,,,70.6,
Z162359,Male,1/5/68,2.00E+11,10/2/18,10/13/18,1,1,1,,,,,1,,12,9/20/18,30 - 35%,7/3/18,60 - 65%,,3,5,4,2.00E+11,10/2/18,10/13/18,11,9.82,UVHE 4 WEST,Cardiogenic shock,21,3.7,135,,134,,69/51,,35 - 40%,,,,,,,,2.00E+11,8/16/18,9/27/18,42,26.97,UVHE 4 WEST,Status post tricuspid valve repair,32,5,138,0.22,107,24.7,74/51,,30 - 35%,,,,,,,,2.00E+11,7/1/18,7/7/18,6,2.86,UVHE 4 EAST,,59,7.9,142,,132,24.2,85/60,,50-55%,,,,,1,,,,,,,,,,,,,,,11/15/18
Z75053,Male,6/23/68,2.00E+11,9/27/17,10/14/17,1,1,1,1,,,,,1,6,2/17/17,20 - 25%,7/29/14,55 - 60%,2,3,,1,2.00E+11,9/27/17,10/14/17,17,2.45,UVHE CORONARY CARE,Acute on chronic systolic heart failure,52,2.9,130,0.36,149,33.3,92/32,,20 - 25%,,,,,,,,66825764,8/5/16,8/7/16,2,,UVHE 4 CENTRAL CV,Acute idiopathic gout involving toe of left foot,32,1.1,138,1.34,134,,123/62,,35 - 40%,,,,,1,,,52787838,7/28/14,8/19/14,22,18.67,UVHE 3 WEST,Hyperthyroidism secondary to amiodarone,15,1,141,1.28,182,34.4,104/58,,55 - 60%,1,,,,1,,,,,,,,,,,,,,,10/14/17
Z1458914,Male,5/11/72,72331509,4/20/17,5/22/17,,,1,,,,,,,7,4/21/17,<15%,4/25/17,15 - 20%,7,,,,72331509,4/20/17,5/22/17,32,18.38,UVHE 4 EAST,Acute systolic heart failure,30,0.7,131,0.34,94,19.6,97/66,,15 - 20%,,,,,1,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,5/18/17,15,41,22,30,18,94,3.94,2.29,4.73,2.75,45.9,
Z855163,Male,9/21/75,2.00E+11,3/21/18,4/13/18,,1,1,,,,1,1,,4,3/22/18,<15%,2/27/19,20 - 25%,4,,,,2.00E+11,3/21/18,4/13/18,23,12.35,UVHE 4 EAST,Acute systolic heart failure,27,2.1,137,1.59,145,29.8,94/62,,15 - 20%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4/9/18,0,32,10,18,12,90,5.81,2.69,6.3,2.92,52,
Z1836407,Male,11/27/61,2.00E+11,6/20/17,7/5/17,,1,,,,1,,,,3,6/26/17,20 - 25%,5/8/17,25 - 30%,1,2,,,2.00E+11,6/20/17,7/5/17,15,6.62,UVHE 4 EAST,Cardiogenic shock,48,1.2,130,0.73,102,27.2,124/61,,20 - 25%,,,,,,,,72670676,5/7/17,5/11/17,4,3.66,UVHE MEDICAL ICU,Shock,27,1.2,132,1.18,80,26.9,130/102,,25 - 30%,1,,,,,,,72071679,4/10/17,4/20/17,10,,UVHE 5 CENTRAL,"Type 2 diabetes mellitus with complication, without long-term current use of insulin",22,0.7,135,1.03,80,,142/72,,,,,,,,,,6/21/17,23,70,34,49,36,85,4.41,2.46,5.23,2.92,55.9,
Z784258,Male,4/26/48,69955067,1/7/17,1/11/17,,,,,,,,,,,,,,,,,,,69955067,1/7/17,1/11/17,4,3.93,UVHE CORONARY CARE,Cardiogenic shock,58,1.4,124,,126,24.2,109/59,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1/9/17, 20; 21,51,25,39,24,,3.33,1.64,3.73,1.84,50,
Z677138,Male,4/22/49,2.00E+11,6/21/19,7/15/19,,1,,,,1,1,1,,6,6/23/19,20 - 25%,10/29/18,50-55%,2,4,,6,2.00E+11,6/26/20,7/2/20,6,,UVHE 4 CENTRAL CV,Cardiogenic shock,34,1.7,142,0.81,108,,117/56,,,,1,,,1,,,2.00E+11,12/10/19,12/15/19,5,2.3,UVHE 4 WEST,Hx of CABG,40,1.6,139,,108,31.5,124/58,,,,1,,,1,,,2.00E+11,6/21/19,7/15/19,24,31.8,UVHE 4 WEST,Coronary artery disease involving native coronary artery of native heart without angina pectoris,36,4.4,136,1.84,103,31.5,115/56,,30 - 35%,,1,,,1,,,6/23/19,13,64,25,43,30,77,3.08,1.46,3.43,1.63,51.3,
Z416867,Male,5/18/95,70856574,2/15/17,5/12/17,1,,,,,,1,,,12,2/15/17,15 - 20%,4/1/14,60 - 65%,1,,1,10,70856574,2/15/17,5/12/17,86,28.61,UVHE 4 WEST,Diabetes mellitus related to cystic fibrosis,32,0.9,141,1.55,78,22.6,94/52,,60 - 65%,,,,,,,,69769477,12/27/16,2/2/17,37,21.3,UVHE 4 WEST,Acute hypoxemic respiratory failure,34,0.9,139,1.5,76,26.2,116/72,,55 - 60%,,,,,,,,69065550,11/19/16,11/23/16,4,,UVHE 4 WEST,AKI (acute kidney injury),19,1.3,141,1.82,,,109/72,,,,,,,,,,,,,,,,,,,,,,2/26/18
Z977261,Female,11/16/71,2.00E+11,10/11/19,10/18/19,1,,,,,,,,,3,10/12/19,15 - 20%,10/14/19,50-55%,1,,1,1,2.00E+11,10/11/19,10/18/19,7,6.67,UVHE 4 NORTH,"Motor vehicle collision, initial encounter",32,1.1,137,,108,38.6,112/55,,45 - 50%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/18/19
Z184013,Female,12/1/56,71904106,4/1/17,4/13/17,,,,,,1,,,,7,4/9/17,50-55%,1/30/17,60 - 65%,,,,7,71904106,4/1/17,4/13/17,12,5.18,UVHE 4 WEST,Nonrheumatic aortic valve stenosis,19,0.8,135,,84,25,108/60,,60 - 65%,,,,,1,,,71412749,3/24/17,3/30/17,6,1.89,UVHE 4 WEST,S/P AVR,17,0.8,136,,132,20.1,101/55,,55 - 60%,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z908051,Female,6/16/30,2.00E+11,8/25/19,8/29/19,,,,,,,,,,1,8/25/19,25 - 30%,8/25/19,25 - 30%,,1,,,2.00E+11,8/25/19,8/29/19,4,3.63,UVHE 4 EAST,Cardiogenic shock,21,1.1,137,1.9,104,27.5,139/78,,25 - 30%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z294865,Male,2/1/31,2.00E+11,2/22/19,3/20/19,1,1,,,,,,,,7,10/24/17,15 - 20%,2/27/19,55 - 60%,1,4,,2,2.00E+11,2/22/19,3/20/19,26,13.09,UVHE CORONARY CARE,Chronic systolic heart failure,136,4.3,135,0.89,144,,70/48,,55 - 60%,,,,,,,,2.00E+11,5/4/18,5/7/18,3,,UVHE 4 CENTRAL CV,Acute on chronic systolic heart failure,39,1.5,138,1.62,141,,103/70,,30 - 35%,,,,,1,,,2.00E+11,10/24/17,11/18/17,25,4.13,UVHE 4 WEST,Acute on chronic systolic heart failure,36,1.3,141,0.76,154,25.9,121/75,,15 - 20%,1,,,,1,,,,,,,,,,,,,,,3/20/19
Z193530,Male,7/12/43,2.00E+11,10/24/19,10/31/19,,,1,1,1,1,1,1,,30,10/25/19,15 - 20%,12/13/13,65 - 70%,1,,1,28,2.00E+11,10/24/19,10/31/19,7,3.95,UVHE 4 EAST,S/P orthotopic heart transplant,62,1.9,137,0.09,124,31.1,115/69,,55 - 60%,,,,,,,,2.00E+11,10/18/19,10/21/19,3,,UVHE 4 EAST,Sepsis due to urinary tract infection,25,1.6,135,0.79,112,,122/76,,,,,,,,,,64878196,4/29/16,4/29/16,0,,UVHE SHORT STAY UNIT,Other acute appendicitis,24,1.9,137,1.27,94,,118/73,,,,,,,,,,11/18/19, 8; 9,28,14,20,12,90,4.93,2.28,6.37,2.95,62.5,
Z511618,Male,8/9/45,71596010,3/19/17,4/15/17,,,1,,,1,,1,1,3,3/21/17,<15%,6/5/19,20 - 25%,3,,,,71596010,3/19/17,4/15/17,27,17.51,UVHE 4 EAST,PAF (paroxysmal atrial fibrillation),38,1.1,134,1.37,164,20.6,106/59,,<15%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z823619,Male,4/6/60,2.00E+11,10/31/19,11/19/19,1,,1,,,,,,,4,4/2/19,<15%,4/2/19,<15%,4,,,,2.00E+11,10/31/19,11/19/19,19,7.99,UVHE 4 EAST,Acute on chronic systolic heart failure,49,2.1,136,0.91,187,31.2,99/69,,<15%,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,11/7/19,6,64,32,42,30,77,3.1,1.52,1.87,0.92,57.2,5/16/20
Z672015,Female,11/24/44,2.00E+11,5/20/19,6/9/19,1,,,,,,1,1,,1,5/21/19,20 - 25%,5/21/19,20 - 25%,1,,,,2.00E+11,5/20/19,6/9/19,20,19.69,UVHE SURG TRAM ICU,Cardiogenic shock,131,2.1,137,,114,27.2,86/42,,20 - 25%,,,,,,,,44167805,3/12/13,3/13/13,1,,UVHE 8 NORTH OB,Preop testing,13,1.2,138,,,25.5,151/61,,,,,,,1,,,16622164,3/24/05,3/27/05,3,,UVHE 8 WEST GYN,,8,0.7,135,,,,,,,,,,,,,,5/22/19,8,45,27,33,24,102,6.35,3.51,4.2,2.32,70.3,6/9/19
Z2495487,Male,11/14/54,72209871,4/16/17,4/24/17,,,,,,,,,,2,4/17/17,20 - 25%,4/20/17,25 - 30%,1,1,,,72209871,4/16/17,4/24/17,8,6,UVHE 4 CENTRAL CV,Cardiogenic shock,16,1.3,139,1.64,78,,118/60,,25 - 30%,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2554879,Female,5/20/39,70582676,2/2/17,2/11/17,,,,,,,,,,3,2/3/17,60 - 65%,12/28/16,>70%,,,,6,2.00E+11,11/26/19,12/4/19,8,,UVHE 4 WEST,Acute on chronic respiratory failure with hypoxia,43,1.4,142,,,42.5,118/56,,60 - 65%,,,,,1,,,71107391,2/28/17,3/10/17,10,9.06,UVHE 4 EAST,Persistent atrial fibrillation,46,1.2,137,,90,33.6,116/57,,,,,,,1,,,70582676,2/2/17,2/11/17,9,9.38,UVHE 3 WEST,Acute respiratory failure with hypoxia,29,1.2,136,0.77,90,36.2,100/58,,60 - 65%,,,,,1,,,,,,,,,,,,,,,
Z2561103,Female,12/30/08,70299152,1/21/17,1/24/17,1,,,,,,,,,,,,,,,,,,70299152,1/21/17,1/24/17,3,2.67,UVHE PEDIATRIC ICU,Septic shock,49,4,156,0,74,,81/37,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1/24/17
Z2562056,Male,7/6/40,2.00E+11,11/21/17,11/29/17,1,,1,,,1,1,,,3,6/10/17,20 - 25%,8/3/17,25 - 30%,2,1,,,2.00E+11,11/21/17,11/29/17,8,1.35,UVHE 4 EAST,Cachexia associated with cardiac disease,52,1.4,139,,91,20.1,97/64,,20 - 25%,,,,,1,,1,2.00E+11,6/9/17,6/14/17,5,0.9,UVHE 4 EAST,NSTEMI (non-ST elevated myocardial infarction),35,1.3,136,1.04,94,22.2,90/55,,20 - 25%,1,,,,1,,1,72553054,5/2/17,5/9/17,7,4.86,UVHE 4 EAST,Coronary artery disease involving native coronary artery of native heart without angina pectoris,48,1.4,135,1.25,86,24.1,94/61,,,1,,,,1,,1,,,,,,,,,,,,,2/2/18
Z2598377,Male,3/18/60,2.00E+11,11/24/17,12/20/17,,1,1,,,,,,,3,8/24/17,<15%,4/8/19,15 - 20%,3,,,,2.00E+11,11/24/17,12/20/17,26,10.79,UVHE 4 EAST,Cardiogenic shock,10,0.7,136,0.5,125,26.4,86/0,,,,,,,1,,1,2.00E+11,10/27/17,11/13/17,17,2.85,UVHE 4 EAST,Hyponatremia,35,1,126,,163,25.8,99/63,,<15%,,,,,,,1,2.00E+11,8/23/17,8/31/17,8,1.08,UVHE 4 CENTRAL CV,Dilated cardiomyopathy secondary to alcohol,14,1.1,136,0.96,150,37.9,103/79,,<15%,,1,,,,,1,8/28/17,11,64,37,49,31,96,3.29,1.73,3.17,1.67,50.9,
Z2610906,Female,6/29/68,2.00E+11,9/14/17,9/20/17,1,,,,,,,,,1,9/15/17,55 - 60%,9/15/17,55 - 60%,,,,1,2.00E+11,9/14/17,9/20/17,6,5.79,UVHE CORONARY CARE,Cardiogenic shock,57,2.4,120,0.59,74,45,52/37,,55 - 60%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9/15/17,15,69,31,45,,,,,3.63,1.53,43.1,9/20/17
Z2619713,Male,2/5/60,2.00E+11,7/17/20,7/19/20,1,,,,,,,,,1,7/17/20,30 - 35%,7/17/20,30 - 35%,,1,,,2.00E+11,7/17/20,7/19/20,2,1.47,UVHE CORONARY CARE,Cardiogenic shock,65,3.9,142,0,115,,102/64,,30 - 35%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7/19/20
Z2629033,Male,8/1/40,2.00E+11,11/28/17,12/3/17,,,,,,1,,,,2,11/29/17,20 - 25%,11/29/17,20 - 25%,2,,,,2.00E+11,11/28/17,12/3/17,5,2.88,UVHE 4 CENTRAL CV,Cardiogenic shock,24,1,139,0.73,149,24.2,127/59,,20 - 25%,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2629926,Male,11/30/17,2.00E+11,1/1/18,1/11/18,,,,,,,,,,,,,,,,,,,2.00E+11,1/1/18,1/11/18,10,6.3,UVHE 7 CENTRAL,Nonrheumatic aortic valve stenosis,16,0.4,138,5.22,,14.3,83/61,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2642077,Male,6/1/79,2.00E+11,7/9/19,8/20/19,1,1,1,,,,1,1,,4,5/22/19,<15%,8/13/19,35 - 40%,3,1,,,2.00E+11,7/9/19,8/20/19,42,26.7,UVHE 4 NORTH,NICM (nonischemic cardiomyopathy),11,1,154,0.11,136,30,98/45,,35 - 40%,,,,,,,,2.00E+11,5/22/19,5/25/19,3,,UVHE 4 CENTRAL CV,Acute on chronic systolic heart failure,31,1.8,138,1.49,,32.1,110/73,,,,,,,,,,2.00E+11,3/22/19,3/28/19,6,,UVHE 4 CENTRAL CV,Acute on chronic systolic heart failure,37,1.8,141,1.28,127,,112/72,,,,,,,,,,7/24/19,23, 73; 70, 43; 44, 54; 56, 52; 42,134,5,2.07,,,39,8/20/19
Z2658271,Male,7/29/46,2.00E+11,3/20/18,4/11/18,,,,,,1,,,,3,3/21/18,15 - 20%,3/23/18,30 - 35%,1,2,,,2.00E+11,3/20/18,4/11/18,22,20.27,UVHE 4 WEST,LV dysfunction,41,1,140,0.64,98,,114/64,,30 - 35%,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2671938,Male,3/31/83,2.00E+11,5/5/18,5/11/18,,1,1,,,,,,,14,5/5/18,15 - 20%,6/3/19,25 - 30%,13,1,,,2.00E+11,5/5/18,5/11/18,6,2.18,UVHE 4 EAST,Acute systolic heart failure,18,0.9,136,2.32,126,23.6,101/60,,15 - 20%,1,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,5/9/18,7,38,16,26,15,101,4.49,2.51,3.8,2.12,66.1,
Z2673388,Female,11/19/50,2.00E+11,5/10/18,7/27/18,1,,1,,,,1,,,25,5/11/18,<15%,10/20/18,25 - 30%,48,2,,,2.00E+11,9/10/18,10/4/18,24,2.78,UVHE 4 EAST,Gastrointestinal hemorrhage with melena,10,0.7,138,,49,29.5,111/69,,15 - 20%,,1,,,,,,2.00E+11,8/6/18,8/14/18,8,,UVHE 4 EAST,Chronic systolic heart failure,11,0.7,138,3.54,57,29.7,104/71,,15 - 20%,,,,,1,,,2.00E+11,5/10/18,7/27/18,78,70.96,UVHE 4 EAST,LVAD (left ventricular assist device) present,16,0.6,140,2.04,66,29.8,94/54,,20 - 25%,,,,,1,,,8/13/18,5,37,8,19,5,74,3.46,2.02,4.27,2.49,63,10/26/19
Z2765794,Female,6/13/92,2.00E+11,2/18/19,3/20/19,,1,,,1,,,,,21,2/18/19,25 - 30%,3/13/19,60 - 65%,,1,,20,2.00E+11,2/18/19,3/20/19,30,11.65,UVHE 4 WEST,S/P orthotopic heart transplant,17,0.7,137,0.92,86,32.2,139/71,,55 - 60%,1,,,,1,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,3/18/19,13,35,16,24, 19; 19,86,5.84,2.8,4.63,2.22,66.6,
Z2771176,Male,3/12/56,2.00E+11,1/23/19,4/3/19,1,,,,1,1,1,1,,17,1/26/19,15 - 20%,4/1/19,>70%,8,,,9,2.00E+11,1/23/19,4/3/19,70,69.37,UVHE 4 NORTH,Cardiogenic shock,12,1.2,148,0.84,85,22.6,131/73,,>70%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4/3/19
Z2776413,Male,3/6/71,2.00E+11,2/19/19,3/15/19,,,,,1,,,,,19,2/20/19,<15%,3/20/19,60 - 65%,3,,,16,2.00E+11,2/19/19,3/15/19,24,15.2,UVHE 4 WEST,S/P kidney transplant,18,0.9,135,1.96,94,30.4,94/59,,55 - 60%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3/13/19,3,25,11,17,7,94,5.51,3.23,5.03,2.95,66,
Z2778189,Male,12/24/51,2.00E+11,2/22/19,2/24/19,1,,,,,,,,,1,2/23/19,<15%,2/23/19,<15%,1,,,,2.00E+11,2/22/19,2/24/19,2,1.93,UVHE CORONARY CARE,Cardiogenic shock,22,3,134,0.44,120,,152/74,,<15%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2/24/19
Z2790166,Male,7/1/58,2.00E+11,4/5/19,4/12/19,1,,,,,,,,,2,4/7/19,<15%,4/6/19,15 - 20%,2,,,,2.00E+11,4/5/19,4/12/19,7,6.37,UVHE CORONARY CARE,ST elevation myocardial infarction (STEMI) involving other coronary artery of inferior wall,45,3.1,134,1.08,111,33.6,117/41,,<15%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4/12/19
Z2809278,Male,6/9/70,2.00E+11,6/11/19,6/26/19,1,,,,,1,,,,8,6/15/19,<15%,6/12/19,20 - 25%,8,,,,2.00E+11,6/11/19,6/26/19,15,14.95,UVHE 4 NORTH,Cardiogenic shock,46,2.8,139,2.63,148,41.6,89/55,,20 - 25%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6/11/19,12,42,32,35,21,118,6.91,2.49,7.2,2.59,68.7,6/26/19
Z2825755,Female,5/11/58,2.00E+11,7/26/19,8/17/19,,,1,,,1,,,,11,4/28/20,20 - 25%,12/2/19,55 - 60%,2,,6,3,2.00E+11,7/26/19,8/17/19,22,21.35,UVHE 4 NORTH,Cardiogenic shock,30,0.5,135,1.67,59,23.9,97/69,,45 - 50%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2839125,Male,9/15/56,2.00E+11,8/25/19,10/2/19,,,1,,,1,1,1,,7,8/26/19,<15%,4/15/20,15 - 20%,7,,,,2.00E+11,8/25/19,10/2/19,38,23.09,UVHE 4 EAST,Cardiogenic shock,30,1,131,0.19,125,21.9,68/0,,<15%,1,,,,1,,1,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,8/26/19,5, 43; 50, 22; 19, 29; 31, 17; 17,83,3.36,1.83,3.2,1.74,62.2,
Z2887631,Male,8/7/65,2.00E+11,12/17/19,1/23/20,1,,1,,,,,,,8,12/18/19,<15%,1/10/20,20 - 25%,8,,,,2.00E+11,12/17/19,1/23/20,37,22.7,UVHE 4 EAST,AKI (acute kidney injury),23,2.6,136,1.98,102,26.5,95/65,,20 - 25%,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3/14/20
Z2903685,Female,2/3/20,2.00E+11,6/4/20,7/20/20,,,,,1,,,,,,,,,,,,,,2.00E+11,6/4/20,7/20/20,46,32.37,UVHE 7 WEST,"Chronic heart failure, unspecified heart failure type",14,0.2,138,0.91,65,13.4,83/44,,,1,,,,,,,2.00E+11,4/24/20,5/4/20,10,4.98,UVHE 7 WEST,Congenitally corrected TGA (transposition of great arteries),12,0.5,131,10.26,,13.7,75/47,,,1,,,,,,,2.00E+11,2/4/20,2/5/20,1,0.74,UVHE NEWBORN ICU,Term birth of infant,,,,,69,10.5,70/42,,,,,,,,,,,,,,,,,,,,,,
Z2921358,Female,4/19/58,2.00E+11,4/17/20,5/15/20,1,,1,,,1,,,,1,4/18/20,20 - 25%,4/18/20,20 - 25%,1,,,,2.00E+11,4/17/20,5/15/20,28,5.05,UVHE 4 EAST,Cardiogenic shock,55,1.2,127,0.84,85,25.4,107/62,,20 - 25%,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5/4/20,15,39,21,27,21,75,1.97,1.17,2.23,1.32,43.8,9/11/20
Z2935577,Male,4/12/59,2.00E+11,5/26/20,6/5/20,1,,,,,,,,,1,5/26/20,25 - 30%,5/26/20,25 - 30%,,1,,,2.00E+11,5/26/20,6/5/20,10,10.2,UVHE CORONARY CARE,Cardiac arrest,32,1.2,152,3.81,165,,170/60,,25 - 30%,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6/8/20
Z2976960,Male,3/5/64,2.00E+11,8/7/20,8/15/20,,,,,,,,,,1,8/7/20,25 - 30%,8/7/20,25 - 30%,,1,,,2.00E+11,8/7/20,8/15/20,8,4,UVHE 3 EAST,Cardiogenic shock,64,1.6,144,,84,,161/74,,25 - 30%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Z2996441,Male,4/15/50,2.00E+11,10/8/20,10/11/20,1,,1,,,,,,,1,10/9/20,15 - 20%,10/9/20,15 - 20%,1,,,,2.00E+11,10/8/20,10/11/20,3,2.8,UVHE MEDICAL ICU,Cardiogenic shock,118,8.5,127,0.63,248,28.9,99/55,,15 - 20%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/11/20